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The use of microbial platforms for the production of commercially valuable compounds has 
grown over the last few decades as concern over the sustainability of other production methods, 
such as extraction and chemical synthesis, has been come into question. Advancements in the 
understanding of microbial metabolism and regulation with the aid of -omics research, and a 
steady increase in the number of available genetic tools, has allowed model organisms such as 
the bacteria Escherichia coli and the yeast Saccharomyces cerevisiae to be engineered for high 
titre production of a number of value products. The economical production of these compounds 
on an industrial scale can, however, be hampered by the toxicity of a given end-product upon 
accumulation in culture. The mode of action by which these products interfere with cellular 
homeostasis is often multifaceted, making it difficult to address. As such, considerable research 
has gone into developing strategies to minimize this microbial toxicity in platform hosts; 
including engineering strains for increased tolerance, and the development of fermentation 
strategies for the in situ removal of toxic end-products. These efforts have had mixed success, 
with the microbial titres of a number of value compounds continuing to be limited due low 
tolerance thresholds of the host.  
In this work, an alternative strategy for minimizing the toxicity of value alcohols in E. coli was 
investigated. This strategy involved the in vivo sequestration of an endogenously produced 
alcohol into a more neutral short/medium chain ester via enzyme mediated esterification by an 
alcohol acyl transferase (AAT). The rationale behind this strategy being that the incorporation of 
a toxic alcohol into a less toxic ester molecule may facilitate higher product accumulation in 
culture, as the ester end-product would be minimally inhibitory. Further, the alcohol component 
of the ester could be easily recovered downstream through hydrolysis, while the recovered acid 
component could be recycled as substrate for this strategy in future cultures. In this work, the 
feasibility of this detoxification strategy was first validated and then applied to two 
commercially valuable alcohols in E. coli. The first alcohol to which this strategy was applied 
was the proposed gasoline alternative short chain alcohol, butanol, which is detrimental to 
culture health when present at concentrations above 1.5% (v/v); and the second alcohol trialled 
was the common flavour and fragrance constituent monoterpene alcohol, geraniol, which is 
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NADP   Nicotinamide Adenine Dinucleotide 
nM   Nanomolar 
nm  Nanometers 
NP  Nitrophenyl 
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NRP  Nonribosomal peptide 
OD   Optical density 
PCR   Polymerase chain reaction 
PFE  Pseudomonas fluorescens esterase 
pH   Power of hydrogen 
PMD  Mevalonate pyrophosphate decarboxylase 
PMK  Phosphomevalonate kinase 
POH   Perillyl alcohol 
Pta-Ack Phosphotransacetylase-acetate kinase 
RBS  Ribosomal binding site 
RNA   Ribonucleic acid 
ROS  Reactive oxygen species 
Rpm    Rotations per minute 
RT-PCR Reverse transcription polymerase chain reaction 
RT-qPCR  Reverse transcription quantitative polymerase chain reaction 
TAE  Tris-acetate-EDTA buffer 
TB   Terrific Broth 
Ter  Trans-2-enoyl reductase 
TRY  Titre, rate, yield 
USD   United States Dollars 
WHO  World Health Organization 
v/v   Volume/volume 












1. General Introduction 
 
 
1.1 Natural products and their biological origin  
 
The natural compounds produced by plants, bacteria, and fungi comprise a broad diversity of 
structures and functionalities and can serve as a rich pool of molecules for incorporation into 
food and beverages, flavour and fragrances, pharmaceuticals, industrial chemicals and biofuels 
(Pickens et al., 2011; Gil-Chavez et al., 2013). These compounds can be divided into two 
overarching biological groups: primary metabolites and secondary metabolites. Primary 
metabolites, also called central metabolite, play a key role in maintaining physiological 
processes and are essential for proper growth and development (Irchhaiya et al., 2015; Gil-
Chavez et al., 2013). Examples of primary metabolites include the building blocks for 
macromolecules such as nucleotides and amino acids, coenzymes such as vitamins, and 
fermentation products such as organic acids and alcohols (Andrio and Demain, 2010). 
Secondary metabolites, on the other hand, are not integral to growth and development, but rather 
play a role in ecological function, including defence and attraction (Wink, 2004; Lee et al., 
2013). Examples of these include antibiotics such as penicillin, and odour components such as 
esters and terpenes. Humans have a long history of utilising both the primary and secondary 
metabolites produced by plant, fungi and bacteria for their own applications. The consumption 
of ethanolic beverages such as wine fermented from yeast dates back 7,000 years ago, while the 
use of plant material for medicine dates back as far as 60, 000 years ago (Fabricant and 
Farnsworth, 2001; Chamber and Pretorius, 2010).  
Plants, specifically, have proven to be prolific producers of commercially valuable secondary 
metabolites, which can be divided into five groups based on their biosynthetic origin: 
isoprenoids (terpenes), alkaloids, polyketides, phenylpropanoids and flavonoids (Oksman-
Caldentey and Inzé, 2004; Gil-Chavez et al., 2013). The magnitude of chemodiversity produced 
by plants is a consequence of their immovability, requiring that they develop alternative 
strategies to mediate functions such as defence against herbivores/pathogens, interaction with 
pollinators, plant-plant signalling, protection against abiotic stressors etc., (Pickens et al., 2011; 
Gil-Chavez et al., 2013; Moore et al., 2014). Thousands of these plant products have been 
17 
 
purposed as medications, cosmetics, fragrances, dyes, nutraceuticals and industrial chemicals. 
Arguable, the most significant contribution plant secondary metabolites have made has been to 
the pharmaceutical industry, with 11% of the 252 drugs the World Health Organization (WHO) 
considers basic and essential being exclusively of plant origin, and a significant number of 
synthetic drugs coming from natural precursors. An excellent example of plant derived 
medication would be the anti-inflammatory agent, acetylsalicyclic acid (commercially known as 
Aspirin) which is derived from the bark of Salix alba L. (willow tree) (Rates, 2001; Der 
Marderosian and Beutler, 2002; Dias et al., 2012; Liu et al., 2017). Outside of the 
pharmaceutical industry plant derived compounds have many applications. Compounds such as 
vanillin and frambinone from orchid pods and raspberry fruit, respectively, are used as 
flavouring agents in food and beverages, while the fragrant essential oils of a number of 
flowering species have long been used in cosmetics and perfumes (Sinha et al., 2008; Preedy, 
2015). The individual components of these oil mixtures, mostly terpenes, have also been isolated 
and employed in multiple industries. An example is the monoterpene geraniol, from Palmarosa, 
which is an ingredient in 76% of deodorants on the European market and 41% of domestic and 
household products, in addition it is used as an insect repellent, antimicrobial agent and potential 
anti-cancer drug (Burke et al., 1997; Rastogi et al., 1998; Rastogi et al., 2001; Barnard and Xue, 
2004; Chen et al., 2010).  
In addition to plants, a number of fungal, and bacterial microorganisms have proven to be a 
valuable source of secondary metabolites with commercial application – especially as antibiotic 
agents. Respectively, bacteria and fungi accounting for 70% and 30% of total natural product 
antibiotics derived from microorganisms. As with plants, these compounds are made by the host 
to mediate interaction with the surrounding environment, including interspecies competition for 
resources and predation. Of the bacterially derived antibiotics, an impressive 75% come from 
actinomycetes, which includes the prolific Streptomyces genus (Bérdy, 2005; Pickens et al., 
2011). Though many other genera of bacteria – including bacilli, myxobacteria and several 
marine bacteria – produce a number of complex secondary metabolites with potential for human 
application (Kim et al., 2016). The largest groups of secondary metabolites produced by bacteria 
include: polyketides, such as tetracycline and erythromycin, β-lactams such as cephamycin, and 
nonribosomal peptides (NRPs), such as vancomycin. Fungi, as well, produce a number of 
valuable polyketides, peptide based compounds, and terpenoids; many of which are medically 
important, including: the β-lactam antibiotic penicillin, terpenoid cholesterol lowering drug 
lovastatin, and the cyclic peptide immunosuppressant drug cyclosporine (Hoffmeister et al., 
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2007; Pickens et al., 2011; Gil-Chavez et al., 2013). In addition to the secondary metabolites 
produced by bacteria and fungi, a number of their primary metabolites have a long history of 
commercial use. Microbially produced alcohols (ethanol, butanol, etc.,) acids (lactic acid, acetic 
acid, succinic acid etc.,), esters, and phenols are all widely used in the food and beverage 
industry. These compounds significantly contribute to the intricate tastes and smells of certain 
products. As well, many of these compounds have further applications as cleaning products, 
polymer precursor, solvents, fuels, and as bulk and fine chemicals and intermediates (Song et 
al., 2006; Raspor and Goranovic, 2008; Ghaffar et al., 2014; Moon et al., 2016; Azhar et al., 
2017). Commercially available amino acids, such as L-glutamic acid and L-lysine, are also 
sourced from microbes, with the former being used as a taste enhancer with a unique flavour 
called ‘umami’, and the latter as a feed additive (Hermann, 2003).  
For a long time, value primary and secondary metabolites were sourced from the host organism 
in which they are produced via extraction methods. This strategy has often suffered, however, 
due to supply limitations, low biological concentrations, and the presence of these compounds in 
conjugates and mixtures (Lam, 2007; Gil-Chavez et al., 2013). In more recent years, with 
advancements in technology, production of these compounds has branched into synthetic 




1.2 Methods for the commercial production of natural products: extraction, 
chemical synthesis and microbial fermentation 
 
Traditionally, value compounds from plants and microorganisms have been obtained through the 
extraction of the raw materials, not only of plants, but also of fungi, algae, and bacteria. 
Strategies for extraction include: solvent extraction, pressurized liquid extraction, subcritical 
fluid extraction, supercritical extraction, microwave-assisted extraction, ultrasonic-assisted 
extraction, and distillation (Want and Weller, 2006; Hattab et al., 2007; Plaza et al., 2010; Soria 
and Villamiel, 2010; Zhang et al., 2011). There are many challenges, however, involved in the 
extraction of value compounds from natural sources, including (i) low biological concentrations 
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of the compound(s) of interest, (ii) seasonal variability in the quality of the extract (especially 
with regards to plant products), (iii) difficulty culturing host species (mostly with regards to 
fungal and bacterial products), and (iv) potential ecological problems associated with demand, 
such as raw material shortages (mostly with regards to plant products) (Dubal et al., 2008; 
Brault et al., 2014; Shaaban et al., 2016; Liu et al., 2017). Together these factors drastically 
increase the production cost of extraction from natural sources. For example, the ester ethyl 
butyrate, which has a pineapple-like odour, extracted from natural sources costs approximately 
5000$ (USD)/Kg (Pandy, 1992; Brault et al., 2014). The high cost of extraction methods and 
increasing product demand lead to the development of alternative strategies for obtaining these 
value compounds. 
With a greater understanding of the chemical structures that constitute these value products, 
chemical synthesis became a popular strategy for their manufacturing. It has since grown into 
the primary method by which we obtain these value products, significantly increasing 
production titres and decreasing both time and cost over raw material extraction. For example, 
chemically synthesized ethyl butyrate costs a mere 4$ (USD)/Kg, and can by produced in much 
larger quantities than what can be obtained through extraction (Pandy, 1992; Dubal et al., 2008). 
However, there are a number of disadvantages to chemical synthesis, as this method often 
requires quite toxic solvents and is thus environmentally unfriendly, and lacks substrate 
selectivity, resulting in undesirable mixtures of regio- and stereo-isomers. Typically, the desired 
end-product is a single isomer, meaning that this latter issue can result in reduced process 
efficiency and increased downstream purification costs (Longo and Sanroman, 2006). As well, 
with regards to flavour and fragrances, United States Code of Federal Regulations (1985) and 
European Communities (1988) legislations state that ‘natural’ compounds can only be prepared 
either by extraction from natural sources or by microbial/enzymatic synthesis which involves 
precursor isolation from nature. Thus, compounds produced though chemical synthesis cannot 
be labelled as ‘natural’ but rather only as ‘natural-identical’, which has created a dichotomy in 
the market with consumers preferring products labelled as the former title (Shaaban et al., 
2016). The number of drawbacks to chemical synthesis of value products has stimulated interest 
in making these products via biotechnological means.  
In recent years, there has been a large amount of research aimed at developing microbial 
platforms for the synthesis of value product using fermentation and bioconversion. With better 
understanding of the metabolic pathways that lead to desired end products, and the tools 
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necessary for heterologous expression of the relevant genes and pathways in microbial hosts, 
biotechnology has become a booming business. There are many advantages to bio-production of 
value compounds over the two strategies described above, including: higher regio- and 
enantioselectivity of biological enzymes compared to chemical synthesis, lower waste/mild 
operational conditions than both chemical synthesis and raw material extraction, and accelerated 
production rates than is possible by raw material extraction of the native host. Moreover, there 
are a number of compounds that can only be produced via enzymatic means, meaning chemical 
synthesis is not an option (Johannes et al., 2006; Brault et al., 2014; Shaaban et al., 2016). 
Microbial production relies heavily on a deep understanding on the enzymatic steps leading to 
the desired end-product, and requires careful consideration of the choice of heterologous host, as 
this will significantly influence substrate/cofactor availability, post-translational modifications, 
organelle targeting, etc. (Fernandez and Vega, 2016). While a relatively new field, it has shown 
great industrial potential for the sustainable production of a number of value products. However, 
there are several disadvantages to microbial synthesis of value compounds, including: culture 
contamination, low titres, and poor titre reproducibility due to a lack of understanding of 
metabolic control – all of which can be improved upon as tools and comprehension of 
metabolism advance. Nevertheless, the price of compounds produced via microbial means is still 
significantly less than that obtained via raw material extraction, for example, bio-produced ethyl 
butyrate costs 180$ (USD)/Kg (Pandy, 1992). In addition to being more environmentally 
sustainably than both raw extraction and chemical synthesis.  
 
 
1.3 Microbial expression platforms for value product synthesis  
 
 
The typical workflow for the development of a microbial production platform of a commercially 
valuable product is (1) choosing a suitable heterologous host, (2) isolation and transfer or 
requisite genes from native producer into the heterologous host, and (3) optimization of product 
formation and recovery from the heterologous host (Zhang et al., 2016). With regards to the first 
step, a number of microbial expression hosts have been developed as platforms for value 
product formation; these include bacterial, yeast and algal systems. While each of these 
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platforms are communally advantageous with regards to: high growth rates, ease of culturing 
and handling, inexpensive growth medium requirements, genetic tractability and traceability 
(Phulara et al., 2016), they each possess their own individual advantages/disadvantages as 
heterologous systems. To date, there is no ‘super host’ capable of heterologously expressing all 
biosynthetic pathways for value product formation, and as such, pathway-microbial host 
compatibility is crucial. Choice of microbial host should take into consideration whether the 
desired metabolic pathway can be reconstituted in the heterologous host with regards to: the 
genetic tools available, the possible need for post-translational modification of heterologous 
pathway proteins, the availability of biosynthetic precursors and enzymes, compatibility of 
regulatory systems, the presence of endogenous pathways that may compete or interact with the 
synthesis of the target product, and the ability of the host to survive under the necessary process 
conditions to produce the desired end product (Zhang et al., 2008; Chen et al., 2010; Keasling, 
2010; Zhang et al., 2016). Often it is the case that metabolic pathways of prokaryotic origin are 
expressed in prokaryotic hosts, while metabolic pathways of eukaryotic origin are expressed in 
eukaryotic hosts, as they would be more easily reconstituted in a genetically similar system 
(Ongley et al., 2013; Alberti et al., 2017). However, there are many exceptions to this. 
The most commonly used prokaryotic hosts are: the Gram-negative hosts Escherichia coli and 
Pseudomonas putida, and the Gram-positive hosts Bacillus subtilis and Streptomyces spp. 
(Wersters et al., 2004; Keasling, 2010; Komatsu et al., 2013; Loeschcke and Thies, 2015). E. 
coli has been described as the workhorse of heterologous expression, and is the most popular 
bacterial platform organism as it is well characterised and possesses an excellent genetic toolbox 
(Naurú-Idalia and Bernardo, 2017). For further discussion of the advantages of each individual 
host strain see Zhang et al., (2016). In addition to these commonly used prokaryotic hosts, 
several other bacteria have been explored on a smaller scale as potential host platform for value 
product fermentation because their particular ecological niche is beneficial to industrial 
production. This may be owing to their ability to grow well in a specific environment (ex. 
thermophiles, anaerobes), use a variety of alternative feedstocks (ex. pentose sugars, gases), or 
naturally produce and tolerate high concentrations of end-product. For example, the 
thermophilic bacterium Geobacillus thermoglucosidasius was developed as a platform for 
ethanol production from cellulose-derived sugars (Cripps et al., 2009). Its ability to grow at high 
temperatures is a desirable industrial phenotype, as culturing at high temperatures exclude the 
growth of common mesophilic contaminants, facilitates product recovery for volatile end-
products, minimizes cooling costs, and, as intrinsic enzymatic rates are generally higher for 
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thermostable enzymes, there is higher productivity (Koffas et al., 1999; Frock and Kelly, 2012; 
Zeldes et al., 2015). 
Eukaryotic microbial hosts for heterologous production of value compounds are typically yeasts, 
though some filamentous fungi have also been employed (Anyaogu and Mortensen, 2015). 
Much like E. coli for bacterial platforms, the yeast Saccharomyces cerevisiae is the eukaryotic 
workhorse for heterologous expression, though other yeasts such as Pichia pastoris and 
Yarrowia lipolytica have been used as hosts for value product synthesis – though the former is 
mostly used as a platform for the production of therapeutic proteins (Zhuang et al., 2015; 
Sabirova et al., 2011). A significant advantage to using S. cerevisiae as a platform host over 
bacterial systems is its ability to perform post-translational modifications of proteins – including 
disulfide bond formation, acylation, glycosylation, proteolytic processing, and subunit assembly 
– which may be required for proper function of pathways originating from eukaryal organisms 
(Görgens et al., 2004; Liu et al., 2012; Hou et al., 2012; Nielsen, 2013). S. cerevisiae is also a 
tolerant organism with regards to factors such as low pH and high osmotic pressure which 
makes it suitable for industrial fermentations (Hahn-Hägerdal et al., 2007; Liu et al., 2012). In 
addition to bacteria and yeast, the unicellular eukaryotic green alga, Chlamydomonas 
reinhardtii, has been proposed as a potential heterologous host (Specht et al., 2010; Meyer et al., 
2012). Several benefits to its use include: the ability to grow phototrophically, heterotrophically 
or using a combination of both; three genomes (nuclear, mitochondrial, chloroplast) each of 
which can be transformed, and each of which possesses distinct transcriptional, translation and 
post-translational properties (Meyer et al., 2012). As of yet, algae have been used mostly for 
commercial protein production, though its industrial applications are branching into value 
chemical synthesis.  
 
 
1.4 E. coli as an expression platform  
 
E. coli is a Gram-negative facultatively anaerobic bacteria that is commonly found in the 
intestine of warm blooded animals, and is arguably the most thoroughly studied species of 
bacteria. Over the years it has been extensively used to investigate the basic mechanisms of 
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molecular genetics and biochemistry – including our understanding of the genetic code, DNA 
replication, gene expression, protein synthesis, etc. More recently, as molecular tools have 
developed and improved, it has also evolved into a preferred platform organism for numerous 
streams of biotechnology (Singleton, 1999; Cooper and Hausman, 2007). It has a relatively 
small genome that codes for approximately 4000 different proteins (Blattner, 1997), and this 
small genome size has been advantageous for genetic analysis. A further advantage to E. coli as 
model organism is the relative ease with which this bacterium can be propagated and studied in 
the laboratory. It has a rapid growth under well-defined laboratory conditions –being able to 
divide every 20 minutes given an optimal environment, it is able to reach high cell densities, it is 
easy to isolate colonies of single cell origin when grown on a semisolid agar containing media, 
and it has simple nutritional requirements which allows it to live on a wide variety of 
inexpensive substrates (Cooper and Hausman, 2007). With years of iterative use of this 
bacterium as a platform for understanding fundamental aspects of molecular biology and 
biochemistry, it was an obvious choice of host for the first attempt at heterologous expression of 
a foreign gene – the first example of genetic engineering (Cohen et al., 1973; Chang and Cohen, 
1974; Morrow et al., 1974). In the decades since this revolutionary work, there have been a huge 
number of ‘molecular tools’ developed for E. coli to facilitate the heterologous expression not 
just of single genes, but of whole pathways as well. These tools include: a variety of available 
expression plasmids – and the ability to create inestimable plasmid permutations with the 
availability of multiple origins of replication (ori) for different copy number, libraries of 
promoters, terminators, and ribosomal binding sites that vary in strength, and a number of 
available selection markers – multiple strategies for the uptake and maintenance of a plasmid by 
E. coli, methods for the genomic integration of a foreign DNA and deletion of endogenous 
genes, high throughput detection for positive recombinants, online databases and resources that 
blend genomic, transcriptomic and proteomic data, etc. (Jensen and Hammer, 1998; Martinez-
Morales et al., 1999; Lodish et al., 2004; Salis et al., 2009; Padmanabhan et al., 2011). As well, 
a number of E. coli expression strains have been developed for improved heterologous gene 
expression and protein folding. The modifications made to these strains have included: 
elimination of specific protease expression, increasing the abundance of uncommon tRNAs, 
increased tolerance to toxic recombinant proteins, the ability to perform select post-
transcriptional modifications, etc (Wagner et al., 2008; Fathi-Roudsari et al., 2016). The choice 




1.5 Metabolic engineering of microbes for improved product formation 
 
After selecting the microbial host to be used as a platform for the synthesis of a given product, 
the next step involves the expression of the requisite genes from the native producer in the 
heterologous host. However, it is often not enough to simply express the foreign genes of a 
metabolic pathway, the development of an economically viable microbial production system 
often requires extensive optimization of expression to maximize: titre (final concentration in the 
fermentation media), rate (production per unit of time), and yield (units of product synthesized 
per unit of raw material consumed), often referred to together at TRY (Stephanopoulos, 2012; 
Nielsen and Keasling, 2016). This optimization frequently involves not only modulating the 
expression of the genes composing the foreign metabolic pathway, but also manipulating the 
genetic and regulatory processes of the host organism in an effort to redirect carbon fluxes 
towards the desired end-product (Keasling, 2010; Yadav et al., 2012; Nielsen and Keasling, 
2016). This practice of maximizing microbial product formation through consideration of whole 
cell metabolism is referred to as metabolic engineering (Stephanopoulos, 1999; Woolston et al., 
2013). Metabolic engineering is a broad multi-disciplinary field that incorporates elements of 
computational science, chemical engineering, biochemistry, molecular biology, synthetic 
biology, and genetic engineering to optimize end-product formation in a platform host organism 
(Yang et al., 1998). In the context of developing a microbial expression platform for the 
production of a value product via a foreign metabolic pathway, metabolic engineering can be 
divided into two levels. At the first level is the genetic engineering of the pathway itself to 
optimize pathway flux, which is to say the rate at which the input metabolite is processed to 
produce the output metabolite (Koffas et al., 1999; Stephanopoulos, 1999). Often the production 
of a secondary metabolite is metabolically costly to the cell, and thus native hosts have evolved 
to produce it in small but sufficient quantities; however, from a biotechnological point of view, 
these quantities are too low to be economically viable (Parekh, 2009; Pickens et al., 2011). 
Thus, optimizing pathway flux requires balancing expression of pathway proteins so that they 
are present at levels that are adequate for efficient transformation of the metabolic intermediates 
to product at an economical rate, but not so high that their expression impacts host cell  health 
by robbing the cell of substrates and cofactors (Keasling, 2010). As well, the relative expression 
of proteins within a pathway may require balancing to avoid the formation of bottlenecks and 
the build-up of intermediates; or the catalytic activity/substrate specificity of one or more 
pathway proteins may require alteration (Woolston et al., 2013; Fisher et al., 2014). Here, the 
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use of labelling methods (ex. with the use of 13C isotopic tracers) to measure the flux of 
intermediates, and the use of enzyme kinetics for protein characterization, are key to elucidating 
potential pathway bottlenecks. Following this, the available genetic engineering tools for a given 
host can be used to appropriately modulate pathway flux to streamline product formation 
(Keasling, 2010; Fisher et al., 2014). However, optimizing of the catalytic steps of a metabolic 
pathway outside of the wider context of the natural cellular metabolism of the host cell is only a 
partial success. The second level of metabolic engineering takes into consideration the interface 
of a given heterologous pathway with host cell metabolism. Often, the interconnectedness of 
cellular metabolism means that the foreign pathway might be competing with endogenous 
metabolism for precursors and intermediates. Thus, redirecting carbon flux towards the desired 
end-product often requires modulation or disruption of native pathways. This can involve 
genetic modifications aimed at increasing precursor or cofactor supply, minimizing product loss 
due to unwanted by-product formation, or knocking down competing pathways (Pickens et al., 
2011; Wohlleben et al., 2012; Nielsen and Keasling, 2016; Kim et al., 2016). Host cell 
metabolism can also be harnessed for improved product formation, there are several examples in 
which expression of a foreign pathway has been intrinsically tied to the maintenance of cellular 
homeostasis, resulting in a drive towards desired end-product formation (Nissen et al., 2010; 
Lee et al., 2011).  
The discipline of metabolic engineering has benefited greatly from advances in adjacent fields: 
DNA sequencing has elucidated previously uncharacterised metabolic reactions and identified 
homologous enzymes and pathways from many different organisms – allowing scientists to 
create hybrid pathways using genes from multiple sources; advancements in ‘omics’ research, 
such as genomics, proteomics, metabolomics, and fluxomics help draw the cellular blueprints 
that are vital to system engineering;  new genetic tools allow for more precise and finetuned 
modifications, while new analytical and computational tools enable researches to both model 
and in vivo track RNA, protein and metabolites in a cell to identify potential bottlenecks and to 
mine, sort, and analyse biological data to further improve metabolic ‘maps’; and the 
development of the field of synthetic biology has allowed the synthesis and codon optimization 
of genes and genetic controls, significantly advancing the rate, and decreasing the cost, at which 
heterologous pathways can be designed and assembled (Keasling, 2010; Yadav et al., 2013; 
Woolston et al., 2013; Nielsen and Keasling, 2016). Over the last couple of decades, metabolic 
engineering has been used to develop cost-effective microbial platforms for the production of 
fuels, chemicals and pharmaceuticals. The tributaries of this field have extended beyond 
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streamlining the flux of ‘substrate to product’ of a given metabolic pathway – whether it be in 
either a native or heterologous host – to all aspects of the fermentation process, from 
engineering microbial utilization of less expensive feedstocks, to improved end-product 
recovery strategies (Kumar et al., 1992; Zhang et al., 1995; Pickens et al., 2011; Jeong et al., 
2012; Scalcinati et al., 2012; Ledesma-Amaro et al., 2016; Gaida et al., 2016). Through the use 
of microbial metabolic engineering, a number of commercial products have been brought to 
market, a few of which are: lysine from Corynebacterium glutamicum for use as a feed additive, 
1,3-propandiol from E. coli for use as a chemical intermediate, and artemisinic acid and 
isobutanol from S. cerevisiae for use as an anti-malaria drug and biofuel, respectively (Tong et 
al., 1991; Koffas et al., 2003; Martin et al., 2003; Chen et al., 2011; Westfall et al., 2012; 
Nielsen and Keasling, 2016). 
Even with these successes, however, metabolic engineering has not provided us with the ability 
to produce any desired end-product from a microbial host at economical titres. Factors including 
global regulatory networks, metabolic burden and intermediate/product toxicity can often 
impede high level production. The connections between these factors and the genotype is 
complex and poorly understood. They often involve multiple genes and trickle on effects, 
making them difficult to target (Woolston et al., 2013). However, as our understanding of a 
host’s metabolic framework improves, and molecular and synthetic biology tools become more 
advanced, the number of producible natural and non-natural products will expand and the titres 
at which they can be produced will increase.  
 
 
1.6 Production of value compounds in E. coli  
 
E. coli is widely employed as a microbial platform host for the production of a number of 
pharmaceuticals proteins, biofuels, fine chemicals and bulk chemicals in both academic research 
and industry. E. coli was the first heterologous host used for the manufacturing of 
biopharmaceuticals, with the production of human insulin and bovine growth hormone (bGH) 
(Baeshen et al., 2014; Baeshen et al., 2015). In the years since, E. coli has been used as a 
platform for the commercial production of a number of therapeutic proteins used in the 
treatment for hepatitis, osteoporosis, various cancers, etc. (Baeshen et al., 2015). As well, a 
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significant amount of work has gone into developing E. coli as a platform for the production of 
biofuels as an alternative to the traditional fossil derived transportation fuels. Strain engineering 
for the production of bioalcohols, such as ethanol, butanol, propanol, and isopropanol has been 
extensively carried out (Ingram et al., 1987; Atsumi et al., 2008a; Atsumi et al., 2008b; Choi et 
al., 2012; Koppolu et al., 2016), and more recently, work has been done to develop strains that 
produce biodiesel (fatty acid methyl/ethyl esters), and hydrocarbons (Nawabi et al., 2011; Choi 
et al., 2013). The production of fine chemicals, such as various hydroxycinnamic acids, 
flavonoids, terpenoids, and amino acids for use as pharmaceuticals, food additives and 
cosmetics has also been a growing research area (Martin et al., 2003; Leonard et al., 2007; Kang 
et al., 2012; Huang et al., 2013). As has the production of bulk chemicals, such as various diols 
and organic acids for use as polymer precursors, solvents, detergents, fumigants and 
antibacterials (Nakamura and Whited, 2003; Thakker et al., 2012; Niu et al., 2014; Jain et al., 
2015). 
Ultimately, E. coli has been developed into a preferred platform organism for the production of 
a vast range of value compounds. While the process of creating an E. coli strain for the synthesis 
of any given end-product often entails a number of stepwise successes and obstacles, only two 
specific examples will be further discussed here. 
 
 
1.6.1 Butanol production in E. coli  
 
Reliance on fossil fuels such as petroleum has increased significantly in the twentieth century, 
and immoderate consumption has led to concern over depletion of reserves in the near future, 
greenhouse gas emission and pollution, and the cost of petroleum derived products (Alper and 
Stephanopoulos, 2009; Sun et al., 2015; Koppolu et al., 2016). In order to reduce dependency on 
petroleum reserves, interest in developing platform for the production of alternative renewable 
fuels that can be derived through the cellular conversion of biomass to biofuel, has grown. As 
such, bioalcohols, such as ethanol, propanol and butanol, have become common gasoline 
additive replacements for use as transportation fuels. Significant success has been achieved for 
the microbial production of bioethanol, specifically, and it has become the major biofuel 
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alternative/additive to gasoline. In 2013, approximately 1040 million m3 of ethanol was 
produced worldwide, more than 80% of which was utilized as biofuel (Peterson and Ingram, 
2008; Borah and Mishra, 2011; Sun et al., 2015; Koppolu et al., 2016). One of the key factors 
that has allowed for the successful development of ethanol producing microbial platforms is the 
ease with which ethanol is fermented from sugar by a number of microbes, including E. coli and 
S. cerevisiae. While bioethanol is often advertised as a major alternative fuel, it does possess 
some limitations, including low energy density compared to gasoline, high vapour pressure, and 
high hygroscopicity leading to corrosiveness (Sun et al., 2015). Another bioalcohol, butanol, 
demonstrates more favourable physical and chemical properties for use as a biofuel when 
compared to ethanol. Butanol is a C4:0 alcohol and thus possesses an energy content closer to 
gasoline than ethanol, making it a more economical fuel. It can also be blended with gasoline to 
higher concentrations than ethanol for use in a standard vehicle engine, has lower water 
solubility resulting in it being less sensitive to water contamination, and is a less volatile and 
corrosive fuel that ethanol. These qualities mean that traditional gasoline fuel pipelines would 
not need to be modified for transporting biobutanol, as would be the case with ethanol fuel 
(Tracy, 2012; Steen et al., 2008; Lee et al., 2008; Inui et al., 2008; Biobutanol fact sheet, BP). In 
addition to its use as a biofuel, butanol possesses a number of other commercial applications as 
an extractant, as a feedstock chemical for many butanol derivatives, and as a solvent (Dürre, 
2007; Ezeji et al., 2007; Papoutsakis, 2008; Lee et al., 2008). Thus, the drive to develop 
economically viable microbial platforms for butanol production is powered by more than just 
the biofuel industry.  
 Butanol can be produced microbially via two distinct biosynthetic pathways: the keto-acid 
pathway and the CoA dependent pathway. In the keto-acid pathway, 2-ketovbutyrate – which is 
derived from the amino acid threonine – is converted to 2-ketovalerate by the action of the 
LeuABCD enzymes (leucine biosynthesis operon) that compose the norvaline biosynthetic 
pathway. 2-ketovalerate is then further converted to butanol via a 2-ketoacid decarboxylase 
(KivD) enzyme and an alcohol dehydrogenase (ADH2) enzyme (Figure 1.1). Via this pathway, 
approximately 1 g/L of butanol from glucose has been achieved in E. coli  (Shen and Liao, 





Figure 1. 1 Schematic illustrating the production of 1-butanol via the unnatural norvaline pathway in 
E. coli. The 2-ketobutyrate substrate is derived from threonine. 
 
 
More successful than the keto-acid pathway for producing butanol is the CoA dependent 
pathway, which is native to certain solventogenic species of clostridia. This pathway is also 
referred to as the ABE pathway, as it produces acetone, butanol and ethanol as its end-products 
in a mass ratio of 3:6:1 (Jones and Woods, 1986; Branduardi et al., 2014). Figure 1.2 shows the 
ABE pathway, with the genes leading specifically towards butanol shown in black. This butanol 
producing pathway starts from acetyl-CoA and involves six enzymes: an acetyl-CoA 
acetyltransferase (Thl), acetoacetyl-CoA thiolase (Hbd), 3-hydroxy-butyryl-CoA dehydrogenase 
(Crt), butyryl-CoA dehydrogenase (Bcd), electron transfer flavoprotein (Etf), and an 
aldehyde/alcohol dehydrogenase (AdhE2) (Figure 1.2). Wildtype strains of Clostridium 
acetobutylicum (the most commonly studied butanol producing strain) produce between 12-13 
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g/L of butanol. However, through the use of genetic and metabolic engineering, achievable 
butanol titres have reached 18.9 g/L from glucose in fed batch from C. acetobutylicum, and 20.5 
g/L from mannitol in fed batch from Clostridia tyrobutyricum (Lee et al., 2012; Yu et al., 2012). 





Figure 1. 2 ABE fermentation pathway from C. acetobutylicum. Reactions leading towards n-
butanol production are in black, while reactions leading to acetone and ethanol production are in dark 





growth rates, and do not have an abundance of genetic tools available for genetic/metabolic 
engineering. For these reasons, the CoA-dependent butanol pathway has been reconstituted in 
more genetically tractable hosts such as E. coli and S. cerevisiae. The first E. coli strain 
engineered for producing butanol was created by Atsumi et al., (2008), with a final titre of 13.8 
mg/L of butanol achieved. Several years of iterative work engineering both the CoA dependent 
butanol pathway as well as endogenous E. coli metabolism to optimize butanol production has 
so far resulted in maximum titres of 15 g/L from glucose in fed batch cultures – less than the 
amount that can be produced by engineered clostridia (Shen et al., 2011). In the years following, 
butanol titres achieved in E. coli have not surpassed this value, though interesting work done by 
Dellomonaco et al., (2011) that same year came close with the production of 14 g/L butanol 
from glucose in E. coli using a strategy that involved the reverse engineering of β-oxidation. A 
significant impediment to achieving improved titres of butanol in E. coli is the high microbial 
toxicity of this short chain alcohol. Native clostridial producers are only capable of tolerating 
2% (v/v) butanol in culture, while E. coli strains rarely tolerate more than 1% (v/v) (Fischer et 
al., 2008; Knoshaug et al., 2009). Butanol toxicity is multifaceted and difficult to address, but 
has proven to be a central problem to the development of an economical butanol producing E. 
coli platform. As a result, research focussed on identifying the mechanisms of butanol 
toxicity/tolerance in E. coli and other bacteria has intensified in the last few years in an effort to 
engineer more tolerant strains (toxicity is discussed further in section 1.7) (Ruhl et al., 2009; 
Mao et al., 2010; Dong et al., 2015). Another tributary of microbial butanol production research 
in recent years has been aimed at decreasing process costs for E. coli fermentation, mostly 
through optimizing the use of cheap substrates such as glycerol, xylose, palmitic acid, etc. 
(Dellomonaco et al., 2010; Dong et al., 2015; Saini et al., 2017). Further, work done towards the 
end of developing a strain of E. coli capable of consolidated digestion of plant biomass and 
butanol production has been trialled using ionic liquid-treated switchgrass as a substrate, and the 
expression of a cellulase, xylanase, β-glucosidase, and xylobioidase in addition to the CoA-
dependent butanol production pathway (Bokinski et al., 2011). While butanol titres achieved 
from cheaper feedstocks is currently uneconomically low, this work is still in early stages, 
leaving a lot of room for optimization.  
The economics of butanol production from E. coli is a fluctuating field, constantly influenced by 
the current climate. The most significant factor impacting how economical microbial production 
of butanol (and other biofuels) is the price of oil. Not only as a direct price point competitor to 
butanol, but also by the more passive means of influencing the amount of interest there is in 
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biofuel research. There is a correlated increase in interest in biofuel research when oil prices are 
high, and a decrease when prices are low (Qureshi and Blaschek, 2001). More direct factors 
influencing the cost of butanol include: type and cost of feedstock, cost of fermentation and 
product recovery, and the productivity of the microbial strain (Qureshi and Blaschek, 2001; Li et 
al., 2016; Baral and Shah, 2016). While companies such as Green Biologics Ltd. currently 
produce butanol via clostridial fermentation, the use of E. coli for industrial scale butanol 
production has not yet been achieved, with further need for improved butanol titres and 
tolerance.   
 
 
1.6.2 Monoterpene production in E. coli 
 
Terpenes (also called isoprenoids) are the most diverse class of natural product found in plants, 
fungi, and bacteria, with tens of thousands of reported structures (Lange and Ahkami, 2013; 
Yamada et al., 2014). All terpenes are built from two or more isoprene (C5) building block. The 
number of isoprene units from which a terpene is composed is used to classify it, with those that 
are composed of 10 carbons referred to as monoterpenes (Table 1.2). The volatility of the short 
chain monoterpenes makes them dominant constituents of plant essential oils, often possessing 
distinct aromas. They play many ecological roles in both plants and microorganisms, including: 
attractants for pollinators, broad-spectrum antimicrobials, herbivore deterrents (direct and 
indirect), and allelopathic agents (Boysen and Hearn, 2010; Tchimene et al., 2013). 
Monoterpenes have many commercial applications, including extensive use in flavour and 
fragrances (ex. pinene, geraniol), as anticancer agents (ex. limonene and perillyl alcohol), 
antiseptics (ex. thymol), insect repellents (ex. citronellol), and their derivatives have application 
as ‘drop in’ replacements to traditional kerosene aviation jet fuel (van der Werf et al., 1997; 
Gould, 1997; Lambert et al., 2001; Fortman et al., 2008; Harvey et al., 2010; Brennan et al., 





Table 1. 1 Class of terpenes based on backbone chain length. 
Terpene Number of carbons Example 
Monoterpene 10 Geraniol 
Sequiterpene 15 Farnesol 
Diterpene 20 Taxadiene 
Sesterterpene 25 Geranylfarnesol 
Triterpene 30 Squalene 
Sesquarterpene 35 Ferrugicadiol 
Tetraterpene 40 Lycopene 
 
 
Monoterpenes can be synthesised via two distinct biosynthetic pathways: the mevalonate-
dependent pathway (MEV) and the mevalonate-independent pathway (also referred to as the 
methylerythritol 4-phosphate pathway, or MEP) (Vranová et al., 2013). Higher eukaryotes and 
some bacteria use the MEV pathway for terpene production, while most prokaryotes and 
eukaryotic protazoans use the MEP pathway. Plants are an exception to this pathway 
exclusivity, as they use both pathways in different organelles (Lichtenthaler, 1999, Boucher and 
Doolittle, 2000; Alonso-Gutierrez et al., 2013).  In the MEV pathway, three acetyl-CoAs are 
condensed successively to produce HMG-CoA, which is then reduced to mevalonate by a 
reductase. Mevalonate is then phosphorylated twice and decarboxylated to form isopentyl 
diphosphate (IPP), which can be isomerized to dimethylallyl diphosphate (DMAPP) (Figure 
1.3). In the MEP pathway, pyruvate and glyceraldedhyde-3-phosphate (G3P) are condensed to 
form 1-deoxy-D-xylulose 5-phosphate (DOXP), which is further reduced to methylerythritol 4-
phosphate (MEP). MEP is then further converted, through several intermediate steps to IPP and 
DMAPP. The final steps of terpene biosynthesis – which are common to both MEV and MEP 
pathway– is first the condensation of the IPP and DMAPP precursors by a chain-length specific 
synthase (Lange and Ahkami, 2013; Figure 1.3). The condensation of one molecule of IPP and 
one molecule of DMAPP leads to geranyl diphosphate (GPP), the C10 precursor to most 
monoterpenes. Finally, this GPP can then be converted to a plethora of structurally diverse 
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monoterpenes through the action of a monoterpene synthase/cyclase (MTPS) (Kinkhead-Reiling 




Figure 1. 3 Mevalonate pathway (MEV; left) and non-mevalonate pathway (MEP; right) leading to 
the production of monoterpenes. Both pathways follow the same reaction sequence after the 
production of IPP (isopentyl diphosphate) and DMAPP (dimethylallyl diphosphate). 
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As traditional monoterpene extraction from plant material is arduous and expensive, efforts have 
transitioned to focus on producing these compounds in microbial hosts. A large amount of work 
has gone into developing S. cerevisiae and E. coli platforms for the production of a range of 
monoterpenes. In E. coli, strategies involving the engineering of the native MEP pathway or 
expression of a heterologous MEV pathway have both been employed for monoterpene 
production (Farmer et al., 2001; Tabata and Hashimoto, 2004; Alper et al., 2005). Of these two 
approaches, those that involve heterologous expression of the MEV pathway have been more 
successful, mostly likely because the native MEP pathway in E. coli is regulated by unknown 
mechanism that limit the achievable titres. Endogenous terpene synthesis is intricately tied to 
cell physiology, and thus far metabolic engineering has not been successful in teasing them apart 
(Martin et al., 2003). Whether the MEV pathway or native MEP pathway is being employed, 
monoterpene production in E. coli requires the heterologous expression of both a GPPS and 
MTPS enzyme. Expression of a GPPS is required as E. coli does not naturally produce 
appreciable quantities of geranyl pyrophosphate – the direct precursor to all monoterpenes. 
While expression of an MTPS is required to dictate the final structure of the monoterpene that 
will be produced (Kinkhead-Reiling et al., 2004). Monoterpenes such as 3-carene and limonene 
have been made in E. coli through engineering of the native MEP pathway and heterologous 
GPPS and MTPS expression; though in quite small quantities of 0.003 mg/L and 35.8 mg/L, 
respectively (Kinkhead-Reiling et al., 2004; Du et al., 2014). In contrast, a larger number of – 
and higher quantities of – monoterpenes have been produced by E. coli through heterologous 
expression of the MEV pathway. These include α/β pinene, myrecene, sabinene, geraniol, and 
limonene (Zhou et al., 2014; Zhang et al., 2014; Sarria et al., 2014; Alonso-Gutierrez et al., 
2015; Kim et al., 2015). Limonene can be used as an illustrative example of the difference in 
monoterpene production titres achieved from E. coli via either MEP or MEV pathways 
engineering, with a recent strain engineered with the MEP pathway producing 35.8 mg/L of 
limonene while a strain engineered with the MEV pathway producing 605 mg/L (Du et al., 
2014; Alonso-Gutierrez et al., 2015). Heterologous expression of the MEV pathway in E. coli 
has undergone a number of iterative improvements over the last few years to optimize flux by 
removing bottlenecks and rate limiting steps in the pathway. Strategies such as gene codon 
optimization, varying promotor strength, and replacing low activity pathway enzymes with more 
active homologs from a different organism have been successful in improving end-product titres 
(Tsuruta et al., 2009; Redding-Johanson et al., 2011; Alonso-Gutierrez et al., 2013). 
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While developing E. coli platforms for the production of monoterpenes is an active field of 
research, none of the titres achieved to date for any of these compounds has been economic for 
industrial production – unlike several sesqui- and diterpenes that can be microbially produced in 
high quantities (Benjamin et al., 2016). A significant impediment towards high titre 
monoterpene production in E. coli is the considerable toxicity these compounds exert in 
microbial culture (Brennan et al., 2012; Chubukov et al., 2015). Several groups have worked 
towards elucidating the toxicity mechanisms of these monoterpenes, as well as engineering 
strains of E. coli with increased tolerance to these compounds (Shah et al., 2013; Tomok et al., 
2015). As with butanol, however, there has been no major breakthrough to the problem of 
toxicity to date. As well, a further consideration in the use of E. coli as a host for monoterpene 
production is the source of the MTPS enzyme, as the majority of these proteins have been 
isolated from plant species. This has implications with regards to the breadth of monoterpenes 
that E. coli may be able to produce given its restricted ability to express eukaryotic proteins. As 
the number of E. coli strains engineered to undertake PTMs increases, so might the library of 
monoterpenes E. coli is capable of synthesizing. 
 
 
1.7 Obstacles to high titre product formation in microbial platforms –  a focus on 
toxicity  
 
High titre microbial production of value compounds can be hindered at a number of process 
steps. Product formation often requires engineering of the relevant metabolic pathway and host 
strain to streamline carbon flux and minimize side product formation in an effort to reach the 
theoretical maxima of product formation. This process necessitates a balance between 
heterologous product synthesis and the physiological processes of the host, so as not to impose a 
cellular burden that negatively impacts titres. Another significant bottleneck in achieving 
optimal microbial production is toxicity The number of products being made via microbial 
platforms consists of: alcohols (ex. ethanol, butanol, fatty alcohols), acids (ex. lactate, succinate, 
fatty acids), ketones, aldehydes, esters, alkanes/alkenes, and isoprenoids. Additionally, the 
number of carbon substrates being used for microbial production is also expanding as the 
hydrolysates of complex carbohydrates sourced from plant biomass or waste are being explored 
as feedstocks (Nicolaou et al., 2010; Mukopadhyay, 2015). Exposure to unnaturally high levels 
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of these substrates and products can disrupt cellular homeostasis and result in toxicity in the 
microbial host. In the case of substrate toxicity, it is usually not the sugars and starches that are 
inhibitory, but rather the side products and impurities produced during the biomass pre-
treatment process that are present in the feedstock (Nicolaou et al., 2010), although high 
concentrations of pure substrate can cause osmotic stress.  
A fundamental necessity for developing strategies for overcoming microbial toxicity is 
understanding the modes by which a compound acts in the cell to exert toxicity, with 
compounds that are physiochemically alike often exerting similar effects. With regards to the 
majority of value compounds produced by engineered microbes, the most significant type of 
toxicity is organic solvent toxicity. This toxicity is attributed to the accumulation of organic 
molecules such as alcohols, aldehydes, aromatics, hydrocarbons, etc (Isken and de Bont, 1998; 
Nicolaou et al., 2010). Many studies have shown that organic solvents impact cell health by (i) 
imparting physical changes to cell membranes and (ii) damaging biological molecules 
(VanBogelen et al., 1987; Ramos et al., 1997; Kobayashi et al., 1998; Isken and de Bont, 1998; 
Ramos et al., 2002; Sardessai and Bhosle, 2002; Volkers et al., 2006). With regards to the 
former mode of action, solvent-like molecules intercalate into the cell membrane resulting in 
altered membrane fluidity and function. The cell membrane not only provides structural 
integrity and a barrier to the extracellular environment, but it is also a matrix in which many 
enzymes and transport proteins are embedded. Disruption of its integrity results in a number of 
trickle down effects, including the inability to: maintain turgor pressure, mediate transport in 
and out of the cell, transduce signals, produce energy, and communicate (Sardessai and Bhosle, 
2002; Nicolaou et al., 2010; Mukopadhyay, 2015). With regards to the latter mode of action, 
impairment to biological molecules can include damage to DNA and lipids via oxidative 
mechanisms, protein denaturation, and RNA unfolding and degradation (Rutherford et al., 2010; 
Nicolaou et al., 2010). Here, the extent of damage to a given type of biological molecules 
depends on the kind of organic solvent. For example, cellular exposure to the short chain alcohol 
butanol can generate reactive oxygen species (ROS) that damage DNA and lipids, while ethanol 
exposure results in a chaotropic effect (Woodruff et al., 2013; Chin et al., 2013; Haft et al., 
2014).  
Cellular response to toxicity is dynamic and can include: (i) induction of metabolic and 
transport-based detoxification mechanisms, such as metabolism of the toxic compound to one 
that is less so, or the employment of efflux pumps to remove the toxic compound from the 
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intracellular milieu; (ii) induction of general and specific stress response systems; (iii) induction 
of long-term adaptive responses to toxicity, such as alteration of cell membrane composition; or 
(iv) induction of complex transcriptional and protein level changes that are currently poorly 
understood (Nicolaou et al., 2010). Each organism, however, has its own intrinsic tolerance 
level for a given organic solvent, which is determined genetically, as well as being influenced by 
environmental factors (Huertas et al., 1998; Kobayashi et al., 1998; Sardessai and Bhosle, 
2002). For example, E. coli is capable of tolerating butanol up to 1.5% (v/v) in culture, while 
Pseudomonas putida is tolerant up to 6% (v/v) (Ruhl et al., 2009; Lamsen and Atsumi, 2012). 
The high solvent tolerance of non-model organisms is a feature that has been exploited for 
engineering increased tolerance in platform hosts such as E. coli. However, due to the complex 
nature of tolerance phenotypes, all the genetic determinants dictating tolerance to inhibitory 
compounds are still not fully understood (Peabody et al., 2014). Ultimately, this lack of 
understanding has hindered rational engineering of tolerant host strains and no all-encompassing 
solution to microbial toxicity has been elucidated, although a number of strategies are currently 
employed with varying degrees of success. 
 
 
1.8 Strategies for increasing microbial solvent tolerance 
 
Microbial solvent tolerance is not a new field of research; it has been tackled for several 
applications, including bioremediation for spills and contamination, bio-catalysis in two phase 
solvent systems, and biotechnology for microbial production platforms of solvent-like 
compounds (Mukopadhyay, 2015). In the field of biotechnology, research into microbial 
tolerance is done with the end goal of developing microbial strains where the sensitivity to a 
desired end-products is alleviated; as this opens the door to higher titre production. Strategies for 
improving microbial tolerance can be divided to general categories: strain engineering and 





1.8.1 Strain engineering  
 
Efforts to rationally engineer microbial strains for increased solvent tolerance are done by 
upregulating the natural detoxification strategies of the host organism, or by employing 
strategies/enzymes from species that have been identified as more tolerant to the given stressor. 
Identification of the genes and pathways involved in microbial detoxification has been 
significantly assisted by transcriptomic studies of wildtype and solvent exposed microbes 
(Rutherford et al., 2010; Winkler et al., 2011; Yang et al., 2013; Peabody et al., 2014). From 
this work, several prominent categories of genes that are involved in tolerance have been 
identified and exploited to alleviate toxicity in desired microbial hosts. These include 
chaperones, redox enzymes, transport pumps, membrane-modifying enzymes, and transcription 
factors/regulators (Dunlop et al., 2011; Ling et al., 2014; Mukopadhyay, 2015). The use of 
chaperone (proteins which mediate proper protein folding) overexpression to increase solvent 
tolerance was first carried out in C. acetobutylicum with overexpression of the chaperone 
GroESL. This resulted in a decrease in butanol sensitivity of 85% (Tomas et al., 2003; 
Papoutsakis, 2008). Overexpression of endogenous chaperones and heterologous expression of 
thermophilic chaperones in E. coli has also improved tolerance to ethanol and a number of other 
solvent-like compounds (Clark et al., 2008; Zingaro and Papoutsakis, 2012; Abdelaal et al., 
2015). Redox enzymes have been overexpressed to address ROS-related protein damage, as its 
believed these enzymes act as scavengers for the ‘reactive aldehydes’ produced by lipid 
oxidation. For example, overexpression of the alcohol dehydrogenase yqhD in E. coli improves 
tolerance to a broad range of compounds, including solvent-like molecules and toxic by-
products of biomass pre-treatment (Pérez et al., 2008; Jarboe, 2011; Foo et al., 2014). As well, 
ROS related stress from butanol exposure was improved in cyanobacteria with overexpression 
of HspA (Anfelt et al., 2013). Transporters and efflux pumps area major mechanism for 
relieving microbial toxicity as they remove the toxic molecule from the intracellular milieu. The 
RND class of efflux pump (such as AcrAB-TolC), specifically, are heavily involved in 
conferring solvent tolerance to Gram-negative bacteria (Ramos et al., 1998; Ramos et al., 2002; 
Segura et al., 2012). E. coli mutant strains that displayed increased tolerance to hexane and 
cyclohexane had upregulated expression of the AcrAB-TolC pump as well as the ABC 
transporter, ManXYZ (Shimizu et al., 2005; Okochi et al., 2007). While the RND efflux pumps 
are well characterised for their activity towards antibiotics – and their contribution to antibiotic 
resistance – they also possess broad substrate range for organic molecules that can range from 
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hydrocarbons to detergents (Takatsuka et al., 2010). A survey of efflux pumps suggested that 
the native E. coli AcrAB-TolC pump is a potential candidate for improved tolerance towards 
monoterpenes. Despite its broad substrate range, this efflux pump does not provide tolerance 
towards more polar compounds, such as short chain alcohol (Ankarloo et al., 2010). Rather, 
overexpression of ABC transporters instead may increase microbial tolerance to polar 
compounds; an example is the MdlB transporter in E. coli, which when overexpressed improves 
tolerance to isopentanol (Foo et al., 2014). Strategies that address toxicity upstream of 
intracellular damage have also been employed successfully. An example of this is maintaining 
membrane integrity during solvent accumulation by overexpression of lipid modifying enzymes 
such as desaturases, epoxidases, and cis-trans isomerases (Bernal et al., 2007; Volmer et al., 
2014; Jin et al., 2014). Overexpression of these enzymes has been successfully used to maintain 
membrane rigidity and increase tolerance during solvent exposure. The use of regulators and 
transcription factors  has also been investigated to increase microbial tolerance to solvents. This 
strategy may prove to be a powerful tool as regulators instigate complex multigenic responses 
which would be difficult to achieve using individual manipulations (Mukopadhyay, 2015). In 
cyanobacteria, overexpression of regulators (ex. Srl1037) and transcription factors (ex. SigE) 
resulted in an increased tolerance to butanol (Kaczmarzyk et al., 2014; Chen et al., 2014); while 
in E. coli, the role of several regulators, including ArcA, has been linked to the butanol an 
isobutanol stress response – suggesting it may be a future target for tolerance engineering 
(Brynildsen and Liao, 2009). Ultimately, the use of global regulators may prove to be 
instrumental for obtaining complex solvent tolerant phenotypes in the future (Mukopadhyay, 
2015).  
In addition to rational engineering, combinatorial approaches to increasing microbial tolerance 
have also been performed successfully. This has included (i) the evolutionary engineering of 
whole strains, as well as (ii) directed evolution of individual protein involved in the tolerance 
response. The former involves the direct propagation of the host in inhibitory solvent conditions 
so that spontaneous mutations that confer increased solvent tolerance can be selected for 
(Peabody, 2014). This process is referred to as adaptive laboratory evolution (ALE), and 
benefits from rapid evolution and screening of mutants (Gong et al., 2017). It has successfully 
been employed to increase the tolerance of microbes to a number of caustic conditions, 
including an increase in tolerance of S. cerevisiae to lactic acid (Fletcher et al., 2017). However, 
the application of this strategy for improved solvent tolerance has yet to be explored and is 
likely to be strain specific. The directed evolution of proteins that play a role in microbial 
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tolerance for higher or more specific activity is a widely used technique. For example, the AcrB 
protein of the AcrAB-Tol efflux pump complex has been a target of directed evolution to 
improve its activity towards solvents such as octanol, hexene, and β-pinene (Foo et al., 2013; 
Mingardon et al., 2015); while global transcriptional metabolic engineering (gTME) – which 
involves creating randomly mutated libraries of global stress regulators that are then screened 
for a desired phenotype – has been successfully used in S. cerevisiae and E. coli to increase 
tolerance traits (Lin et al., 2013; Si et al., 2014). However, with the redundancy of microbial 
metabolism, strain engineering for increased solvent tolerance may still not result in 
economically viable titres. This has led to the development of alternative strategies to minimize 
toxicity and improve end-product titre that involve in situ product sequestration.  
 
 
1.8.2 Product sequestration 
 
Microbial toxicity can be reduced by limiting exposure of the solvent-like compound to the cells 
through either in situ product removal (ISPR during fermentation or, perhaps, through 
compartmentalization of the toxic product in organelles. With ISPR, the choice of technique 
employed will rely on the physicochemical properties of the target compound – taking into 
consideration its volatility, hydrophobicity, size, and charge (Stark and von Stockar, 2003). A 
product may be removed from culture by four main techniques. (i) Evaporation via gas 
stripping, distillation, or pervaporation. This strategy has been successful for short chain 
alcohols such as ethanol and butanol, with butanol productivity increasing from 0.24 g/L/h to 
0.35 g/L/h from C. acetobutylicum in a study where gas stripping was used intermittently (Xue 
et al., 2012). Pervaporation has also been used to overcome butanol toxicity and improve 
product recovery in cultures of C. acetobutylicum, with a productivity increase of 16% using this 
technique (Xue et al., 2015). (ii) In situ extraction into a second phase; this can be done using a 
water-immiscible organic solvent, or an aqueous two-phase system (Brennan et al., 2012; Iqbal 
et al., 2016). The use of an aqueous-organic two-phase system has been used extensively for 
microbial terpene production in S. cerevisiae and E. coli (Peralta-Yahya et al., 2011; Alonso-
Gutierrez et al., 2013; Jongedijk et al., 2015; Liu et al., 2016), as well as being successfully used 
in free fatty acid producing cultures of cyanobacteria (Kato et al., 2017). (iii) Size selective 
permeation techniques such as reverse osmosis, dialysis, electrodialysis or nanofiltration. 
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Dialysis has been used to increase the titre of salicylic acid produced by Pseudomonas 
fuorescens by 20-fold (Abbott and Gerhardt, 1970). And, (iv) immobilization strategies 
including ion exchange resins, adsorption onto hydrophobic carriers, and affinity absorption. 
The use of an ion exchange resin has been successfully applied to in situ extraction of lactic acid 
from cultures of Lactobacillus casei (Ataei and Vasheghani-Farahani, 2008). 
In addition to extracellular sequestration of toxic compounds from microbial cultures to 
minimize exposure, it may be possible to sequester these molecules internally, either into 
microcompartments or into less toxic molecules. The former option would involve localizing the 
biosynthetic pathway of interest to an organelle so that the toxic end-product (or intermediates) 
would not interact with cellular function (Woolston et al., 2013). This strategy would also have 
the added benefits of limiting unwanted side reactions by endogenous metabolism, as well as 
increasing the local concentration of intermediates to potentially drive higher production. While 
prokaryotes lack true organelles, proteinaceous bacterial microcompartments (BMCs), and other 
small protein shells do occur naturally (Cheng et al., 2008; Yeates et al., 2010). These BMCs 
are believed to be involved in encasing sequentially acting metabolic enzymes that catalyse a 
reaction sequence involving a volatile or toxic intermediate (Cheng et al., 2008). The study of 
BMCs, however, is relatively new, and a number of questions still remain regarding how the 
protein shell assembles and selectively allows the movement of certain molecules, but not 
others, into and out of the compartment (Cheng et al., 2008; Sutter et al., 2017). While 
preliminary studies have successfully reconstituted functional heterologous BMCs in E. coli 
(Parson et al., 2010; Bonacci et al., 2012), this strategy has not been rationally employed for the 
sequestration of a metabolic pathway that leads to value end-products that possess high 
microbial toxicity. However, it represents a potentially powerful tool for microbial 
detoxification in the future. A simpler strategy for in vivo sequestration that has not been 
explored is the further incorporation of a toxic value compound into a more neutral molecule. 
Unlike bacterial catabolism of toxic compounds, which typically involves a number of substrate 
conversion steps – such as toluene breakdown by P. putida (Nicolaou et al., 2010), this strategy 
would incorporate the toxic compound into a more neutral molecule from which it would be 
easy to retrieve downstream. This is a strategy that bacteria already exploit for the accumulation 
of poly-β-hydroxybutyrate, but has not been explored for the detoxification of value products in 
microbial platforms. 
Ultimately, the goal of engineering microbial strains for improved tolerance is to increase final 
production levels. There are a number of examples where engineering strains for improved 
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tolerance, or end-product sequestration have been successful for increasing final titres. For 
example, a strain of S. cerevisiae engineered for improved salt tolerance also resulted in 
improved ethanol tolerance and resulted in a dramatic increase in ethanol titres (Lam et al., 
2014); while two-phase fermentation has significantly improved the production of styrene in E. 
coli (McKenna et al., 2015). However, while growth and productivity are intimately linked, an 
improvement in tolerance does not necessarily mean there will be an increase in productivity, as 
other bottlenecks and pathway regulation may also be limiting improved production 
(Mukopadhyay, 2015). This stresses the importance of the field of metabolic engineering, which 




1.9 General aims and objectives 
 
The overall aim of this project was to investigate a previously unexplored strategy for reducing 
the microbial toxicity of heterologously produced value compounds in the platform host, E. coli. 
This strategy involved the in vivo sequestration of a toxic end-product into a compound that is 
more tolerated by the microbial host. Specifically, this work targeted the incorporation of 
endogenously produced toxic alcohols into less toxic esters via enzymatic esterification in order 
to evaluate the effectiveness of this strategy for decreasing toxicity/increasing productivity. 
From this broad aim, a set of objectives were outlined for the project as follows:  
• Validation of esterification as a strategy for detoxification of value alcohols in E. coli 
using butanol as a model alcohol. 
• Application of this strategy to the short chain alcohol, butanol, in E. coli. 






2. Materials and Methods 
 
All chemicals were supplied by Sigma-Aldrich (Gillingham, UK) or Fisher Scientific (Waltham, 
USA) unless otherwise stated. 
 
 
2.1 Microbial Growth Media 
 
 
2.1.1 Luria Broth (LB) 
LB media contained 10 g Tryptone (Merk, UK), 5 g Yeast Extract (Melford, UK) and 10 g NaCl 
dissolved in 1 L of distilled water (dH2O) and was sterilized by autoclaving (at 121℃ and 15 psi 
for 30 minutes) before use. For LB agar plates, agar was added to a final concentration of 1.5% 
(w/v) before autoclaving. For antibiotic resistance selection ampicillin was added to a final 
concentration of 100 µg/mL, kanamycin to a final concentration of 50 µg/mL, tetracycline to a 
final concentration of 20 µg/mL, and hygromycin (Roche, UK) to a final concentration of 100 
µg/mL. 
 
2.1.2. 2X Tryptone Yeast Broth (2TY) 
2TY contained 16 g Tryptone, 10 g Yeast Extract, and 5 g NaCl dissolved in 1 L of dH2O and 
autoclaves to sterilization before use. 
 
2.1.3 Terrific Broth (TB) 
TB media contained 12 g Tryptone, 24 g Yeast Extract, 4 mL Glycerol, 0.17 M KH2PO4, and 
0.72 M K2HPO4 were dissolved in 1 L of dH2O and autoclaved to sterilization before use.  
 
2.1.4 Modified Terrific Broth (MTB) 
MTB media contained 12 g Tryptone, 24 g Yeast Extract, 4 mL Glycerol, and 5 g of NaCl were 
dissolved in 1 L of dH2O and autoclaved to sterilization before use.  
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2.1.5 Fermentation Media (FM) 
FM media contained 9.8 g K2HPO4, 5 g yeast extract, 0.3 g ferric ammonium citrate, 2.1 g citric 
acid monohydrate, 0.06 g MgSO4 and 1 mL of trace element solution which includes 0.37 g 
(NH4)6Mo7O24·4H2O, 0.29 g ZnSO4·7H2O, 2.47 g H3BO4, 0.25 g CuSO4·5H2O and 1.58 g 
MnCl2·4H2O) were dissolved in 1 L of dH2O and autoclaved to sterilization before use. 
 
2.1.6 M9 minimal media  
M9 minimal media contained 12.8 g Na2HPO4·7H20, 3 g KH2PO4, 0.5 g NaCl, 1 g NH4Cl, 1 
mM MgSO4, 100 µM CaCl2, 3 nM (NH4)6Mo7O24·4H20, 0.4 µM H3BO3, 30 nM 
CoCl2·6H20, 10 nM CuSO4·5H20, 80 nM MnCl2·4H20, 10 nM ZnSO4·7H20, 1 µM 
FeSO4·7H20, and 0.5% yeast extract were dissolved in 1 L of dH2O and filter sterilized before 
use. 
 
2.1.7 Reinforced Clostridia Media (RCM) 
RCM media contained 13 g Yeast extract, 10 g peptone, 5 g glucose, 1 g soluble starch, 5 g 
NaCl, 3 g NaOAc, and 0.5 g cysteine hydrochloride was dissolved in 1 L of dH2O and 
autoclaved to sterilize before use. 
 
 
2.2 E. coli strains and plasmids 
 
 
Table 2. 1 E. coli plasmids and strains used in this study. 
Name Descriptiona Source 
Plasmid   
pJOE2792 AmpR, PRha, PFEPf A gift from Uwe T. 
Bornscheuer  
 
pET21a::EcAAT pColE1 ori, AmpR, PT7, AATEc This study 
pIM8 pCola ori, KanR, PLlacO1, TerTd  Atsumi et al., 2013 
pEL11 pCola ori, AmpR, PLlacO1, AtoBEc, adhE2Ec, 
crtCa, hbdCa,  
Atsumi et al., 2013 




plasmid # 40019) 
pAG32 pBR322 ori, AmpR, PT7, HygB A gift from John 
McCusker (Addgene 
plasmid # 35122) 
pFRANK p15A ori, HygR, PT7, AATEc This study 
pVICTOR p15A ori, HygR, PT7, AATEc, TerTd, fdhEc This study 
pVICTOR2.0 p15A ori, HygR, PT7, AATEc, PT7, TerTd, fdhEc This study 
pADAM p15A ori, HygR, PT7, AATEc, PT7, TerTd, fdhEc, 
fadDEc 
This study 
pSHELLEY p15A ori, HygR, PT7, AATEc, PT7, TerTd, fdhEc, 
FatB1Cp, fadDEc 
This study 
pET21a::CpFATB1 pColE1 ori, AmpR, PT7, FatB1Cp This study 
pET28a::RhAAT pColE1 ori, KanR, PT7, AATRh This study 
pET28a::GES pColE1 ori, KanR, PT7, GESOb This study 
pMIB13 p15A ori, AmpR, PlacUV5, AtoBEc,  HMGSSa, 
HMGRSa, 2Tb, Ptrc, MKSc, PMKSc, PMDSc, 
idiEc, T1002c, Ptrc, trGPPSAgd,    GESOb 
This study; modified 
from Alonso-
Gutierrez et al., 
2013) 
pET21a::Cs2848 pColE1 ori, AmpR, PT7, 2848Cs This study 
pET21a::Cs4859 pColE1 ori, AmpR, PT7, 4859Cs This study 
pET21a::Cs5680 pColE1 ori, AmpR, PT7, 5680Cs This study 
pET21a::Cs2944 pColE1 ori, AmpR, PT7, 2944Cs This study 
pET21a::Cs2130 pColE1 ori, AmpR, PT7, 2130Cs This study 
pET21a::Cs5781 pColE1 ori, AmpR, PT7, 5781Cs This study 
pET21a::Ca2917 pColE1 ori, AmpR, PT7, 2917Ca This study 
pET21a::Ca1962 pColE1 ori, AmpR, PT7, 1962Ca This study 
pET21a::CaLipG pColE1 ori, AmpR, PT7, LipGCa This study 
Strain Genotype/plasmids  
BioBlue K-12 background; recA1, endA1 gyrA96 thi-
1 hsdR17(rk-, mk+) supE44 relA1 lac [F’ 
proAB lacIqZΔM15 Tn10(Tetr)] 
Bioline 
DH5α fhuA2 lac(del)U169 phoA glnV44 Φ80' 
lacZ(del)M15 gyrA96 recA1 relA1 endA1 
thi-1 hsdR17 
Thermo Fisher 
C43 (DE3) F – ompT hsdSB (rB- mB-) gal dcm (DE3) Lucigen 
JCL166 BW25113/F’ [traD36 proAB+ 
lacIqZΔM15(Tetr)] ΔldhA ΔadhE ΔfrdBC 
Atsumi et al., 2008 
JW5020 F-, Δ(araD-
araB)567, ΔfadE739::kan, ΔlacZ4787(::rrnB-
3), λ-,rph-1, Δ(rhaD-rhaB)568, hsdR514 
Baba et al., 2006 
Coli Genetic Stock 




DLB JCL166 pEL11 + pIM8 This study 
DLBO1 JCL166 pEL11 + pVICTOR This study 
DLBO2 JCL166 pEL11 + pIM8 + pFRANK This study 
DLG2 C43(DE3) pMIB13 This study 
DLGA3 C43(DE3) pMIB13 + pET28a::RhAAT This study 
a in plasmid description, subscripts indicate the source of the gene as follows: Pf, Pseudomonas 
fluorescens; Ec, Escherichia coli; Td, Treponema denticola; Ca, Clostridia acetobutylicum; Cp, 
Cuphea palustris; Rh, Rosa hybrid; Sa, Staphylococcus aureus; Sc, Saccharomyces cerevisiae; 
Ab, Abies grandis; Ob, Ocimum basilicum; Cb, Clostridia saccharoperbutylacetonicum 
b in plasmid description, antibiotic abbreviations are as follows: Amp, Ampcillin; Kan, 
Kanamycin; Hyg, Hygromycin; Tet, Tetracycline 
c 2T: both the rrnB T1 terminator and T7Te terminator 
d T002: terminator 
e tr-GPPS: truncated sequence of GPPS  
 
 
2.3 Molecular biology methods 
 
 
2.3.1 Codon harmonization and optimization 
The alcohol acyltransferase 16 (AAT16) gene from Actinidia chinensis was codon harmonized 
to E. coli using codon usage tables. The A. chinensis codon usage table was created using 
DAMBE (Data Analysis and Molecular Biology and Evolution, Xia, 2013). The harmonized 
sequence was subsequently termed EcAAT16. All other synthesized genes were codon 
optimized to the genome of E. coli using GeneArt software (Thermo Fisher Scientific, UK). 
 
2.3.2 Acquisition of bacterial knockout strains, genomic DNA, and harmonized/ 
optimized gene sequences 
The genomic DNA from clostridium acetobutylicum and C. saccharoperbutylacetonicum was 
purchased from the DSMZ collection catalogue (Germany). The E. coli knockout strain JW5020 
(ΔFadE) was obtained from the Coli Genetic Stock Center (CGSC) (Connecticut, USA). All 




2.3.3 Polymerase chain reaction (PCR) 
2.3.3.1 End point PCR 
PCR reaction were carried out in 0.25 mL PCR tubes using a final liquid volume of 50 µl 
composed of: 1 µl of template DNA, 5 µl of each of the 10 µM primers, 5 µl of 2.5 mM dNTPs, 
10 µl of 5X Phusion HF-buffer, 19 µl of Milli-Q water (18.2 mΩ), and 1 unit Phusion Hot Start 
II polymerase. PCR reactions were performed according to the manufacturer’s instructions for 
30 cycles. The annealing temperature was varied depending on the Tm of the specific primers 
used for the given reaction. Reactions were performed using a Bioer Genepro thermal cycler 
(Alpha Laboratories, UK). 
 
2.3.3.2 Point mutation PCR for site-directed mutagenesis  
PCR reactions were carried out as described in section 2.3.1.1 for end point PCR, in two 
sequential DNA amplifications. Figure 2.1 demonstrates the two-step process. The first 
amplification consisted of flanking primers (A & B) that were complementary to the ends of the 
target sequence, and internal primers (C & D) that contained a mismatch capable of generating a 
mutation corresponding to the desired amino acid change. The first PCR reactions involved 
creating fragments AD and BC, each of which contain the desired point mutation. The second 
PCR reaction involved using both fragments AD and BC as a template and using the flanking 
primers (A & B). The complementary ends of both templates hybridize allowing initial fragment 
extension followed by PCR amplification of the full sequence, creating a final single product 
containing the desired internal point mutation. A modification to the second PCR reaction 
involved using a larger volume of equimolar amounts of fragments AB and CD than described 
above in section 2.3.1.1. The PCR reaction contained: 10 µl of fragment AB, 10 µl of fragment 
CD, 5 µl of each of the 10 µM primers, 5 µl of 2.5 mM dNTPs, 10 µl of 5X Phusion HF-buffer, 






Figure 2. 1 Site-directed mutagenesis by primer extension. 
 
 
2.3.3.3 Diagnostic/colony PCR 
PCR reactions were carried out in a final volume of 25 µl composed of: 1.5 µl of each of the 10 
µM primers, 12.5 µl of 2X KAPATaq ReadyMix, and 9.5 µl of Milli-Q water (18.2 mΩ), and a 
E. coli colony added directly to the mix. PCR reactions were performed according to the 
manufacturer’s instructions for 35 cycles, with the annealing temperature varying depending on 
the Tm of the specific primers used (Appendix). 
 
2.3.4 Quantitative reverse transcription polymerase chain reaction (qRT-PCR) 
2.3.4.1 Isolation of RNA from E. coli cells 
Overnight cultures of E. coli strain C43 (DE3) harbouring either no plasmid, pFRANK or 
pVICTOR2.0 were inoculated into TB + 2% glucose to 1% (v/v) and incubated at 37°C and 250 
rpm until the OD600 reached ~1. Each culture was then induced with 0.4 mM IPTG before 
continuing incubation at 37°C for a further16 hours. RNA was isolated from 1 mL culture 
samples using the GenEluteTM Total RNA purification Kit (Sigma-Aldrich) according to the 
manufacturer’s instructions for the preparation of RNA from bacteria, with one modification to 
the protocol. During the DNase I digestion step, the incubation time was extended from 15 
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minutes to 1.5 hours. RNA concentration and purity was determined using a NanoVue Plus 
spectrophotometer (GE Healthcare, UK).  
 
2.3.4.2 Reverse transcription of RNA samples (RT-PCR) 
An Applied Biosystems High Capacity cDNA Reverse Transcription Kit was used to prepare 
cDNA from the previously purified RNA samples according to the manufacturer’s instructions 
using random primers. 1 µg of RNA sample was diluted in 10 µl of nuclease free water, and 
used for a single cDNA reaction. Samples were subsequently stored at -20°C. 
 
2.3.4.3 Quantitative polymerase chain reaction (qPCR) 
qPCR was used as tool to compare expression of the EcAAT and Ter genes when expressed from 
either plasmid pFRANK or pVICTOR2.0. 16S ribosomal RNA (rrsA) from E. coli was used as a 
reference transcript. qPCR primers for target genes were designed using an online tool called 
Primer3 (http://bioinfo.ut.ee/primer3/) under the following constraints:  
 
• Primer size ranges from 18-24 bp 
• The amplified region of DNA does not exceed 200 bp 
• GC content of 50-60% 
• Tm range between 60-63°C 
• Tm difference between primers does not exceed 5°C 
• Maximum 3’ self complementarity score of 1 
 
A 1/10 dilution of the previously isolated cDNA in Milli-Q water (18.2 mΩ) was prepared to 
give a working stock of template at 5 ng/µl based on the concentration of the original RNA 
sample. A total reaction volume of 20 µl consisted of: 5 µl of diluted template, 0.25 µM 
forward/reverse primer (see Methods section 2.3.2.4), 1X LuminoCt® SYBR® Green qPCR 
ReadyMixTM, after which each sample was centrifuged at 2000 rpm for 1 minute before running. 
qPCR reactions were run in triplicate for each sample using the DNAEngine Peltier Termal 
cycler coupled with the Chromo4TM Real-Time PCR Detector (BioRad, UK), and data was 
analysed by the Opticon 3 thermal cycler software program (BioRad, UK). qPCR conditions 
were set as specified by the manufacturer’s instructions for the qPCR of RNA templates with 
SYBR® Green pPCR ReadyMixTM, specifically an initial denaturation step of 95°C for 20 
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seconds, followed by 40 cycles consisting of a denaturation step of 95°C for 3 seconds, and an 
annealing/extension step of 60°C for 30 seconds. Following this, a melt curve to confirm the 
formation of single products during qPCR was performed for each sample, to do this, the 
temperature was raised from 55°C to 95°C and fluorescence readings were taken at 0.2°C 
increments.  
Cycle threshold (Ct) values were determined for each sample using a method first described by 
Pfaffl (Pfaffl, 2001) and modified by Abad et al., (2010) to determine fold expression relative to 




In this equation, ‘R’ represents the relative abundance of the target gene to the reference gene, 
‘E’ is the efficiency or amplification achieved through 1 cycle by the specific primer pair 
amplifying the detected region of either the target or reference gene and ΔCt is calculated as the 
difference in Ct value between the no template control and the sample.  
 
2.3.4.4 Determination of amplification efficiency for qPCR primer set 
To maximize the validity of the results obtained from the RT-qPCR experiments, 5 qPCR 
primer sets for a single target gene were tested for amplification efficiency, and a single set with 
optimal efficiency was chosen. A 10 – fold serial dilution of cDNA was carried out to provide a 
range of 5 template quantities of 0.001 ng, 0.1 ng, 1 ng, 10 ng, and 100 ng per 20 µl reaction. 
qPCR reactions with the tested primer sets were conducted in triplicate for each condition and 
the final Ct values were plotted against the logarithm of the original template quantity. The 
gradient of the linear plot was then used to calculate the efficiency of the primer set according to 




Where ‘E’ is the amplification efficiency (%) and ‘g’ is the gradient of the line. Primer sets that 
displayed an efficiency between 90-110%, and that only produced single products during PCR – 
as determined by melt curve analysis and gel electrophoresis of samples – were used in further 
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qPCR experiments. Table 2 shows the chosen primer sets for each gene examined in this study, 
and their amplification efficiency. 
 
 
Table 2. 2 List of primers used for RT-qPCR and their respective amplification efficiency. 













2.3.5 Gel electrophoresis of DNA 
For separation of DNA fragments, a 1% (w/v) agarose gel was used. Agarose gels were set in 
1X TAE buffer (0.48% (w/v) Tris base, 0.11% (v/v) acetic acid, 0.2% EDTA, pH 8.0), with 
0.5X SYBR® Safe. 7 µl of the GeneRulerTM 1kb DNA molecular weight ladder (Figure 2.2) was 
loaded in the first well of each agarose gel. 4 µl of 5X DNA loading buffer (30% (v/v) glycerol, 
and 0.25% (w/v) bromophenol blue) was added to each PCR sample before being loaded onto 
the gel. Gels were run in a Bio-Rad Wide Mini-Sub cell GT Tank (Bio-Rad, UK) containing 1X 
TAE buffer at 110V for approximately 30 minutes. Visualization and imaging of each gel was 






Figure 2. 2 DNA fragment size estimation was done using a GeneRulerTM 1kb DNA Ladder. 
 
 
2.3.6 Purification of DNA 
2.3.6.1 from agarose gel 
DNA from agarose gels were visualized via UV light exposure using an UV box (Fotodyne, 
USA), and bands were excised using a scalpel. A ZymocleanTM Gel DNA Recover Kit 
(Cambridge Bioscience, UK) was used to purify DNA from the excised gel fragment according 
to the manufacturer’s instructions. DNA was eluted into 6 µl of Milli-Q water (18.2 mΩ). 
 
2.3.6.2 from PCR reaction 
DNA from PCR reactions was purified using a DNA Clean & Concentrator kit from Zymo 
Research (Cambridge Bioscience, UK) according to the manufacturer’s instructions. DNA was 




2.3.6.3 from E. coli culture  
Plasmid DNA was purified from 5 mL of E. coli culture incubated overnight in LB media. A 
Qiaprep Spin Miniprep Kit (Qiagen, UK) was used according to the manufacturer’s instructions 
and DNA was eluted into 50 µl of Milli-Q water (18.2 mΩ). 
 
2.3.7 DNA and RNA quantification 
DNA and RNA concentration was measured using a NanoVue Plus spectrophotometer (GE 
Healthcare, UK). 2 µl of DNA sample was loaded and quantified by measuring the absorbance 
of light at 260 nm. Purity of the DNA/RNA sample was quantified by calculating the ratio of 
absorbance at 260 nm to 280 nm.  
 
2.3.8 DNA restriction digestion 
Restriction enzymes were purchased from either Thermo Fisher Scientific (UK) or New England 
Biolabs (UK). Restriction digestions were carried out according to the manufacturer’s 
instructions in a total volume of 20 µl for approximately 1 hour at 37°C. Digest reactions were 
then run on a 1% (w/v) agarose gel for separation of fragments and subsequent gel DNA 
purification.  
 
2.3.9 DNA ligation 
T4 DNA ligase was used for DNA ligations carried out according to the manufacturer’s 
instructions in a total reaction volume of 10 µl. Insert to vector ratios of 3:1 and 5:1 were 
employed, and reactions were incubated at room temperature overnight before being 
transformed into chemically competent E. coli cells. 
 
2.3.10 Gibson assembly  
Gibson assembly was carried out according to Gibson (2009). PCR primers (Appendix) used for 
amplifying the insert fragment were designed to include a 40 bp linker that shares identity with 
the regions flaking the site of insertion in the vector. This was done for the primers amplifying 
from both the 5’ and 3’ ends of the insert. A master mix containing 320 µl of 5X isothermal 
reaction buffer (25% PEG-8000, 500 mM Tris-HCl pH 7.5, 50 mM MgCl2, 50 mM DTT, 1 mM 
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full set of dNTPs, and 5 mM NAD), 0.64 µl 10 U/µl T5 exonuclease (New England Biolabs, 
UK), 20 µl 2 U/µl Phusion DNA polymerase, 160 µl 40 U/µl Taq DNA Ligase, and Mili-Q 
water (18.2 mΩ) was made up to a final volume of 15 µl. To this, 5 µl of volume containing 100 
ng of linearized vector and an equimolar quantity of insert was added and incubated at 50°C for 
1 hour. 5 µl of assembled Gibson mix was then transformed into chemically competent E. coli 
cells.  
 
2.3.11 Transformation into chemically competent E. coli  
A 50 µl aliquot of chemically competent BioBlue E. coli cells was thawed on ice for 
approximately 10 minutes. To the aliquot, 5 µl of the ligation or Gibson assembly mix was 
added, followed by a further 20 minute incubation on ice. The cells were then heat shocked for 
45 seconds at 42°C, and held on ice for 5 minutes before the addition of 1 mL of LB media. 
Transformations were then recovered at 37°C for 1 hour shaking at 250 rpm. Following this, 
cells were centrifuged at 4000 rpm for 1 minute and resuspended in 100 µl of LB media before 
being plated onto an LB + antibiotic plate and incubated at 37°C overnight.  
 
 
2.4 Protein methods  
 
 
2.4.1 SDS-PAGE  
2.4.1.1 SDS-PAGE gel composition 
SDS-PAGE gels were made in house between glass plates in a casting frame (BioRad, UK) 
using dH20, 30% (w/v) acrylamide mix, 1.5 M Tris-HCl pH 8.8 for resolving gels or 1.0 M Tris-
HCl pH 6.8 for stacking gels, SDS, 20% (w/v) ammonium persulfate, and 
tetramethylethylenediamine (TEMED). The volume of each component used to make the 





Table 2. 3 List of ingredients used to make resolving and stacking SDS-PAGE gels. 
 Volume required to make 10 mL total volume 
(mL) 
 
 12% resolving gel Stacking gel 
H20 4.2 7.2 
30% (w/v) acrylamide mix 6.4 1.25 
1.5 M Tris-HCl pH 8.8 5.2 - 
1.0 M Tris-HCl pH 6.8 - 1.25 
SDS 0.16 0.1 
20% (w/v) Ammonium 
persulfate 
0.024 0.03 
TEMED 0.02 0.01 
 
 
2.4.1.2 Sample preparation and running conditions 
1 mL of E. coli culture was centrifuged at 14 000 rpm for 5 minutes and the supernatant was 
discarded. The cell pellet was resuspended in 100 µl of buffer A (20 mM Tris pH 8.0, 0.3 M 
NaCl, and 10 mM imidazole) and sonicated on ice at 12 microns for 10 seconds using a 
Soniprep 150 plus (MSE, UK). Samples were centrifuged again at 14 000 rpm for 10 minutes 
and 20 µl of supernatant was removed and mixed with 5X SDS-PAGE loading buffer (10% 
(w/v) SDS, 20% (v/v) glycerol, 10 mM DTT, 0.2 M Tris pH 6.8, and 0.05% bromophenol blue) 
to a final concentration of 1X. Samples were then incubated at 98°C for 3 minutes before 
loading 10 µl onto the SDS-PAGE gel. 6 µl of a Pierce Unstained Protein Moleclar Weight 
Marker (Thermo Fisher) was run in the first well as an indicator for protein size (Figure 2.3).  
Gels were run in SDS-PAGE running buffer (25 mM Tris base, 192 mM glycine, and 0.1% 
(w/v) SDS) at 30 mA per gel for approximately 1 hour using a Mini-PROTEAN® Tetra System 










2.4.1.3 Staining/Destaining and imaging of SDS-PAGE gel 
Following gel electrophoresis, SDS-PAGE gels were stained with Coomassie Blue stain solution 
(0.2% (w/v) Coomassie blue, 10% (v/v) acetic acid, 50% (v/v) methanol) for 1 hour. Gels were 
then de-stained in a 10% (v/v) acetic acid and 30% (v/v) methanol solution until protein band 
could be visualized clearly. SDS-PAGE gels were visualized in a Syngene G:Box ChemiHR and 
the paired GeneSNAP software (Syngene, UK) using white light.  
 
2.4.2 Recombinant protein expression in E. coli 
E. coli strain C43 (DE3) heterologously expressing the desired protein was grown at 37°C in LB 
broth supplemented with the relevant antibiotic, overnight. The culture was then diluted 1/100 
into 1L of 2TY + antibiotic and grown at 37°C and 250 rpm until an OD600 of 1.0 was reached. 
At this point gene expression was induced with the addition of either rhamnose (final 
concentration of 0.2% (w/v)) or IPTG (final concentration of 0.4 mM) – depending on the 
promotor– and further incubated for another 16 hours at 37°C. Cultures were centrifuged at 
4000 rpm for 20 minutes at 4°C and cell pellets was harvested and stored at -80°C for future use. 
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2.4.3 Protein purification using His-Tag 
The cell pellet was removed from -80°C, allowed to thaw on ice, resuspended in 2.5 mL of 
Buffer A (20 mM Tris pH8.0, 300 mM NaCl, 10 mM imidazole), and sonicated using a 
Soniprep 150 plus (MSE, UK) on ice at 12 microns for four intervals of 30 seconds. The sample 
was centrifuged at 14,800 rpm for 15 minutes to obtain the soluble fraction. The soluble fraction 
obtained was then loaded onto a Poly-Prep chromatography column (0.8 x 4 cm, BioRad, UK) 
with a pre-equilibrated metal affinity resin charged with cobalt (Clontech, UK). The soluble 
fraction was run through the column, followed by a column wash with 20 mL of Buffer A. The 
His-tagged protein was then eluted from the column into a final volume of 2 mL using a mixture 
of Buffer A and Buffer B (20 mM Tris pH8.0, 300 mM NaCl, 1 M imidazole) that contains a 
final imidazole concentration of 500 mM.  
 
2.4.4 Crude cell extract preparation  
The cell pellet was removed from -80°C, allowed to thaw on ice, resuspended in 5 mL of 
resuspension buffer (50 mM Tris-HCl pH 7.5, protease inhibitor tablet EDTA-free) and 
sonicated using a Soniprep 150 plus (MSE, UK) on ice at 12 microns for four internals of 30 
seconds. The sample was then centrifuged at 14,800 rpm for 15 minutes to obtain the soluble 
fraction. The soluble fraction was further concentrated using a Protein Concentrator PES spin 
column with a 10K MWCO (Molecular Weight Cut Off) (Pierce, UK) by centrifuging at 14,800 
rpm until the final sample concentration was approximately 1 mL. 
 
2.4.5 Protein quantification  
Protein concentration was determined using the Bradford Method (Bradford, 1976). Bovine 
serum albumin (Pierce, USA) was used as a protein standard, and using a 2:7 dilution of 
Bradford reagent, (BioRad, UK) a standard curve ranging from 0-100 µl/mL was used for 
sample quantification. Dilutions of protein samples were prepared in dH2O. Absorbance of 
standards and samples were read at 595 nm using a Cary50 Bio (Varian, UK).  
 
2.4.7 pH indicator assay of esterase activity  
Esterase activity was determined with a spectrophotometric assay using a pH indicator. The final 
assay solution was prepared by mixing BES (N,N-bis[2-hydroxyethyl]-2-aminoethanesulfonic 
59 
 
acid) buffer (5 mM pH 7.2), 1 mM ethyl octanoate, -decanoate, or butyl octanoate, -decanoate as 
substrate, 4-nitrophenol (4.5 mM dissolved in 5 mM BES pH 7.2; ɛ=18x103m-1cm-1) as a pH 
indicator, 3.9% acetonitrile, and 1 µl purified esterase in a final volume of 1 mL. Reaction rate 
was determined by following the decrease in absorbance at 404 nm in 96 microtiter plates 
(Greiner Bio-One, UK) using a BioTek Synergy HT plate reader (BioTek, UK) at 37°C for 10 
minutes. Initial rates were calculated from the slope of the linear potion of the curve, usually the 
first 120 seconds. 
 
2.4.8 p-nitrophenyl acid assay of esterase activity 
Esterase activity was determined spectrophotometrically using a Cary 50 Bio spectrophotometer 
(Varian, UK). Reactions were carried out in a sodium phosphate buffer (50 mM pH 7.5) using 
either p-nitrophenol acetate, -butyrate, -octanoate, or -decanoate (pNPA, pNPB, pNPO, and 
pNPD 10 mM dissolved in DMSO) as substrates. Buffer solution was mixed with increasing 
volumes of p-nitrophenyl substrate and the reaction was started with the addition of 10 µl of 
protein to a final reaction volume of 1 mL. The amount of liberated p-nitrophenol was 
determined at 400 nm (ɛ=15x103 M-1cm-1) and 25°C. From the initial reaction rate, the esterase 
activity was calculated. One unit (U) of esterase activity was defined as the amount of enzyme 
releasing 1 mmol p-nitrophenol/min under assay conditions. Kinetic parameters were calculating 
using Sigma Plot graphing software (Systat software Inc.). 
 
2.4.9 p-nitrophenyl acid assay of lipase activity 
Lipase activity was determined spectrophotometrically using a 6305 UV/Vis spectrophotometer 
(Jenway, UK). Reactions were carried out in a sodium phosphate buffer (50 mM pH 7.5) using 
p-nitrophenol myristate or –palmitate (10 mM dissolved in hexane). Buffer solution was mixed 
with either 200 µM or 50 µM of p-nitrophenol substrate, 1% (v/v) Triton X-100, and the 
reaction was started with the addition of 30 µl protein to a final volume of 1 mL. Reaction was 
incubated at 37°C. The amount of liberated p-nitrophenol was determined at 410 nm (ɛ=15x103 
M-1cm-1) at various time points up to 3 hours. From the initial reaction rate, the esterase activity 
was calculated. One unit (U) of esterase activity was defined as the amount of enzyme releasing 
1 mmol p-nitrophenol/min under assay conditions. 
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2.4.10 Assay for Alcohol Acyltransferase (AAT) activity 
Reactions were carried out in a total volume of 500 µl containing: 10 µl crude cell lysate of E. 
coli strain C43 (DE3) expressing the AAT enzyme, buffer (50 mM Tris HCl pH 8.5, 10% (v/v) 
glycerol, and 1 mM DTT), 10 mM butanol, and 0.75 mM hexanoyl-CoA. Reactions were 
incubated at 30°C for 30 minutes before being halted with the addition of 50 µl of 10% (w/v) 
SDS. Each reaction was then extracted into 100 µl of hexane for future product analysis by GC-
MS. 
 
2.4.11 Assay for trans-2-enoyl-CoA reductase (TER) activity 
Ter activity was determined on a Cary 50 Bio spectrophotometer (Varian, UK) by measuring the 
decrease in absorbance at 340 nm. Reactions were carried out in a total volume of 1 mL 
containing: phosphate buffer pH 6.2, 200 µM NADH, 2 µl FAD, 200 µM crotonyl-CoA, and 5 
µl of crude cell lysate of E. coli strain C43 (DE3) expressing the Ter enzyme. All ingredients, 
except for the cell lysate, were pre-incubated at 30°C for 5 minutes before the addition of the 
lysate and the commencement of absorbance reading. Initial reaction rates were calculated from 
the slope of the linear potion of the curve, usually the first 60 seconds. 
 
2.4.12 Malachite Green assay for terpene synthase activity 
The malachite green assay was performed in 96-well microtiter plates (Greiner Bio-One, UK) in 
a total volume of 50 µl according to Vardakou et al., (2014). The assay mix contained malachite 
green assay buffer (25 mM MES, 20 mM CAPS, 50 mM Tris, 2.5 mU of inorganic 
pyrophosphatase (Saccharomyces cerevisiae), 5 mM MgCl2) pH 7.5, 0.008 µM purified GES 
enzyme, geranyl pyrophosphate (GPP) ranging in concentration from 10-400 µM, and a fixed 
concentration of geraniol (either 0, 100, 200, or 400 µM). Reactions were set up on ice and 
incubated at 30°C for 5 minutes. The reaction was halted by the addition of 12 mL of malachite 
green development solution, and incubated a further 15 minutes at 30°C prior to reading at 623 
nm on a BioTek microplate reader. Malachite green development solution was prepared by 
mixing 10 mL of malachite green dye stock solution (300 mL of 18 M H2SO4 mixed with 1.5 L 
of water and 2.2 g of malachite green powder) with 2.5 mL of 7.5% (w/v) ammonium 
molybdate, and 0.2 mL 11% (v/v) Tween 20. Standard curves of monophosphate (Pi) and 
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pyrophosphate (PPi) ranging from 0.39-50 µM were used for product quantification. Kinetic 
parameters were calculating using Sigma Plot graphing software (Systat software Inc.). 
 
2.4.13 3D protein structure construction and analysis of EcAAT from A. chinensis  
2.4.13.1 3D protein structure modelling 
A 3D model of EcAAT was built by comparative modelling based on the high-resolution crystal 
structure of homologous proteins. Swiss-Model (Arnold et al., 2006) was used for selecting 3D 
models with the closest homology available in the PMDB. The crystal structures of three 
proteins (PMDB codes: 4KEC, 4G22, and BGH2) were selected as the template for EcAAT 
model construction, which was then done using MODELLER 9.18 software 
(www.salilab.org/modeller/). The model showing the lowest MODELLER objective function 
and RMSD with respect to trace (Cα) atoms of the crystal structure templates was carried 
forward.  
2.4.13.2 Binding pocket identification  
The solvent pocket associated with the AAT active site motif were identified using the 
ICMPOCKETFINDER feature of ICM software (Abagyan et al., 1994; www.molsoft.com). 
This feature identifies all voids and pockets of the protein 3D structure and measures the volume 
and area of each. As well, it identifies the surrounding residues that compose said pockets. The 
pocket associated with the acyltransferase catalytic motif (HxxxD) was identified as the 
substrate binding pocket, and the residues composing this pocket were individually manipulated 
using ICM software to identify potentially favourable changes in binding pocket size. From this, 








2.5 Cell biology methods 
 
 
2.5.1 Growth curves of wild type E. coli grown in the presence of butanol and butyl 
esters 
Wild type cultures of E. coli strain DH5α were incubated in 5 mL cultures of LB media 
overnight at 37°C and 250 rpm. Following this, cultures were newly inoculated into 7 mL of LB 
media to a final OD600 of 0.4 and incubated at 37°C and 250 rpm with the OD600 being recorded 
every 30 minutes with a 6305 spectrophotometer (Jenway, UK). 1.5 hours post inoculation, 
varying concentrations of either a butyl ester (butyl acetate, -butyrate, -hexanoate, -octanoate, 
and -decanoate) or butanol was individually added to the cultures. Cultures continued to be 
incubation at 37°C and 250 rpm, and the OD600 continued to be recorded every 30 minutes until 
one hour after stationary phase was reached. Each condition was run in triplicate.  
 
2.5.2 Growth curves of wild type C. acetobutylicum and C. 
saccharoperbutylacetonicum in the presence of butyl esters 
30 mL of RCM media was inoculated with 200 µl of a glycerol stock culture of either C. 
acetobutylicum or C. saccharoperbutylacetonicum and incubated at 32°C overnight in an 
anaerobic stationary incubator. Following this, cultures were newly inoculated into 15 mL of 
RCM media with 5% of the overnight culture, and then incubated at 32°C and 150 rpm. After 
1.5 hours of incubation, the OD600 of each culture was recorded and butyl esters as various final 
concentrations were added individually into each culture using a Hamilton syringe to pierce the 
bottle stopper. The cultures were then incubated at 32°C and 150rpm with OD600 readings being 
taken every 1.5 hours for approximately 8 hours. Samples were run in duplicate.  
 
2.5.3 Butyl ester feeding in E. coli cultures heterologously expressing an esterase 
from Pseudomonas fluorescens 
E. coli strain DH5α expressing the plasmid pJOE2792::PFE (Pseudomonas fluorescens esterase) 
was incubated in LB media supplemented with ampicillin (100 µg/mL) at 37°C and 250 rpm for 
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16 hours. The cultures were then diluted 1:100 and grown to an OD600 of 0.4 in LB with the 
relevant antibiotic before being induced with the addition of rhamnose (0.2% w/v). Following 
this, cultures were further incubated another 2 hours under the same culture conditions before 
the addition of either 10 mM butyl octanoate or -decanoate. Wild type DH5α E. coli cultures 
individually supplemented with 10 mM of either butyl ester were used as controls. Cultures 
were then further incubated at 37°C and 250 rpm for a total of 48 hours. Following this, 5 mL 
samples of each culture was taken at 12, 24, and 48 hours and the OD600 was determined. Each 
sample was then centrifuged at 4000 rpm for 5 minutes and the supernatant poured into a 
separate tube and stored at -20°C for future analysis. 
 
2.5.4 Analysis of supernatant esterase activity due to cell lysis in E. coli  
E. coli strain DH5α expressing the plasmid pJOE2792::PFE (Pseudomonas fluorescens esterase) 
was incubated in LB media supplemented with ampicillin (100 µg/mL) at 37°C and 250 rpm for 
16 hours. The cultures were then diluted 1:100 and grown to an OD600 of 0.4 in LB with the 
relevant antibiotic before being induced with the addition of rhamnose (0.2% w/v). Following 
this, cultures were incubated at 37°C and 250 rpm for 12 hours before being divided into two 
groups. Group one had 10 mM of either butyl octanoate or -decanoate added to the culture and 
was further incubated another 12 hours at 37°C and 250 rpm, while the cultures of group two 
were centrifuged at 4000 rpm to separate culture supernatant and pellet and the supernatant 
exclusively was incubated with 10 mM of either butyl octanoate or -decanoate for 12 hours at 
37°C and 250 rpm. Following this, 5 mL samples from the cultures of each group were 
centrifuged at 4000 rpm for 5 minutes and the supernatant was poured into a separate tube and 
stored at -20°C for future analysis. 
 
2.5.5 1-Butanol production by E. coli 
E. coli strain JCL166 expressing the relevant plasmids for butanol production was incubated in 
LB media supplemented with appropriate antibiotic (ampicillin 100 µg/mL, kanamycin 50 
µg/mL, hygromycin 100 µg/mL, tetracyclin 20 µg/mL) at 37°C and 250 rpm for 16 hours. 
Cultures were then diluted 1:100 into 25 mL of TB-2% (w/v) glucose media with relevant 
antibiotics in anaerobic vials (Supelco, UK), and grown to an OD600 of 0.8 aerobically before 
induction with 0.1 mM isopropyl-β-D-thiogalactopyranoside (IPTG). Following this, cultures 
were grown aerobically for a further 2 hours before the displacement of oxygen from cultures 
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vials using an N2 stream, and the capping of vials with an anaerobic crimp cap (Supelco, UK). 
Cultures were then incubated at 37°C and 250 rpm with 5 mL samples taken at 24 hour intervals 
for 96 hours. As well, cultures were supplemented with 1.5% glucose daily. The OD600 of 
samples were determined and stored at-20°C for future analysis. 
 
2.5.6 Shake-flask aerobic production of butyl esters in E. coli with substrate 
feeding 
E. coli strain C43 (DE3) expressing a relevant butyl ester producing plasmid was incubated in 
LB media supplemented with relevant antibiotic (ampicillin 100 µg/mL, or hygromycin 100 
µg/mL) at 37°C and 250 rpm for 16 hours. Cultures were then diluted 1:100 and grown to an 
OD600 of 0.8 in TB + 2% (w/v) glucose media with relevant antibiotics before being induced 
with 0.4 mM IPTG. Following this, cultures were further incubated 2 hours at 20°C and 250 rpm 
before the addition of 5 mM octanoic acid and 10 mM butanol. A culture of wild type C43 
(DE3) was used as a negative control. After 18 hours of incubation at 20°C and 250 rpm the 
OD600 of each sample was determined and culture pellet and supernatant were separated and 
stored at -20°C for future analysis. 
 
2.5.7 Shake-flask anaerobic production of butyl esters in E. coli with substrate 
feeding 
E. coli strain JCL166 expressing the relevant plasmids for butanol and butyl ester production 
was incubated in LB media supplemented with appropriate antibiotic (ampicillin 100 µg/mL, 
kanamycin 50 µg/mL, hygromycin 100 µg/mL, tetracycline 20 µg/mL) at 37°C and 250 rpm for 
16 hours. Following this, cultures were grown as described in section 2.5.4 with several 
modifications, including: cultures were induced with 0.4 mM IPTG as opposed to 0.1 mM, after 
induction cultures were grown at 30℃ as opposed to 37℃, and 24 hours after the anaerobic 
switch cultures were supplemented with 3 mM octanoic acid. A sample was then taken 48 hours 
post-anaerobic switch to determine the OD600 and the culture supernatant and pellet were 




2.5.8 Shake-flask culturing of E. coli for fatty acid profile analysis 
E. coli strains C43 (DE3) and JW5020 (ΔFadE) were incubated in LB media supplemented with 
relevant antibiotics (kanamycin 50 µg/mL) at 37°C and 250 rpm for 16 hours. Cultures were 
then diluted 1:100 and grown to an OD600 of 0.8 in M9 + 2% (v/v) glucose media with relevant 
antibiotics, and then incubated at 20℃ before the exogenous addition of 2.5 mM octanoic acid. 
Following this, cultures were incubated at 20°C and 250 rpm for 18 hours before samples were 
taken to determine OD600, and culture pellets were stored at -20°C for future analysis. 
2.5.9 Heterologous expression of thioesterase in E. coli  
E. coli strains C43 (DE3) and JW5020 (ΔFadE) expressing a plasmid holding a thioesterase 
(TE) named FATB1 from Cuphea palustris were incubated in LB media supplemented with 
relevant antibiotics (ampicillin 100 µg/mL and/or kanamycin 50 µg/mL) at 37°C and 250 rpm 
for 16 hours. Cultures were then diluted 1:100 and grown to an OD600 of 0.8 in M9 + 1% (v/v) 
glycerol media with relevant antibiotics before being induced with 0.4 mM IPTG. At this time, 
some cultures were additionally supplemented with 4 µg/mL of the antibiotic cerulenin for fatty 
acid elongation retardation. Following induction, all cultures were incubated at 30°C and 250 
rpm for 24 hours before samples were taken to determine OD600, and culture pellets were stored 
at -20°C for future analysis. 
 
2.5.10 Shake flask production of geranyl acetate in E. coli with substrate feeding 
E. coli harbouring the plasmid holding the AAT from Rosa hybrida was inoculated into LB 
media supplemented with kanamycin (50 µg/mL) and grown overnight at 37°C and 250 rpm.  
Cultures were then inoculated at 1:100 into 25 mL of TB + 2% (w/v) glucose media with 
relevant antibiotic with kanamycin (50 µg/mL), and grown at 37°C until an OD600 of 1 was 
reached. Cultures were then induced with 0.4 mM IPTG and moved to 20°C and 250 rpm for 2 
hours before being fed 10 mM acetic acid and 0.5 mM geraniol. Cultures were then further 
incubated for 18 hours at 20°C and 250 rpm. Following this, the OD600 was measured and 





2.5.11 Shake-flask geraniol and geranyl acetate production in E. coli 
Strains DLGA2 and DLGA3 were inoculated into LB media and grown overnight at 37°C.  
Cultures were then inoculated at 1:100 into 25mL of TB + 2% (w/v) glucose media with 
relevant antibiotic, and grown at 37°C until an OD600 of 1 was reached. 
 
2.5.11.1 Geraniol  
Cultures of the DLG2 strain were then induced with 50 µM IPTG, and a 10% (v/v) dodecane top 
layer was added to trap geraniol and other monoterpenes. Cultures were then transferred to a 
rotary shaker (250 rpm) at 30oC. After 24 hours, the OD600 in the aqueous phase was measured 
and a sample of the dodecane layer was taken and diluted into ethyl acetate for analysis by gas-
chromatography mass-spectometry (GC-MS).  
 
2.5.11.2 Geranyl acetate 
Cultures of the DLGA3 strain were induced with 100 µM IPTG and supplemented with either 0, 
5, 10 or 20 mM acetic acid before a 10% (v/v) dodecane top layer was added to trap geranyl 
acetate. Cultures were then incubated at 30°C in a rotary shaker (250 rpm) for 24 hours and 
analysed as described above. 
 
2.5.12 Analysis of endogenous isomerization and reduction of geraniol and nerol in 
E. coli 
E. coli strain C34 (DE3) was inoculated into LB media and grown overnight at 37°C.  The 
following day, cultures were inoculated at 1:100 into 5 mL of TB + 2% (w/v) glucose media, 
and grown at 37°C in a rotary shaker (250 rpm) until an OD600 of 4 was reached. Cultures were 
then fed either 0.5 mM geraniol or 0.5 mM nerol and further incubated at 37°C and 250 rpm for 




2.5.13 Fed-Batch fermentation of Geraniol and Geranyl Acetate in Bioreactor 
2.5.13.1 MTB media 
Strains DLG2 and DLGA3 were incubated overnight at 37 °C in 100 mL of LB media and used 
to inoculate a 1.5 L fermenter (BIOSTAT B plus MO5L, Sartorius, Germany) containing 1.2 L 
of MTB media containing the relevant antibiotics. Strain DLG2 was induced when OD600 
reached approximately 20 with 50 µM IPTG, and a 10% (v/v) dodecane top layer was then fed 
into the culture. Strain DLGA3 was induced when OD600 reached approximately 20 with 125 
µM IPTG, 20 mM acetic acid and a 10% (v/v) dodecane top layer were then fed into the culture. 
Culture temperature was maintained at 30°C and pH was maintained at 6.8 by automatic 
addition of 5 M KOH or 5 M H2SO4. Antifoam 204 was used to minimize foam development. 
Dissolved oxygen was maintained at 20% saturation through air flow and stir speed. Intermittent 
feeding of a MTB + 65% (w/v) glucose solution was initiated to maintain culture glucose 
concentration between 5-10 g/L. Fermentation samples were periodically collected to determine 
culture OD600, glucose concentration, and terpene product formation.  
 
2.5.13.2 FM media 
Strain DLGA3 was also run in fed-batch fermentation using a semi-defined fermentation media 
(FM). Conditions were as described above for strain DLGA3, with an exception being that the 
culture was induced with 100 µM IPTG at an OD600 of 5.5. Intermittent feeding of an FM + 65% 
(w/v) glucose solution was used to maintain culture glucose concentration between 5-10 g/L.  
 
2.5.14 Solubility of geraniol and geranyl acetate 
10 mL of TB+2% (w/v) glucose media was supplemented with either 100 mg/L of geraniol or 
geranyl acetate followed by the addition of a 10% (v/v) dodecane top layer before being 
incubated at 30°C and 250 rpm for 6 hours. After incubation, a sample of the organic dodecane 
top layer was taken directly for analysis by GC-MS, while the aqueous layer was further 





2.6 Lipid product extraction 
 
 
2.6.1 Ester extraction  
2.6.1.1 From culture supernatant 
25 mL of culture was removed and centrifuged at 20℃ and 14,800 rpm for 10 minutes to 
separate the culture pellet and supernatant. The supernatant was poured off into a glass vial and 
extracted with 1.5 mL of hexane by vortexing in three 30 second intervals. The supernatant 
sample was then centrifuged again at 14, 800 rpm for 5 minutes to separate the organic and 
aqueous phases and ~300 µl of the organic phase was removed and placed in a 1.5 mL gas 
chromatography vial (Varian, UK) to run on the GC-MS.  
 
2.6.1.2 From culture pellet 
The remaining pellet was resuspended in 3 mL of 0.9% (w/v) NaCl and sonicated on ice at 12 
microns for four intervals of 30 seconds. Pellet samples were then extracted with 500 µl of 
hexane and vortexed in three 30 second intervals. Samples were then centrifuged at 14, 800 rpm 
for 5 minutes and ~300 µl of the organic phase was placed in a 1.5 mL gas chromatography vial 
(Varian, UK) to run on the GC-MS.  
 
2.6.2 Free fatty acid esterification and extraction 
2 mL of culture was centrifuged at 5000 rpm for 10 minutes to separate the supernatant and 
pellet, the supernatant was discarded. To the pellet, 10 µg of undecanoic acid (C:11) was added 
as an internal standard, and then the pellets were resuspended in 3 mL of 1 M MeOH-HCl 
before being heated to 80°C for 90 minutes. Samples were then cooled to room temperature 
before the addition of 1 mL of 0.9% (w/v) NaCl followed by extraction with 500 µl of hexane. 
and ~300 µl of the organic phase was placed in a 1.5 mL gas chromatography vial (Varian, UK) 





2.7 Product quantification methods 
 
 
2.7.1 Gas Chromatography-Mass Spectroscopy (GC-MS) 
2.7.1.1 For butanol and esterified acid products 
Butanol and butyl ester products were quantified by a model 7890B gas chromatograph and 
5977A mass spectrometer (Agilent technologies, Stockport, UK). Samples were separated on a 
DB-FFAP 30m x 20 µm x 0.25 µm capillary column under the following conditions: 1 µl of 
sample was injected onto the column which was held at 40°C for 5 minutes, the temperature was 
then ramped at a gradient of 15°C/min to a final temperature of 250°C and held for 4 minutes. 
Butanol and butyl ester products typically eluted between 4 and 12 minutes and were monitored 
on both MS and FID detectors. The concentration of product was quantified using calibration 
curves for each compound analysed. 
 
2.7.1.2 For terpene and terpene ester products 
Terpene and ester products were quantified by a model 7890B gas chromatograph and 5977A 
mass spectrometer (Agilent technologies, Stockport, UK). Samples were separated on a DB-
FFAP 30m x 20 µm x 0.25 µm capillary column under the following conditions: 1 µl of sample 
was injected onto the column which was held at 40°C for 1 minute, the temperature was then 
ramped at a gradient of 20°C/min to a final temperature of 250°C and held for 8 minutes. 
Terpene and ester products typically eluted between 7 and 11 minutes and were monitored on 
both MS and FID detectors. The concentration of product was quantified using calibration 
curves for each compound analysed.  
 
2.7.2 Ion Chromatography (IC) 
During fermentation, culture glucose was monitored using ion chromatography with a Dionex 
5000+ fitted with a 4x250 mm analytical CarboPac PA1 column (Thermo Fisher, UK). Filtered 
supernatant was injected and run isocratically for 15 minutes at a flow rate of 1.0 mL/min (50 
mM NaOH at 30°C). Glucose concentration was quantified using a calibration curve. 
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3. Validation of an esterification strategy for the detoxification 





Butanol is a valuable compound and intermediate in a number of industries, and its applications 
include use as a solvent, as a feedstock chemical in the plastics industry, as an extractant in the 
food, flavour, cosmetic and pharmaceutical industries, and as a renewable fuel (Parekh et al., 
1999; Dürre, 2007; Ezeji et al., 2007; Papoutsakis, 2008; Lee et al., 2008; Lütke-Eversloh and 
Bahl, 2011; Ndaba et al., 2015). With all of these commercial applications, the global demand 
for n-butanol is estimated to be more than 5 million tons per year, with a market value of nearly 
6 billion USD for butanol alone, and 50 billion USD for butanol derivatives (Branduardi, 2014; 
www.nexant.com). This ever-growing demand, paired with the fluctuating cost of the 
petroleum-based feedstocks used to chemically synthesise butanol, has stimulated interest in the 
development of renewable and sustainable strategies for butanol production (Zheng et al., 2009; 
Nielsen et al., 2009). Specifically, microbial platforms for butanol production have been a 
growing market in the biotechnology industry over the last few decades. Butanol can be 
produced naturally by carbohydrate fermentation using certain species of clostridia via the ABE 
fermentation pathway (Introduction, Figure 1.1), with wild type solventogenic strains producing 
between 12-13 g/L from simple sugars in batch fermentation (Papoutsakis, 2008). To improve 
upon these titres to an economically practical level, a significant amount of research has gone 
into not only optimizing butanol production in clostridia, but also heterologous reconstruction of 
the butanol biosynthetic pathway in other more tractable microbial hosts that possess more 
established genetic toolboxes. This heterologous expression in non-native strains has been done 
in a number of organisms including: E. coli, S. cerevisiae, P. putida, B. subtilis, and 
cyanobacteria (Nielsen et al., 2009; Shen et al., 2011; Lan et al., 2011; Schadeweg et al., 2016). 
However, the butanol titres achieved by these heterologous hosts have been moderate, and have 
not yet exceeded those of the natural clostridial producers, even with extensive metabolic 
engineering of both the butanol pathway and the host strain (Atsumi et al., 2008; Lee et al., 
2011; Shen et al., 2011; Chin et al., 2013; Wang et al., 2015; Dong et al., 2016).  
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A significant impediment to achieving higher microbial butanol titres, not only in the 
heterologous hosts – but also in the native clostridial species – is the high cytotoxicity of 
butanol. Butanol exhibits inhibitory effects on microbial growth at low concentrations, with 
even native clostridial producers only able to tolerate 2% (v/v) (Papoutsakis, 2008; Liu et al., 
2012). Non-native producers are generally less tolerant to butanol, with E. coli strains rarely 
being able to tolerate above 1.5% (v/v) (Fischer et al., 2008; Knoshaug et al., 2009). The modes 
of toxicity butanol exert on cellular function are multifaceted and often intimately linked to 
general stress responses, making them difficult to address (Rutherford et al., 2010; Dunlop et 
al., 2011). Butanol is relatively hydrophobic and accumulates in cytoplasmic membranes where 
it disrupts structure and function by increasing membrane fluidity. This has several trickle-down 
effects, including the inability to maintain transmembrane ion gradients, leading to energetic 
uncoupling and leakage of intracellular metabolites. Additionally, it has been implicated in 
increasing the production of reactive oxygen species (ROS), and hindering metabolite transport 
and biosynthesis (Isken and de Bont, 1998; Dong et al., 2009, Nielsen et al., 2009; Rutherford et 
al., 2010). To address this microbial toxicity, a number of groups have employed rational 
(directed) and/or random (combinatorial) approaches to developing butanol-resistant E. coli 
strains. Several notable successes at improving tolerance include the co-overexpression of 
multiple molecular chaperones, expression of a heterologous efflux pump from P. 
putida/directed evolution of a native efflux pump, expression of metallothioneins to act as 
scavengers for ROS, and global transcription machinery engineering (Zingaro et al., 2012; Chin 
et al., 2013; Fisher et al., 2014; Bui et al., 2015; Zhang et al., 2015). Additionally, butanol 
recovery techniques have been developed that are designed to minimize the fermentation 
culture’s exposure to butanol. Strategies such as gas-stripping and in situ liquid-liquid extraction 
have successfully been implemented, usually in complementation with strain engineering (Ezeji 
et al., 2007; Fischer et al., 2008; Zheng et al., 2009). However, butanol tolerance remains a 
complex, multigenic phenotype, and the successes that have been achieved have been moderate. 
Ultimately, there has been no all-encompassing solution to the problem of microbial butanol 
toxicity through strain engineering thus far. 
An alternative strategy to combat microbial toxicity may be to modify the butanol molecule 
itself to be less toxic, as opposed to engineering the bacterial system for increased tolerance. 
Similar to the effects of extraction this would sequester the butanol into a less reactive form that 
does not accumulate in – and disrupt the function of – cell membranes, thus improving the 
achievable titres in culture. A simple molecule into which to sequester butanol would be an 
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ester. Previous work done to engineer E. coli strains for the production of fatty acid methyl and 
ethyl esters (FAMEs and FAEEs, respectively) have reported their accumulation has no impact 
on culture heath – suggesting the same may be the case for butyl esters (Elbahloul et al., 2010; 
Fan et al., 2013; Sherkhanov et al., 2016). An advantage of this strategy over the iterative 
engineering of E. coli for improved butanol tolerance is that in vivo butanol esterification 





Figure 3. 1 Mechanism showing the in vivo enzyme catalysed condensation of butanol and an acyl-
CoA to form a butyl ester. 
 
 
This strategy for addressing butanol toxicity via esterification has not been attempted 
previously, and as such requires fundamental validation of its potential efficacy. The primary 
consideration for this strategy is the target ester into which butanol will be sequestered. This 
ester should possess certain characteristics, including: the ability to accumulate to higher 
concentrations in culture than butanol with little to no impact on culture health, and the ability to 
permeate across the plasma membrane into the extracellular milieu. This latter consideration, 
regarding molecule permeability, is an important consideration with regard to downstream 
recovery of the butyl ester. Generally, industrial fermentation of E. coli strains engineered for 
the production of long chain FAMEs and FAEEs suffers from high extraction costs as these 
compounds remain intracellular and therefore require a more intensive recovery process than 
compounds that are secreted in to the culture supernatant (Elbahloul et al., 2010). 
Here, the work carried out was toward investigating butyl esters as a less toxic derivative of 
butanol in E. coli as a potential detoxification strategy. To do this (i) the microbial toxicity of a 
number of butyl esters of varying acid moiety chain length compared to butanol was assessed, 
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and (ii) the ability of those butyl esters with minimal microbial toxicity to move across the 
plasma membrane in E. coli was assessed.  
 
 
3.2 Results and discussion 
 
3.2.1 Identification of an end-product butyl ester with low toxicity to E. coli 
 
To determine which butyl ester(s) would be the most suitable candidate for sequestering butanol 
wild type E. coli DH5α was cultured with exogenously fed butyl esters of increasing acid moiety 
length from acetate to decanoate, over a concentration range of 0 mM to 100 mM. Cultures fed 
butanol at the same concentrations were run in parallel for comparison of toxicity (Figure 3.2). 
The general trend observed from these toxicity tests is that butyl ester toxicity becomes 
progressively greater as the length of the acid moiety of the ester increases from acetate (C2:0) 
to hexanoate (C6:0), with the minimum concentration of ester required to impart an observable 
impact on growth rate decreasing over this range (Figure 3.2). However, it appears that both 
butyl octanoate and -decanoate exposure had very little impact on the growth rate of E. coli; 
with cultures exposed to even 100 mM of either butyl ester growing comparably to the wild type 
controls. The observed high toxicity of the shorter chain butyl esters correlates to some degree 
with the solubility of these compounds, and their resultant bioavailability to the cell. Their 
solvent-like nature allows them to partition into the hydrophobic cell membrane. An indirect 
metric to assess the ability of a compound to interact with a membrane is its partition coefficient 
(log P), which is defined as the ratio of the concentration of a compound between an aqueous 
(water) and hydrophobic (1-octanol) phase (de Bont, 1998). Compounds with a log P in the 
range of 1-3.8 tend to be toxic to the growth of E. coli due to this membrane perturbation, while 
solvents with a log P >4 being highly insoluble in the media, minimizing bioexposure, and 
solvents with a log P <1 typically being water soluble, meaning they would impose any toxic 
effect via a different mechanism to the solvent-like compounds (Vermuë et al., 1993; Isken et 
al., 1999; Rutherford et al., 2010; Mukhopadhyay et al., 2015). Table 3.1 shows the log P value 
of each of the butyl esters studied in this work. From here we can see that butyl acetate, -
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butyrate, and -hexanoate have values within the range of 1-3.8, while butyl octanoate and -
decanoate have values above this threshold. Thus, the shorter chain butyl esters were discarded 
as viable candidates for this strategy, as their toxicity was even higher than butanol, and 
progressed with C8 and C10 butyl esters as potential end-point products. 
 
 
Table 3. 1 The 1-octanol/water partition coefficient (Log P) values for the butyl esters evaluated in 
this work. 
Alcohol/Ester LogP valuea 
Butyl acetate 1.82 
Butyl butyrate 2.83 
Butyl hexanoate 3.84 
Butyl octanoate 4.73 
Butyl decanoate 5.88 
a values were determined using the ALOGPS calculator from http://www.vcclab.org/lab/alogps/ 
 
 
At a nominal concentration of 100 mM in culture, the aqueous solubility of both butyl octanoate 
and -decanoate is greatly exceeded (aqueous solubility of butyl octanoate = 3.5 mg/L at 25℃ 
and butyl decanoate = 0.36 mg/L at 25℃; http://www.thegoodscentscompany.com), suggesting 
these compounds truly lack any molecular toxicity. However, an alternative type of microbial 
toxicity named ‘phase toxicity’ can occur when a culture is grown in the presence of a second 
organic phase (Bar et al. 1987). Occasionally the presence of an aqueous/solvent interface can 
lead to interfacial cell contact and adsorption, extraction of membrane components, partitioning 
of nutrients from the aqueous phase, and limited nutrient availability to the cell (Bar et al., 1987; 
Bothun et al., 2005). To determine whether or not butyl octanoate or -decanoate causes phase 
toxicity, the concentration of each exogenously fed ester was increased to 125 mM, 150 mM, 





Figure 3. 2 Growth of wild type E. coli DH5α fed 0 mM, 1 mM, 10 mM, and 100 mM of either: A, 
butanol; B, butyl acetate; C, butyl butyrate; D, butyl hexanoate; E, butyl octanoate; or F, butyl 
decanoate. Cultures were grown at 37℃ and 250 rpm, and the OD600 was taken every 30 minutes 
until stationary phase was reached. Butyl ester was added 1 hour after first reading (indicated with 
the black arrow). Data are the mean ± standard deviation from three biological replicates. 
 
 
had no impact on the growth rate of E. coli, suggesting that they cause no phase toxicity, at least 
not at these concentrations. Conversely, a concentration of 125 mM butanol resulted in 
arrestment of culture growth (Figure 3.3). This is unsurprising as this concentration is the 
equivalent of 1.15% (v/v), which exceeds the reported tolerated level in E. coli (Fischer et al., 





Figure 3. 3 Growth rate of wild type DH5α E. coli endogenously fed 0 mM, 125 mM, 150 mM, and 
200 mM of either: A, butanol; B, butyl octanoate, or C, butyl decanoate. Cultures were grown at 
37℃ and 250 rpm, and the OD600 was taken every 30 minutes until stationary phase was reached. 
Butyl ester was fed 1 hour after first reading (indicated with black arrow). Data are the mean ± 
standard deviation from three biological replicates. 
 
 
These results suggest that both butyl octanoate and -decanoate could be ideal esters into which 
to sequester butanol as neither have any impact on E. coli culture health at high nominal 
concentrations, that far surpass the toxicity limit of butanol. However, although they are 
probably not partitioning significantly into cell membranes, a possible alternative explanation 
for the lack of an observable toxicity could be that, due to their size, they are too bulky to 
readily permeate across the cellular membranes into the cell interior to interact with, and disrupt 
the function of, intracellular components. This would present two significant problems; first, the 
possibility that these two esters would be more toxic to the cell if produced endogenously, as 
their inability to cross the plasma membrane may skew the true measure of their toxicity. 
Second, the inability of these esters to permeate across the plasma membrane into the cell upon 
external exposure would suggest that they would be equally unable to pass across the membrane 
out of the cell into the culture media when being made endogenously. Should this be the case, it 




3.2.2 Investigation of the ability of butyl octanoate and decanoate to permeate 
across the plasma membrane of E. coli to the extracellular milieu 
 
To determine whether butyl octanoate and -decanoate are able to move across the plasma 
membrane into and out of the cell, a non-secreted esterase from Pseudomonas fluorescens was 
heterologously expressed in E. coli. Esterases are a class of hydrolase enzyme that are 
responsible for the hydrolysis of short and medium chain carboxylic esters (Jensen et al., 2016). 
The rationale behind this strategy was that exogenously fed butyl esters which can move across 
the E. coli cell membranes into the cytoplasm would be hydrolysed by the P. fluorescens 
esterase (PFE) into their alcohol and acid components, which can then be detected by 
chromatography. Heterologous expression of a non-native esterase was required for this 
experimental strategy as E. coli has no documented esterase enzymes with specific activity for 
hydrolysing butyl esters. These compounds are not natural products of E. coli metabolism and, 
generally, E. coli expresses only low levels of nonspecific esterase activity. While individual 
esterases have been identified in E. coli, such as one from the hormone-sensitive lipase (HSL) 
family of proteins that has been characterised for hydrolysing carboxylic esters with acyl chains 
≤ C8, the in vivo activity of these esterases is basal (Kanaya et al., 1998; Antonczak et al., 
2009). The PFE that was heterologously expressed has been well characterised by Krebsfänger 
et al., (1998), and shown to be active in hydrolysing ethyl esters. Typically, the substrate 
preference of an esterase is dictated by either the acyl chain length or the alcohol chain length, 
but rarely both (Bornscheuer, 2002). This particular esterase from Pseudomonas has substrate 
specificity that is dictated by the acyl chain length of the ester, and is thus promiscuous with 
regard to the alcohol length it will accept as a substrate. This suggests that it would also be able 
to hydrolyse butyl esters, such as butyl octanoate and -decanoate, in addition to the ethyl esters it 
was already characterised for. 
To confirm that PFE does in fact have activity for hydrolysing butyl octanoate and -decanoate 
the PFE gene was overexpressed from the rhamnose inducible pJOE2792::PFE+His6x plasmid 
(a generous gift from Dr. Uwe Bornscheuer from the Institut für Technische Biochemie, 
Universität Stuttgart) in E. coli and purified the esterase (Figure 3.4). Activity of this enzyme 
towards  the ethyl and butyl esters of octanoate and decanoate was determined using a 
continuous in vitro pH indicator assay where 4-nitrophenol was used as the indicator. This assay 
progresses as the given ester is hydrolysed to its alcohol and acid components, which 
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accumulate in the reaction mixture and increase the local pH. In turn, the 4-nitrophenolate 
indicator is protonated and the resulting 4-nitrophenolate can be quantified at a wavelength of 
404 nm (Janes et al., 1998). From the results (Table 3.2), it is evident that PFE does have 
activity for both ethyl and butyl esters of octanoate and decanoate. It was lower for the butyl 
esters compared to their ethyl counterparts, which was expected as it had also previously shown 
lower activity towards methyl esters compared to ethyl esters, suggesting ethyl esters are its 
preferred substrate (Krebsfänger et al., 1998). For further analysis of PFE enzyme kinetics 
towards the hydrolysis of esters with C8 and C10 acyl chain lengths, a continuous in vitro assay 
which followed the PFE mediated hydrolysis of either p-nitrophenyl octanoate or -decanoate 
was carried out by quantifying the amount of released p-nitrophenol at a wavelength of 410 nm. 
This later kinetic data confirms the preference of the PFE for the shorter octanoate chain length 
over decanoate, with kcat/Km values of 39.9 µM-1/s-1 and 1.4 , respectively. Ultimately, the PFE 
enzyme suited our needs as it is a non-secreted esterase, known to be actively expressed in E 




Figure 3. 4 Coomassie-stained SDS-PAGE gel showing the PFE protein purified from a 1 L culture 
of E. coli strain BL21 (DE3) expressing plasmid pJOE2792::PFE+His6x. PFE was purified using a 
cobalt affinity column and is predicted to be 30 kDa in size. Lane A, B, and C represent 1 µl, 2 µl, 
and 5 µl, respectively, of a 7 mg/L sample of purified PFE. The size of the bands (in kDa) is 






Table 3. 2 In vitro activity of PFE for hydrolysing ethyl and butyl octanoate and -decanoate using a 
pH indicator assay. Activity is mean + standard deviation from four replicates. 
Substrate Activity (mmol/min/mg)a 
Ethyl octanoate 1.48 + 0.13 
Ethyl decanoate 0.42 + 5.7x10-2 
Butyl octanoate 0.42 + 7.3x10-2 
Butyl decanoate 0.13 + 1.3x10-2 
a Activities were determined at 37°C and pH 7.2 using purified PFE and 1mM of respective substrate 
 
 
Table 3.3 1 In vitro activity of PFE for hydrolysing p-nitrophenyl octanoate and -decanoate. Kinetic 
parameters were determined using a colorimetric assay. Data are the mean + standard deviation from 
three replicates. 
 p-nitrophenyl octanoate (C8) p-nitrophenyl decanoate (C10) 
Km (µM) 0.1 + 8e-3 23 + 4 
Vmax (µmol/mg/min) 8 + 0.3 63 + 6 
kcat/Km (µM-1/s-1) 39.9 1.4 
 
 
With confirmation that PFE was able to hydrolyse butyl octanoate and -decanoate esters, we 
then expressed this enzyme in E. coli strain DH5α and fed either 10 mM of octanoate or 
decanoate butyl esters to growing cultures. The culture supernatant was then analysed at 12, 24, 
and 48 hours for the presence of ester breakdown products, i.e. butanol and either octanoic acid 
or decanoic acid (Figure 3.5). While the exogenously fed butyl ester substrates could be detected 
in both the culture supernatant and pelleted cell fractions (data not shown), the acid and alcohol 
breakdown products were detected primarily in the culture supernatant, with only trace amounts 
present in the pellet. This was not unexpected as it is known that both butanol and free fatty 
acids are diffused extracellularly by E. coli (Shen et al., 2011; Lennen et al., 2013). Therefore, 
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only the material in the culture supernatant was quantified. Figure 3.5 shows that the amount of 
butanol and decanoic acid in the supernatant of cultures supplemented with butyl decanoate was 
considerably lower than that of butanol and octanoic acid present in cultures supplemented with 
butyl octanoate. This difference is most likely the result of a combination of two factors, the first 
being the respective substrate specificity of the PFE enzyme for hydrolysing these two esters – 
with a preference for the shorter, octanoate chain length (Table 3.2) – and the second being the 
respective ability of these two esters to move across the plasma membrane. The proportion of 
butyl decanoate present in the culture supernatant was consistently higher than the proportion of 
butyl octanoate present in the supernatant at each time point sampled (data not shown), 
suggesting that the larger ester may move more slowly across the membrane into the cytoplasm. 
This would ultimately influence the intracellular concentration of butyl decanoate available to 
the PFE enzyme for hydrolysis. These results indicate that butyl-octanoate would be a more 
suitable end-product ester for butanol sequestration as it should move more easily across the 
plasma membrane – a desirable quality for this strategy.  
Additionally, this confirmation that both butyl octanoate and -decanoate are capable of moving 
across the plasma membrane into the cytoplasm suggests that the lack of microbial toxicity 
observed for both of these esters even at high concentration in culture (Section 3.2.1) is a 
reflection of true molecular inertness, and not a result of their inability to interact with, and 






Figure 3. 5 Quantification of the butanol, octanoic acid and decanoic acid found in the supernatant 
of cultures of E. coli strain DH5α heterologously expressing an esterase from P. fluorescens (PFE) at 
12, 24, and 48 hours after feeding with either 10 mM butyl octanoate or -decanoate. Data are the 
mean + standard deviation from three biological replicates.  
 
 
A potential criticism of the strategy employed above – with the heterologous expression of a 
non-secreted esterase in E. coli to confirm the movement of esters across the plasma membrane 
into the cytoplasm – is that it does not take into consideration the effects of cell lysis. While the 
PFE enzyme used in this work is non-secreted, it is possible that through cell lysis it becomes 
exposed to esters present in the extracellular milieu, hydrolysing them and ultimately confusing 
the analysis. Thus, depending on the amount of cell lysis taking place, this could skew the 
results to indicate these esters move across the plasma membrane more readily than they truly 
do. To account for hydrolysis due to enzyme released by cell lysis, two culture conditions were 
compared: (1) at 12 hours of growth post induction for PFE expression, either 10 mM butyl 
octanoate or -decanoate was fed into the culture and incubated for a further 12 hours before 
analysis, as done previously, and (2) at 12 hours of growth post induction for PFE expression, 
only the culture supernatant was isolated and incubated with either 10 mM butyl octanoate or 
decanoate for a further 12 hours before analysis of culture supernatant for breakdown products. 
Condition (2) allows for comparison of the amount of ester hydrolysis that occurs via 
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extracellular PFE activity as a result of cell lysis. Figure 3.6 shows that the amount of ester 
hydrolysis that can be attributed to extracellular PFE activity accounts for approximately 10% of 
the total butyl octanoate hydrolysis in culture and 30% of the total butyl decanoate hydrolysis in 
culture. Thus, the majority of breakdown product detected in the supernatant can be attributed to 
intracellular ester hydrolysis as opposed to extracellular hydrolysis, confirming that both these 
esters are able to move across the cell membranes into the cytoplasm. 
Ultimately, there is very little known about the mechanism by which esters move across the 
plasma membrane into the cell, however these results would tentatively suggest that the size of 
the ester plays a role in the efficiency of the translocation – with longer chains moving across 
less proficiently. Though much further work would need to be done to confirm this, which is out 
of the scope of this project. For our purposes, this work has confirmed that both butyl octanoate 
and -decanoate and able to translocate across the plasma membrane, further supporting their use 




Figure 3. 6 Comparison of the amount of octanoic acid and decanoic acid found secreted into the 
extracellular milieu of either: cultures of E. coli strain DH5α heterologously expressing PFE, or just 
the supernatant from E. coli strain DH5α cultures expressing PFE. Breakdown products were 
quantified after 12 hours of sample incubation with either 10 mM butyl octanoate or -decanoate. 





The preliminary work carried out here determined that the strategy of sequestering butanol into 
an ester molecule as a means to decrease microbial toxicity is a valid strategy. Toxicity tests 
aimed at identifying butyl esters that are more tolerated than butanol by E. coli identified two 
potential candidates, butyl octanoate and decanoate. In addition to causing no molecular or 
phase toxicity in culture, it was confirmed that both these butyl esters are able to move across 
the plasma membrane – an ideal feature with regards to downstream processing. Of these two 
butyl esters, the shorter chain octanoate ester was identified as a more suitable candidate for this 
strategy because, though it is equally as non-toxic and the decanoate ester, it appeared to move 
across the plasma membrane more easily. This is beneficial as it would mean (i) no further strain 
modification would be required to facilitate the export of our end-product ester, and (ii) no cost 
intensive fermentation extraction process would be required.  
In this chapter, it was established that developing a E. coli platform that endogenously 
sequestration of butanol into an ester could offer a simple solution to the complex and 
multifaceted problem of microbial butanol toxicity. To put this strategy into practise, an enzyme 
capable of esterifying an alcohol and an acid – named an alcohol acyltransferase (AAT), will be 
required. Specifically, an AAT that is capable of esterifying butanol and octanoic acid to 

















4. Engineering E. coli for the production of medium chain 





Volatile short and medium chain esters (C4-C14) are found naturally in the flowers and ripening 
fruit of plants, where they play a dual function in contributing to the aroma and flavour of the 
plant as an attractant to animals, as well as acting as a deterrent towards microbes and pathogens 
(Beekwilder et al., 2004; Rodriguez et al., 2014). In addition, they can be produced during 
fermentation by certain species of yeast and lactic acid bacteria (LAB) – the results of which can 
be seen in beer and wine (Verstrepen et al., 2003; Costello et al., 2013). The enzyme responsible 
for the synthesis of these esters is called an alcohol acyltransferase (AAT), which catalyses the 
condensation of an alcohol with an acyl-CoA. These enzymes are capable of combining 
different acyl-CoA and alcohol substrates to produce a wide range of esters – which together 
contribute to the complexity of the aroma (Harada et al., 1985; El-Sharkawy et al., 2005). These 
enzymes are members of the BAHD acyltransferase family (an acronym for the first letter of the 
first four enzymes characterised in this family). Members of this family contain a conserved 
HXXXD catalytic motif and a DFGWG motif (Galaz et al., 2013; Morales-Quintana et al., 
2013; Molina and Kosma, 2015). These enzymes typically have promiscuous activity for 
producing short chain esters, often with acyl chain lengths of C2 or C4. Table 4.1 shows all the 
characterised AAT enzymes to date which have been isolated and characterised for substrate 
specificity either by in vitro assay or heterologous expression. AAT activity has been identified 
in several other organisms, but the individual enzymes responsible have not been isolated.   
A number of groups have utilized the heterologous expression of AAT enzymes for the 
production of these short and medium chain esters in E. coli and other model hosts with the 
intention of developing platforms for the microbial production of these compounds for 
cosmetics, perfumes, food/beverages, solvents, plasticizers, and biofuels (Vadali et al., 2003; 
Park et al., 2009; Rodriguez et al., 2013; Guo et al., 2014; Tai et al., 2015). The choice of AAT 
enzyme employed in a given platform will depend on the host organism itself and the desired 
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end product ester(s). Thus far, the most commonly used AAT enzymes for these purposes have 
been ATF1 and ATF2 from S. cerevisiae and SAAT from Fragaria x ananassa because of their 
high activity and promiscuous substrate specificity (Table 4.1). In addition to the choice of AAT 
enzymes used, several additional considerations must be made when engineering a system for 
high titre production of a desired end-product ester. First, the alcohol and acid substrate 
availability in a chosen host. For example, E. coli is only able to natively produce a single 
alcohol, ethanol, and minimal amounts of short chain free fatty acids (Rodriguez et al., 2013), 
and as such, this platform requires either exogenous substrate feeding (Horton et al., 2005; Guo 
et al., 2014), or further heterologous expression of the requisite pathways for endogenous 
substrate production. As exogenous culture feeding can often be limited by the microbial 
toxicity of a given compound, a number of groups have opted to engineer the endogenous 
production of desired short chain alcohol and acid substrates – such as butanol, isobutanol, 
isoamyl alcohol, and butyrate (Rodriguez et al., 2013; Layton et al., 2014; Tai et al., 2015). 
Second, tailoring of the final ester profile being produced. AAT enzymes are often promiscuous 
and will synthesise a range of different esters in a heterologous host as opposed to a single end-
product. Depending on the commercial application, either a single ester product may be 
desirable or a mixture containing certain proportions of constituent esters. As such, several 
groups have looked at modelling the structure of an AAT enzyme to identify strategies to 
broaden or narrow their substrate specificity (El-Sharkawy et al., 2005; Lucchetta et al., 2007). 
To date, there is no available crystal structure for an AAT enzyme. Third, often additional 
genetic manipulation of the host strain is required to minimize competing pathways for 
substrates and cofactors, and to engineer driving forces towards ester production (Valdali et al., 
2003; Rodriguez et al., 2013; Layton et al., 2014; Guo et al., 2014). For example, Layton et al. 
(2014) utilized an E. coli strain with nine gene knock outs and one gene knock in that was 
designed to block major fermentative pathways, an inefficient electron transport system, fatty 
acid degradation, and the oxidative pentose phosphate pathway. With this strain, they were able 
to increase ethyl butyrate titres 14-fold compared to their base strain. Ultimately, through the use 
of heterologous AAT expression and further strain engineering, a number of microbial platforms 
for the production of short chain acetate and butyrate ester have been created.  
In contrast, however, progress in the development of microbial platforms for the production of 
medium chain esters has lagged behind, with one of the limiting factors being the identification 
of AAT enzymes with substrate specificity towards medium chain acids and alcohols. While 
many AAT enzymes have been characterised with activity towards a diverse number of 
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substrates, their activity is typically highest for alcohol chain lengths of <C4, and acid chain 
lengths of <C6, and lower for larger and bulkier substrates (Table 4.1). Unfortunately, the 
medium chain ester butyl octanoate – our target end-product – falls within the latter category, 
and very few AAT enzymes have documented activity for synthesizing it. To date, three AAT 
enzymes from Malus pumila (Royal Gala apple), Actinidia eriantha (kiwi fruit) and Actinidia 
chinensis (kiwi fruit) have reported ability to synthesize butyl octanoate (Souleyer et al., 2005; 
Günther et al., 2011), and of these three, the AAT from A. chinensis has the highest reported 
activity. In this work, our strategy for detoxification of butanol via its esterification requires an 
AAT with high activity and substrate specificity, as this esterification step should not be a 
bottleneck reaction. Successful detoxification requires that butanol be efficiently sequestered 
into butyl octanoate to minimize alcohol accumulation in culture. As well, this strategy requires 
minimal promiscuity from the AAT enzyme for producing other carboxyl esters as it was 
determined previously that shorter chain butyl esters, such as butyl butanoate and -hexanoate, 
are inhibitory to E. coli growth at low concentrations (see chapter 3).  
Here work is done towards engineering a strain of E. coli for the production of butyl octanoate 
as a strategy for the detoxification of endogenously produced butanol. To do this (i) an AAT 
enzyme from A. chinensis was expressed in E. coli that has activity for synthesizing butyl 
octanoate; (ii) optimize anaerobic butanol production in E. coli through heterologous expression 
of the butanol production pathway from C. acetobutylicum, (iii) investigate improving butyl 
octanoate production and minimizing side product formation in E. coli through engineering of 
both the AAT enzyme and E. coli metabolism; (iv) investigating bottlenecks in butyl octanoate 
synthesis in the butanol producing E. coli strain. 
 
 
Table 4. 1 List of characterised AAT enzymes, their native host and their substrate specificity for 
alcohol and acyl-CoA substrates. Only enzymes that have been isolated, heterologously expressed, 
and characterised for esterification activity and substrate specificity have been included. The two 
letters in front of each AAT represent the host organism. 
AAT 
enzyme 
Organism Alcohol chain length Acid chain 
length 
Reference 





C3:0, C4:0, C6:0, 












and C8:0 CoAs 
AeAAT9 Actinidia eriantha -C1:0-OH, C2:0-OH, 
C3:0-OH, C4:0-OH 
-C2:0, C3:0, 





Günther et al., 
2011 
AcAAT16 Actinidia chinensis -C2:0-OH, C3:0-OH, 
C4:0-OH 
-C2:0, C4:0, 







Günther et al., 
2011 













SAAT Fragaria x 
ananassa 
var. Chandler 
-C1:0 to C4:0-OH, and 















C2:0, C3:0, C4:0 
and C6:0 CoAs 
Aharoni et al., 
2000; Olias et al., 
2002; Beekwilder 
et al., 2004 
VAAT Fragaria vesca -C1:0 to C4:0-OH, and 































-C2:0, C3:0, and 
C4:0 CoA 
Goulet et al., 
2015 








C4:0, and C6:0 
CoA 
Goulet et al., 
2015 











C4:0, and C6:0 
CoAs 
Yahyaoui et al., 
2002; Lucchetta 





CmAAT2 Cucumis melo 
var. cantalupensis 
NA NA Lucchetta et al., 
2007 











Lucchetta et al., 
2007 
CmAAT4 Cucumis melo 
var. cantalupensis 








-C2:0 and C4:0 
CoAs 
Lucchetta et al., 
2007 






-C2:0 to C4:0 
CoAs 
Olias et al., 1995 





-C2:0 CoA Beekwilder et al., 
2004 
BEAT Clarkia breweri -Benzyl alcohol 
-Cinnamyl alcohol 























D’auria et al., 
2002 




-C2:0 CoA Salas, 2004 





Orlova et al., 











-C2:0, C4:0, and 
C6:0 CoAs 
Balbontín et al., 
2010 
AMAT Vitis labrusca -C1:0-OH, C2:0-OH, 
C4:0-OH, C6:0-OH, 












NsAAT Neurospora sp. -C1:0-OH to C6:0-OH, 
C3:1-OH, C5:1-OH  
-C4:0 to C8:0, 
and C10:0 CoAs 
-Isovaleroyl-CoA 
Yamauchi et al., 
2014 







C4:1, and C6:0 
CoAs 
Verstrepen et al., 
2003; Rodriguez 
et al., 2014 




-C2:0 CoA Verstrepen et al., 
2003 
Lg-ATF1 S. bayanus -C3:0-OH, C6:0-OH, 
C7:0-OH  
-Isobutanol 












4.2.1 Production of butyl esters in E. coli by heterologous expression of an AAT 
from A. chinensis 
 
The AAT gene sequence from A. chinensis was codon harmonized to the genome of E. coli 
(Materials and Methods 2.3.1) as a gene string, and subsequently cloned into the high copy 
pET21a plasmid between restriction sites BamHI and XhoI to drive expression under the strong 
T7 promotor. From this point onwards, this harmonized AAT is referred to as EcAAT where Ec 
represents the gene’s harmonization to the E. coli genome. Plasmid pET21a::EcAAT was 
transformed into E. coli strain C43 (DE3) and cultured as described by Souleyre et al., (2005), 
with the exogenous addition of alcohol and acid substrate for butyl ester production. Two 
modifications were made to the original protocol (full protocol in materials and methods 2.5.6). 
The first modification was that TB+2% glucose media was used in the place of 2TY media. This 
was done as a comparison of the final butyl ester titres achieved from culturing in different 
medias showed that TB+2% glucose resulted in the highest titres (Appendix Supplementary 
Figure 3). The second modification made was that cultures were incubated for 18 hours instead 
of 20, this was done as a time course of butyl ester production over 21 hours showed that the 
highest titres were achieved at 18 hours (Appendix Supplementary Figure 4). Culturing 
conditions were optimized according to final butyl ester titres as opposed to EcAAT protein 
levels as it was not tagged for purification (it was found that the presence of a C-terminal His6x 
tag significantly reduced butyl ester formation by the AAT – data not shown), and expression 
was too low to distinguish from background proteins in either the soluble or insoluble extracts. 
For butyl octanoate production, cultures were exogenously fed 10 mM butanol and 5 mM 
octanoic acid 2 hours post induction, this was done to provide an excess of substrate for the 
AAT enzyme. Concentrations of octanoic acid above 5 mM were found to negatively impact 
culture growth rate (data not shown). Under these optimised expression conditions, E. coli was 
able to produce a mixture of short and medium chain butyl esters that included butyl butyrate, -
hexanoate, and -octanoate (Figure 4.1). These esters were found in both the culture supernatant 
and cell pellet fractions that were obtained after centrifugation, with the proportion of ester 
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found in the pellet increasing as the chain length of the ester increased, i.e. approximately 11% 
of total butyl butyrate was found in the cell pellet, whereas 78% of total butyl octanoate was 
found in the pellet. This is possibly a result of the increased hydrophobicity of the longer 
octanoate ester, which allows it to partition more efficiently into the cell membrane compared to 




Figure 4. 1 The butyl ester profile found in the culture supernatant and cell pellet after centrifugation 
of E. coli expressing a codon harmonized AAT from A. chinensis. Cultures were induced with 0.4 
mM IPTG and then fed 10 mM butanol and 5 mM octanoic acid before being further incubated at 
20℃ for 18 hours. Final average OD600 was 31.6. Inset shows a gas chromatography trace of the 
butyl esters present in supernatant fraction. Butyl butyrate, hexanoate, and octanoate are indicated. 





The presence of butyl butyrate and butyl hexanoate in EcAAT expressing E. coli cultures was 
not completely unexpected as this AAT enzyme has previously been shown to have activity for 
synthesising esters of these chain lengths (Günther et al., 2012). Indeed, it has shown higher 
catalytic activity for making these shorter chain esters over butyl octanoate. As neither butyric 
acid nor hexanoic acid were exogenously fed into the culture this suggests that EcAAT is 
utilizing endogenously produced C4:0 and C6:0 acyl-CoAs to make these esters. A probable 
source for these shorter acyl chains is the intracellular degradation of the octanoic acid fed into 
the culture. As an extracellular free fatty acid is transported across the internal cell membrane 
into the cystol by the FadD enzyme it is coupled with the esterification of the free acid to an 
acyl-CoA. This acyl-CoA is then a direct substrate for β-oxidation, which is the iterative 
breakdown of a fatty acyl-CoA by two carbon units for every cycle (Figure 4.17) (Jaβen et al., 
2014; Yao et al., 2015). Therefore, in this system, the octanoic acid being fed into the culture is 
first being converted to octanoyl-CoA which is then acting both as a direct substrate for the 
EcAAT enzyme as well as being sequestered into the β-oxidation pathway where it is 
progressively broken down to hexanoyl-CoA and butyryl-CoA – both of which are also 
substrates for our AAT enzyme. The proportion of butyl octanoate produced compared to the 
shorter chain butyl hexanoate and -butanoate esters suggest that our EcAAT enzyme is not 
acting on the octanoyl-CoA as fast as it is being transported into the cell, so that the intracellular 
substrate is preferentially being metabolised by the fatty acid degradation pathway. This 
suggests that either the activity, or substrate specificity of this enzyme for octanoyl-CoA, will 
need to be improved for the success of our detoxification strategy. Interestingly, exogenous 
feeding of either hexanoic or butyric acid instead of octanoic acid into cultures of E. coli 
expressing the EcAAT resulted in significantly less ester formation, though they are preferred 
substrates of the EcAAT enzyme compared to the octanoic acid chain length (Figure 4.2). For 
example, cultures fed butyric acid produced approximately 6% of the amount of butyl butyrate 
compared to those cultures fed octanoic acid (Figure 4.2). This is perhaps due to the uptake rate 
of fatty acids by E. coli, which has been shown to decrease as the acid chain length decreases, 
with long-chain fatty acids (C12-C18) being preferred over medium-chain acids (Klein et al., 
1971), or the substrate specificity of FadD (the enzyme responsible for converting a free fatty 
acid into a fatty acyl-CoA thioester), which preferentially acts on longer chain fatty acids (Ford 
and Way, 2015). This might suggest that modulation of the β-oxidation pathway may be 
required downstream to improve uptake of exogenously fed octanoic acid. As an aside it should 
be noted that the AAT enzyme from A. chinensis was found to have highest catalytic activity for 
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producing butyl benzoate, and as such we considered whether butyl benzoate would be a more 
suitable end product for our detoxification strategy. An added benefit to using benzoyl-CoA as a 
substrate is that it is not a direct substrate for β-oxidation, as the benzene ring must first be 
reduced and cleaved (Egland et al., 1997), so it would not be sequestered away from EcAAT  
 
 
Figure 4. 2 The proportion of butyl butyrate, -hexanoate, and -octanoate present in the supernatant of 
E. coli cultures of strain C43 (DE3) expressing EcAAT when exogenously fed 10 mM butanol and 5 
mM of either octanoic, hexanoic, or butyric acid. Supernatant was analysed 18 hours post induction. 
Data are the mean + standard deviation of three replicates 
 
 
activity. However, it was found that butyl benzoate was not be an ideal end-product as toxicity 
tests revealed that it is inhibitory to E. coli growth at lower concentrations than butanol 
(appendix Supplementary Figure 2).  
With confirmation that the EcAAT protein was capable of producing butyl esters in E. coli upon 
exogenous feeding of both the butanol and acid substrates, the next step was to integrate this 
enzyme into a system that endogenously produced butanol. Several groups have developed 
strains of E. coli capable of synthesising butanol through heterologous expression of the butanol 
production pathway from C. acetobutylicum (Atsumi et al., 2008; Lee et al., 2011; Shen et al., 
2011; Chin et al., 2013; Wang et al., 2015; Dong et al., 2016). One such strain was gifted to the 
Leak  lab by James C. Liao from the University of California (Los Angeles). This butanol 
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producing strain was a triple knockout of E. coli (JCL166) expressing two plasmids which 
together harbour the genes for the butanol production pathway (pEL11 and pIM8). While this 
strain will be described in detail in the following section (4.2.2), here the integration of the 
EcAAT gene in to this established butanol production platform is discussed.  To do this, a three-
plasmid system was developed in which plasmids one and two were pEL11 and pIM8 for 
butanol production, and the third plasmid was one that harboured the EcAAT enzyme. In 
constructing this three-plasmid system, two criteria required consideration; first, it was 
necessary that the third plasmid had an origin of replication (ori) that was compatible with those 
of pEL11 and pIM8 to avoid origin incompatibility. Origin incompatibility occurs when 
multiple plasmids within a single cell replicate by the same mechanism, and ultimately results in 
the loss of one of said plasmids (Velappan et al., 2007). The origins of replication used by 
pEL11 and pIM8 are ColE1 and Cola, respectively, which are compatible with one another and 
both medium/high copy number. Thus, a third ori that is compatible with both those in pEL11 
and pIM8, and which is also medium/high copy number, was required. Second, the third plasmid 
must possess a different antibiotic selection marker from those present in pEL11 and pIM8 so 
that it can be selected for, individually. pEL11 and pIM8 contain ampicillin and kanamycin 
resistance markers, respectively. Unfortunately, it was not possible to identify a previously 
constructed plasmid that satisfied these two requirements and thus, for this work, one was 
created. To do this, a pET21a plasmid was modified by replacing the original ColE1 ori with a 
p15A ori that is compatible with those present on pEL11 and pIM8 and results in a medium 







Figure 4. 3 Plasmid maps of A pET21a::EcAAT and B pFRANK. Plasmid pFRANK is a derivative 
of the pET21a vector where the antibiotic resistance marker was changed from ampicillin (light 
green) to hygromycin (light blue), and the origin of replication was changed from pColE1 to P15A 
(both in yellow). As well, the basis of mobility (bom) and rop protein sequence associated with the 
pColE1 origin of replication were removed in pFRANK. 
 
 
A full description of how this was done with intermediate plasmid maps is described in 
Appendix Supplementary Figure 6. The resultant plasmid was named pFRANKENSTEIN 
(pFRANK for short) and fulfilled both criteria required for being compatible with the butanol 
pathway harbouring plasmids, as well as possessing the EcAAT gene (Figure 4.3). To confirm 
pFRANK was able to express the AAT enzyme and produce butyl esters, it was transformed into 
E. coli strain C43 (DE3), and cultured with butanol and octanoic acid supplementation 2 hours 
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post induction, as was done previously with pET21a::EcAAT. Figure 4.4 shows the resulting 
titres of butyl butyrate, -hexanoate, and -octanoate recovered from the supernatant of cultures 
expressing pFRANK. Here it can be seen that ester production was comparable to that achieved 
from pET21a::EcAAT, which produced 4.1 mg total ester/OD600 after 18 hours, while pFRANK 
produced 3.3 mg total ester/OD600. E. coli cultures harbouring pFRANK produced 
approximately 20% less total ester than those harbouring pET21a::EcAAT, with the assumption 
that this difference is attributed to the difference in plasmid copy number (with pET21a being 
high copy and pFRANK being medium copy) given the absence of any other noticeable 
difference between the two plasmids or expression conditions. Unfortunately, an ori that would 





Figure 4. 4 Accumulation of butyl butyrate, - hexanoate and -octanoate in the supernatant of E. coli 
strain C43 (DE3) expressing pFRANK. Cultures were induced with 0.4 mM IPTG and grown for 18 
hours at 20℃   before analysis. Final average OD600 was 30.1. Data are the mean + the standard 




4.2.2 Production of butanol in E. coli through heterologous expression of the C. 
acetobutylicum butanol pathway and the establishment of an NADH driving force 
 
As mentioned previously in section 4.2.1, a butanol producing strain of E. coli constructed by 
the Liao lab at UCLA was acquired. There, they created a modified butanol production pathway 
that utilises an ‘artificial’ driving force to achieve high titre butanol production in E. coli (Shen 
et al., 2011). The driving force that is taken advantage of is NADH, the primary reducing 
cofactor used throughout the butanol pathway. This driving force is established by deleting 
several mixed-acid fermentation reactions – those for the synthesis of lactate, ethanol, and 
succinate – that are NADH consuming reactions during anaerobic E. coli growth. The resulting 
strain, JCL166 (Δldh ΔadhE ΔfrdBC), is therefore no longer able to grow anaerobically due to 
its inability to recycle NADH (Figure 4.5). This cofactor build-up, therefore, creates a driving 
force for pathways that are NADH consuming. By expressing the NADH consuming butanol 
production pathway from C. acetobutylicum in this JCL166 strain, anaerobic growth is rescued 
and a driving force towards butanol production is established. To further couple the NADH 
driving force to the butanol pathway, the bcd-etfAB gene responsible for the reduction of 
crotonyl-CoA to butyryl-CoA in the C. acetobutylicum butanol pathway was replaced with a 
trans-enoyl-CoA reductase (Ter) gene from Treponema denticola, who’s encoded protein 
carries out the same reduction reaction, but unlike bcd-etfAB, does so in an irreversible fashion, 
and uses NADH directly as a reducing agent (bcd-eftAB additionally requires ferrodoxin). As all 
the other reactions steps in the butanol pathway are reversible, the introduction of the 
physiologically irreversible Ter catalysed step further strengthens the driving force to channel 
carbon flux towards butanol synthesis (Figure 4.5; Shen et al., 2011). The JCL166 knockout 
strain, as well as plasmids pEL11 and pIM8 – which together harbour the butanol pathway genes 
– were provided by the Liao group. Plasmid pEL11 contains the atoB, adhE2, crt, and hbd 
butanol pathway genes from E. coli and C. acetobutylicum, and plasmid pIM8 contains the Ter 







Figure 4. 5 Diagrams showing the engineered driving force leading towards improved butanol 
production in E. coli. A shows the modifications made to E. coli strain JCL166, which has three 
knockouts (frdBC, ldhA, and adhE). Each of these enzymes controls an NADH (shown in blue) 
consuming reaction, resulting in an NADH build up in the triple knockout strain. B the 1-butanol 
production pathway expressed in E. coli from C. acetobutylicum. This pathway utilises NADH as an 
electron donor, providing a sink for the build-up of this cofactor in strain JCL166, leading to driving 
force towards butanol production. The organism from which heterologously expressed genes have 
been sourced are in brackets next to the gene name: CA, C. acetobutylicum; EC, E. coli; and TD, 
Treponema denticola. Modified from Shen et al., 2011. 
 
 
A time course of butanol production from E. coli strain JCL166 transformed with pEL11 and 
pIM8, named strain DLB, was performed. Cultures were grown aerobically in glass vials to an 
OD of 0.8, induced with IPTG and grown an additional 2 hours aerobically to increase cell 
density before being flushed with nitrogen gas (N2) and crimp-capped to maintain a micro-
aerobic/anaerobic environment. The JCL166 knockout strain demonstrated retarded growth rate 
compared to wild type E. coli, and – even with the additional two hour incubation time between 
induction and the nitrogen flush – did not exceed an OD600 of 2. Butanol production and culture 
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OD600 were analysed at intervals of 24 hours for a total of 96 hours for strain DLB (Figure 4.6). 
Over this time course, butanol production by the DLB strain continued to increase to a 
maximum of 245 mg/L at 96 hours, however, the culture OD600 dropped, perhaps as a result of a 
drop in culture pH as the mixed-acid fermentation reactions that have not been knocked out in 
this strain produce acetate and formate. Though not measured here, Shen et al., (2011), showed 
that culture pH dropped from 7 to approximately 5.4 over a similar 96 hour time course using 
this butanol producing strain. Concerningly, however, while butanol was successfully produced 
by strain DLB, titres were much lower than reported in the literature. At 24 hours Shen et al., 
(2011) were able to produce approximately 500 mg/L butanol under microaerobic conditions, 
whereas here only 125 mg/L of butanol was achieved, a four-fold reduction in titre (Figure 4.6). 
125 mg/L butanol is approximately 1.7 mmol/L, well below the toxicity limit and significantly 
less than the 10 mmol/L of butanol previously being fed into cultures expressing the EcAAT. In 
those exogenously fed cultures, analysis after 18 hours showed only trace amounts of butanol, 
suggesting that any lesser amount would be limiting to ester production. A number of 
optimization attempts were carried out to improve butanol titre, these involved varying the time 
of induction, IPTG concentration, length of aerobic incubation before N2 flush, etc. However, no 
improvement on titre was made. As a result of this, it was hypothesized that a condition that 
could not be controlled using the crimp cap culture technique – such as pH, glucose availability, 
anaerobicity – was responsible for limiting butanol production. Therefore, a small bioreactor 
fermentation of strain DLB was run where all conditions would be monitored and maintained for 
optimal butanol production. Unexpectedly, butanol titres were not improved (data not shown), 
suggesting that the limiting factor was to do with the pathway itself, rather than the culturing 
conditions. It was previously shown that in a strain of JCL166 harbouring only the pEL11 
plasmid, some butanol was produced (Shen et al., 2011). Therefore, it was possible that the low 
level of butanol production could reflect poor expression of the Ter gene present on pIM8. 
Sequencing of the Ter gene showed no errors in the nucleotide sequence suggesting that, if 






Figure 4. 6 Anaerobic fermentation of E. coli strain JCL166 harbouring plasmids pEL11 and pIM8 
over the course of 96 hours. Cultures were flushed with nitrogen (N2) and crimp capped three hours 
after induction with IPTG and grown at 30℃. The green line represents the amount of butanol 
present at each 24 hour time point, and the hashed mauve line represents the culture OD600 over the 
course of the fermentation. Data are the mean + standard deviation of four biological replicates. 
 
 
To confirm this hypothesis, the Ter gene, as well as a formate dehydrogenase (Fdh) gene from 
Candida boidinii, were synthesised – with RBS (ribosomal binding site) sequences directly 
upstream of each gene – and together inserted by Gibson assembly into pFRANK (a plasmid we 
had previously confirmed was able to express inserted genes) directly downstream of the EcAAT 
gene. Gibson assembly was used for this insertion as the only available restriction site 
downstream of the EcAAT gene was XhoI, and unlike digestion/ligation cloning, Gibson 
assembly would ensure that the Ter and Fdh genes would be inserted in the correct orientation. 
This new plasmid was named pVICTOR (Figure 4.7), and in addition to the Ter and Fdh genes, 
several additional restriction site were inserted downstream of the Fdh gene to allow for 
flexibility with any future gene insertion (Figure 4.7). Fdh is responsible for the oxidation of 
formate to CO2 and NADH, and its over expression further increases the intracellular NADH 
driving force (Figure 4.5; Berrios-Rivera et al., 2002; Nielsen et al., 2009; Shen et al., 2011). It 
has been shown previously by Shen et al., (2011) that the introduction of the Fdh protein from 
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C. boidinii into the JCL166 system resulted in a slight increase in butanol production. To 
determine whether Ter activity was recovered when expressed on plasmid pVICTOR, it was 
transformed into E. coli JCL166 with pEL11 (pIM8 was excluded), and this new strain was 
named DLBO1. Cultures were grown as described previously for strain DLB in crimp capped 
glass vials, and butanol production was analysed after 24 hours of anaerobic growth. Butanol 
production was greatly improved in this new system where the Ter gene was expressed from 
pVICTOR instead of pIM8. These cultures produced butanol titres of approximately 400 mg/L 
at 24 hours (Figure 4.7). While this was slightly less than the literature value after 24 hours of 
culturing, it was still a significant improvement over the 125 mg/L achieved with the pEL11 and 
pIM8 system. These results confirm that expression of Ter from pIM8 was a problem, and that 
by moving it to pVICTOR, good expression was restored. This is additionally beneficial as by 
eliminating the need for the pIM8 plasmid the butyl ester production platform was now a two-
plasmid system, instead of the three-plasmid system that was originally envisaged. This 
ultimately relieves some of the metabolic burden associated with maintaining and copying 




Figure 4. 7 Plasmid map of pVICTOR, a derivative of pFRANK. A Ter gene from T. denticola and 
an Fdh gene from Candida boidinii were cloned in downstream of the EcAAT gene. Ter and Fdh 
were inserted using Gibson assembly and possess a KpnI restriction site between them. Downstream 




Figure 4. 8 Anaerobic butanol production from E. coli strain JCL166 harbouring plasmids pEL11 
and pVICTOR. Cultures were induced with 0.1 mM of IPTG and grown aerobically for an additional 
2 hours before being flushed with N2 and crimp capped. Cultures were then analysed after 24 hours 
of anaerobic growth. Data are the men + standard deviation of four biological replicates.  
 
 
Ultimately, the E. coli butanol production system developed by the Liao lab was successfully 
recreated. While the butanol titres achieved here were slightly lower than the literature values, 
this most likely reflected different culturing condition and perhaps an in-house difficulty in 
maintain cultures as micro aerobic/anaerobic when grown in vials. From this point, it was 
possible to move forward to the next step of investigating this detoxification strategy, which was 
the expression of the EcAAT in this butanol production background. 
 
 
4.2.3 Butyl ester production in an E. coli strain harbouring the butanol synthesis 
pathway 
 
The next step of this detoxification strategy was to initiate butyl octanoate production via the 
EcAAT enzyme in the context of the butanol producing E. coli strain to assess the success of 
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butanol sequestration into an ester molecule for detoxification. In this strategy, the source of the 
octanoate substrate could either be from culture medium supplementation with octanoic acid, 
genetic modifications to increase the intracellular availability of octanoyl-CoA, or a combination 
of both techniques. Economically, following downstream recovery and hydrolysis of the butyl 
octanoate for the production of butanol, the octanoic acid by-product should be recycled as a 
substrate for future expression cultures. As a preliminary experiment, prior to the creation of 
pVICTOR with improved Ter expression, E. coli strain JCL166 was transformed with the initial 
three-plasmid system of pEL11, pIM8 and pFRANK. This strain was named DLBO2. Strain 
DBLO2 was cultured aerobically as described above in section 4.2.1, including media 
supplementation with both butanol and octanoic acid. Butanol supplementation was necessary 
during aerobic culturing of strain DLBO2 as butanol production via the synthetic butanol 
pathway is driven by the need to re-oxidize NADH that arises during oxygen limited conditions 
when mixed-acid fermentation is typically triggered (Wen and Shen, 2016). Analysis of the 
supernatant of strain DLBO2 at 18 hours showed the presence of all three butyl esters (Figure 
4.9), however the final titre of each ester was notably lower than the final titres produced by 
cultures of E. coli C43 (DE3) expressing either pET21a::EcAAT or pFRANK alone. From the 
supernatant of strain DLBO2, approximately 7 mg/L butyl butyrate, 0.8 mg/L butyl hexanoate, 
and 0.2 mg/L butyl octanoate was recovered (Figure 4.9); this is nearly 10-fold less than the titre 
seen with E. coli strain C43 (DE3) expressing pFRANK (Figure 4.9). As well, it was noted that 
at the point of analysis that the proportion of residual butanol present in the supernatant was 
significantly higher than previously observed in cultures of E. coli C43 (DE3) expressing either 
pET21a::EcAAT or pFRANK – in which it was nearly completely consumed. While cultures of 
DLBO2 did not quite reach the same cell density and those of C43 (DE3) expressing either 
pET21a::EcAAT or pFRANK – with an average OD600 of 26.9 – the difference in culture density 
was not enough to explain the observed difference in ester production. Cultures of E. coli strain 
C43 (DE3) expressing pFRANK produced 3.3 mg total ester/OD600 after 18 hours, while 
cultures of strain DLBO2 produced only 0.3 mg total ester/OD600 after 18 hours. The low butyl 
ester titres achieved by strain DLBO2, paired with the high proportion of residual butanol at the 
point of analysis at 18 hours, suggested that EcAAT activity in this strain is not sufficient to 
incorporate butanol into an ester as quickly as those strains of C43 (DE3) expressing either 
pET21a::EcAAT or pFRANK alone. Further, strain DLBO2 cultured anaerobically, as described 
previously for strains DLB in section 4.2.3, with the addition of only 5 mM octanoic acid 
immediately before the anaerobic switch (no exogenous butanol was fed into cultures grown 
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anaerobically) was analysed 18 hours after the N2 flush, and showed low levels of butanol and 
0.6 mg/L butyl butyrate in the supernatant. No other butyl esters could be detected in either the 
supernatant or cell pellet (data not shown).  
It may be that the reduced activity of EcAAT when expressed in strain DLBO2 compared to its 
activity when expressed in strains of E. coli C43 (DE3) harbouring either pET21a::EcAAT or 
pFRANK, alone, is a result of a metabolically stressed system. DLBO2 is composed of E. coli 
strain JCL166 – which possesses three gene knock-outs and a single gene knock-in strain – 
maintaining three plasmids (pEL11, pIM8 and pFRANK) which together hold the six genes 
required for butyl ester production, in addition to expressing resistance to four antibiotics. All 
together this places a large metabolic load on the host that can result in lower heterologous 
protein expression (Glick, 1995). Protein expression of EcAAT was already shown to be low in 
E. coli strain C43 (DE3) expressing pET21a::EcAAT, as a band for the EcAAT protein could not 
be resolved on SDS-PAGE gels (Appendix Supplementary Figure 5). While this was the original 
hypothesis to explain the decreased butyl ester formation from E. coli strain DLBO2, 
experiments that followed these experiments contradicted this explanation.  
Following this preliminary work, and the creation of pVICTOR for improved Ter expression, it 
was necessary to confirm that expression of pVICTOR continued to produce butyl ester tires 
that were comparable to its parent plasmid, pFRANK – as had been done previously with 
pFRANK and pET21a::EcAAT. To do this E. coli C43 (DE3) was transformed with pVICTOR 
and cultured aerobically as described in section 4.2.1, including exogenous substrate addition. 
Unexpectedly, this strain produced only trace amounts of butyl butyrate in the supernatant and 
butyl octanoate and the cell pellet (Figure 4.10), with no improvement in titre regardless of 






Figure 4. 9 Quantification of butyl esters present in the supernatant of cultures of E. coli strain 
DLBO2 (JCL166 harbouring plasmids pEL11, pIM8, and pFRANK) grown aerobically. Cultures 
were induced at an OD600 of 0.8 and incubated for 2 hours before being exogenously fed 10 mM 
butanol and 5 mM octanoic acid. Cultures were grown for 18 hours at 20℃ before analysis. Final 
average OD600 was 26.9. Data is the mean + standard deviation of three biological replicates. 
 
 
upstream and downstream of the AAT gene, showed no changes to the nucleotide sequence. 
Furthermore, it had previously been shown (section 4.2.2) that the Ter gene downstream of the 
EcAAT in pVICTOR was being successfully expressed, suggesting that the plasmid was 
functional. In literature reports, heterologous expression of AAT enzymes has been notoriously 
temperamental, with some AAT enzymes forming protein aggregates when expressed in E. coli 
(though enzyme activity was not completely lost, but rather reduced most likely due to occlusion 
of active sites), and some only expressing in certain strains of E. coli (Souleyre et al., 2005; Zhu 
et al., 2015). With this EcAAT, it was found that activity in E. coli was increased with the 
removal of a C-terminal His6x tag (data not shown). Considering that the only difference 
between the pVICTOR plasmid and its parent plasmid, pFRANK, was the addition of the Ter 
and Fdh genes downstream of the EcAAT within the same operon, it appeared that the 
transcription of EcAAT as part of an operon was compromising its translation, possibly due to 
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the formation of secondary structure. Thus, in an effort to bypass this problem, the AAT gene 
was removed from the operon by inserting a transcriptional terminator directly downstream of 
the AAT, and a second T7 promotor in front of the Ter and Fdh genes. This plasmid was named 
pVICTOR 2.0 and contained two operons, one of which expresses just the EcAAT, and a second 
that expresses the Ter and Fdh genes (Figure 4.11). With EcAAT removed from the operon, it 
was hoped that activity would be restored to that of the parent plasmid, pFRANK. 
Unfortunately, AAT expression from this plasmid resulted in no improvement in butyl ester 
production over pVICTOR (data not shown), and E. coli C43 (DE3) cultures transformed with 
pVICTOR 2.0 continued to produce only trace amounts of ester in vivo. As well, in vitro assays 
of AAT activity from the crude cell extracts of cultures expressing either pFRANK or 
pVICTOR 2.0 showed an approximately 55-fold reduction in product formation from AAT 
expressed from the latter plasmid (Table 4.2). In contrast, in vitro Ter activity from cultures 
expressing pVICTOR 2.0 was comparable to literature values (Table 4.2; Shen et al., 2011). 
Therefore, the hypothesis that EcAAT’s low activity was a result of its incorporation in an 




Figure 4. 10 Quantification of butyl esters present in the supernatant and pellet of E. coli C43 (DE3) 
transformed with plasmid pVICTOR. Cultures were induced at an OD600 of 0.8 and incubated for 2 
hours before being exogenously fed 10 mM butanol and 5 mM octanoic acid. Cultures were grown 





Figure 4. 11 Plasmid map of pVICTOR2.0, a derivative of pVICTOR. A terminator was inserted 
behind the EcAAT gene to remove it from the operon. A second T7 promotor and was inserted 
upstream of the Ter gene to initiate separate transcription of the Ter and Fdh genes. 
 
 
Thus, it appeared that the activity of EcAAT was significantly reduced when expressed in 
combination with the Ter and/or Fdh genes, suggesting that one or both was in some way 
responsible for the reduced alcohol acyltransferase activity, either at the mRNA or protein level. 
However, work done by the Trinh group at the University of Tennessee suggested that it was 
most likely the Ter that was hindering alcohol acyltransferase activity, rather than the fdh. In 
their work, they expressed the SAAT alcohol acyltransferase from F. ananassa in E. coli to 
make ethyl butyrate in two separate systems. In one system, they expressed the SAAT along 
with the requisite genes to produce ethanol and exogenously fed in butyric acid. There they 
produced approximately 140 mg/L of ethyl butyrate (Layton et al., 2016). In the second system, 
they expressed the SAAT along with the requisite genes to produce butyrate, including the Ter 
from T. denticola, and exogenously fed in ethanol. There they made just 6 mg/L of ethyl 
butyrate (Layton et al., 2014). In both this work and ours, co-expression of the Ter gene and an 
AAT gene appears to drastically reduce ester production by the AAT protein, but neither butanol 
111 
 
(our work) or butyrate (Layton et al., 2014) production via the Ter enzyme. Ter inhibition of 
AAT activity may also explain the low butyl ester production observed for strain DLBO2 
cultured aerobically (Figure 4.9). This strain possessed the Ter gene on plasmid pIM8, a plasmid 
which was previously suspected to have either low or no expression of the Ter gene. It may be 
the case that, in fact, that there is a small amount of Ter expression from pIM8, which would 
account for the above basal levels of butanol production by strain DLB compared to a strain of 
JCL166 harbouring only the pEL11 plasmid (Figure 4.6, Shen et al., 2011), as well as the 
significant reduction in butyl ester production of strain DLBO2. Ultimately, this evidence 
suggests that expression of the Ter gene in some way inhibits AAT activity, however, the means 
by which this occurs was unclear. 
 
 
Table 4. 2 In vitro activity of Ter and AAT in crude cell extracts of wild type E. coli C43 (DE3), and 
E. coli C43 (DE3) harbouring either pFRANK or pVICTOR 2.0. Activity is the mean + standard 
deviation of four replicates. 
 Activity (µmol product/min/mg crude protein)  
 Tera AATb 
C43 (DE3) 0.22 + 0.003                -- 
pFRANK 0.16 + 0.01 9.34x10-2 + 8.8x10-3 
pVICTOR 2.0 2.31 + 0.14 1.65x10-3 + 1.9*10-4 
a Ter assay performed at 30℃ and 340 nm using 200 µmol NADH, 2 µmol FAD, and 200 µmol crotonyl-
CoA 
b AAT assay performed at 30℃ for 30 minutes using 10 mM butanol and 0.75 mM hexanoyl-CoA 
 
 
With the evidence that Ter expression was in some way hindering AAT activity, it was 
necessary to identify at what point this inhibition was occurring; whether it be at the 
transcriptional level, translational level, or post-translational interference with enzyme activity. 
The possibility of transcriptional interference of the EcAAT gene was initially examined using 
RT-qPCR to compare EcAAT transcript abundance when expressed from plasmid pFRANK 
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versus pVICTOR 2.0 (Figure 4.12 A), as well as the transcript abundance of the EcAAT and Ter 
when both expressed from plasmid pVICTOR 2.0 (Figure 4.12 B). Results represent the fold 
change in target gene expression compared to a wildtype E. coli C43 (DE3) harbouring no 
plasmid (no template) control – which did have a low fluorescence signal, but not more than a 
no cDNA control. This low fluorescence signal may have been due to primer dimer formation or 
non-specific annealing; however, no other products were discerned through melt curve analysis 
or end-product analysis by DNA agarose gel (data not shown). This wildtype E. coli C43 (DE3) 
control, to which fold change of target gene expression was normalized to, was done to ascertain 
whether observed expression from each plasmid was valid, or no different from background. 
Transcript abundance of the EcAAT or Ter under all conditions have been normalised to the 
expression levels of the reference gene, 16S ribosomal RNA (rrsA) (Zhou et al., 2011; Peng et 
al., 2014). From panel A, it can be observed that EcAAT transcript abundance in E. coli C43 
(DE3) expressing pFRANK is nearly 4.8-fold higher than the no template control, whereas 
EcAAT transcript abundance in E. coli expressing pVICTOR 2.0 is only 1.4-fold higher, 
indicating it is being expressed only slightly above background levels. Considering that 
background expression represents the signal produced from no expression of AAT, the results 
suggest that EcAAT expression from plasmid pVICTOR 2.0 is minimal. As well, transcript 
abundance of EcAAT and Ter from cultures expressing pVICTOR 2.0 were compared (Figure 
4.12 B) and it was found that Ter expression from this plasmid is 4.5-fold higher than the no 
template control, whereas EcAAT is only 1.6-fold higher, which is again only slightly above 
background levels. In all cases it would be expected that the level of gene expression would be 
the same for EcAAT and Ter regardless of the plasmid they are expressed from as both genes are 
under the control of a T7 promotor, however these results demonstrate that EcAAT gene 
expression is significantly reduced when co-expressed with the Ter gene. However, that the fold 
change in expression of the Ter gene from pVICTOR2.0 is comparable to EcAAT expression 
from pFRANK suggests that expression of Ter is unaffected by its co-expression with EcAAT. 
Ultimately, these results suggest that the EcAAT is being inhibited at the transcriptional level by 
the Ter gene a unidirectional manner, however the mechanism by which this is occurring is still 
unknown. Interestingly, this phenomenon may not be unique to our EcAAT, as a similar decrease 
in ester product formation was observed in E. coli cultures co-expressing Ter and the SAAT from 






Figure 4. 12 Fold change in expression of A the EcAAT gene in E. coli strain C43 (DE3) 
transformed with either plasmid pFRANK or pVICTOR 2.0, B fold change in expression of either 
the EcAAT or Ter gene in E. coli strain C43 (DE3) transformed with pVICTOR 2.0. Values are 
given as fold change in expression relative to wildtype signal – the no template control (=1.0) – using 
16S ribosomal RNA (rrsA) as a reference gene. Data is the mean + standard deviation of three 
biological replicates.  
 
 
4.2.4 Engineering substrate specificity for improved butyl octanoate production 
 
An on-going and fundamental problem with using the EcAAT protein in this butanol 
detoxification strategy is the substrate specificity of this enzyme. Like most AATs, it has a 
broad substrate specificity (Table 4.1), and when expressed in E. coli supplemented with butanol 
and octanoate it produced several additional butyl esters in addition to the desired butyl 
octanoate end-product. Ultimately this is detrimental to this detoxification strategy, as the 
shorter chain length butyl esters (butyl butyrate and -hexanoate) are toxic to E. coli at low 
concentrations. Additionally, degradation of the octanoate will affect the economics of the 
proposed fatty acid recycling step. Therefore, methods for improving the product specificity of 
this system were considered, and two strategies were employed: (i) protein engineering of the 
EcAAT enzyme to increase its substrate preference for the octanoic acid chain length, and (ii) 




4.2.4.1 Rational protein engineering  
 
Alcohol acyltransferase proteins are members of the BAHD superfamily (named after the first 
four biochemically characterised enzymes in this family from plants) that is composed of 
acyltransferase enzymes involved in the synthesis of secondary metabolites such as 
anthocyanines, esters, phytoalexins, etc. (El-Sharkawy et al., 2005; Lucchetta et al., 2007; Galaz 
et al., 2013; Navarro-Retamal et al., 2016). Members of this family share two conserved motifs: 
the HxxxD catalytic motif located in the middle of the protein sequence, and the C-terminal 
DFGWG motif involved in maintaining protein structural integrity (Galaz et al., 2013; Morales-
Quintara et al., 2015). The first member of the acyl-CoA dependent BAHD acyl transferase 
superfamily to be crystallised was a vinorine synthase (an acetyl transferase) from Rauvolfia 
serpentine. From this structure, it was determined that the proteins in the BAHD family are 
composed of two equal sized domains connected through a large crossover loop (Ma et al., 
2005). To date, no crystal structure of a plant alcohol acyltransferase has been resolved, and as a 
result several groups have instead modelled these proteins in an attempt to identify: (i) the mode 
by which they catalyse the esterification reaction, (ii) the residues involved in composing the 
substrate binding pocket and how they determine the substrate specificity of an given AAT, and 
(iii) the role the individual residues that compose the conserved motifs play in catalysis and 
maintenance of solvent channel integrity (Morales-Quintara et al., 2012; Morales-Quintara et 
al., 2013; Galaz et al., 2013; Morales-Quintara et al., 2015; Navarro-Retamal et al., 2016). As to 
date there is no publicly available crystal structure, or model, for the AAT protein from A. 
chinensis. Instead, here, a model was built for EcAAT using Modeller 9.18 software and three 
template crystal structures: a hydroxycinnamoyl CoA:shikimate hydroxycinnamoyl transferase 
from Sorghum (PDB: 4KE4), a hydroxycinnamoyl-CoA shikimate/quinate hydroxycinnamoyl 
tranferase from Coffea canephora (PDB: 4G22), and the vinorine synthase from R. serpentine 
(PDB: 2BGH) (Ma et al., 2005; Lallemand et al., 2012; Walker et al., 2013). The purpose of this 
model being that it would act as an aid in the rational protein engineering of the EcAAT protein 
for improved butyl octanoate product specificity. The templates used to build the EcAAT model 
were chosen based on their sequence similarity (33.25%, 32.9%, and 21.2%, respectively) and 
sequence coverage to the EcAAT protein. Of the 5 models produced through the modeller 9.18 
software, the quality of the 3D protein structure of each model was assessed using a 
Ramachandran plot analysis (using RAMPAGE software). A Ramachandran plot assesses the 
backbone dihedral angles of each residue in the model and determines whether they are 
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favourable or unfavourable (Ho and Brasseur, 2005). From this analysis, the model with the 
highest Ramachandran value, which had 98% of residues in a favourable/allowed region, was 
chosen. This model can be seen in Figure 4.13 alongside the amino acid sequence for EcAAT. 
Both the sequence and model have been colour coded to identify protein domains I and II 
(colours blue and purple, respectively), the loop linker region (orange), the HxxxD catalytic 




Figure 4. 13 Amino acid sequence (left) and protein model of EcAAT (right). The model was 
constructed using Modeller 9.18 software (www.salilab.org/modeller) with three template crystal 
structures (PMDB codes: 4KEC, 4G22, and 2BGH2). Domain I = blue, cross over loop = orange, 
domain II = purple, HXXXD catalytic motif = yellow, and DFGWG structural motif = red. The 
residues in the protein sequence (left) corresponding to each colour coded region is underlined in its 






Figure 4. 14 Predicted solvent pocket of the modelled EcAAT enzyme. A shows the pocket in 
relation to the whole protein and B shows a close up of the pocket and its relation to the Histidine 
and Aspartic acid residues that are present in the catalytic motif. The solvent pocket was modelled 
using the Internal Coordinate Mechanics (ICM) program from www.molsoft.com. 
 
 
Previous modelling work done for AAT enzymes from fruit have identified that both the alcohol 
and acyl-CoA substrate enter through a solvent channel located in the centre of the protein to 
access the catalytic residues (Morales-Quintara et al., 2012; Galaz et al., 2013; Navarro-Retamel 
et al., 2016). Thus, this solvent channel into which the alcohol and acid substrates dock for 
esterification was further modelled for the EcAAT protein. From this, the residues that 
potentially compose this substrate binding pocket could be identified, facilitating the 
identification of target residues for site directed mutagenesis for increased substrate specificity 
for octanol-CoA. Morales-Quintara et al., (2012) found that the binding pockets of two AAT 
enzymes from two different cultivars of papaya varied greatly in the size, corresponding with 
their respective substrate preferences for large and small acyl-CoA substrates. To model the 
solvent channel of EcAAT, ICMPOCKETFINDER software was used (Abagyan et al., 1994; 
www.molsoft.com), which utilises only the protein 3D structure to predict cavities and clefts. 
Using this software, three potential solvent pockets were identified (data not shown), however 
only one was associated with the catalytic domain. Figure 4.14 shows this solvent pocket in the 
context of the entire protein model (panel A), and in the context of the catalytic HxxxD motif 
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(panel B). In panel B, it can be seen that the side chains of the histidine and aspartic acid 
residues of the catalytic motif that are directly involved in the esterification reaction are oriented 
into the solvent pocket, consistent with other models, and their role in catalysis (Morales-
Quintara et al., 2012; Galaz et al., 2013). Following this, simulations using ICM docking 
software were performed (www.molsoft.com) to identify from which direction the alcohol and 
acyl substrates enter the solvent pocket docking. These simulations consider electrostatic and 
van der Waals forces as the main inputs (Galaz et al., 2013). From this it was identified that the 
octanoyl-CoA substrate probably enters the solvent pocket through the bottom channel shown in 
panel B of Figure 4.14. This further narrowed down the number of residues that might influence 
EcAAT substrate specificity for the acyl chain length. Based on this evidence, each of these 
residues that compose this bottom channel was sequentially mutated to the corresponding 
residue(s) present at that location in other AAT enzymes, and the impact of each mutation on the 
solvent channel was assessed (a line up of all AATs assessed is found in Supplementary Figure 
7). This was done as an attempt to prevent wholly unfavourable mutations with the presumption 
that should a given residue be present at that location in another AAT, that a mutation to that 
residue in the EcAAT protein is less likely to result in complete abolishment of activity. Where 
more than one residue was present at a given location in different AAT enzymes, each 
permutation was computationally assessed. The purpose of this work was to identify possible 
point mutations that would increase the size of the binding pocket channel into which the acyl-
CoA chain enters. The rational for this being that a larger channel might improve the ability of 
the larger octanoic chain length to access the catalytic residues. This represents a cursory 
approach to rational engineering of the EcAAT enzyme. In principle, by mutating the relevant 
residues to those present at that location in other functional AAT enzymes, the chances of 
making a mutation that decreased enzyme activity were minimized. From this, five point 
mutations were identified that favourably increased the size of the solvent channel, they were: 
M94F, S99G, L178F, F185I, and F313V. For the most part, these substitutions were from a 
hydrophobic residue to another hydrophobic residue. The exception being S99G where serine 
was substituted for glycine. Interestingly, glycine appeared to be highly conserved at this 
position in other AATs (Supplementary Figure 7). Additionally, if a mutation to known residues 
at the same location in other AATs did not increase the size of the solvent channel, the effect of 
mutating that residue to any alternative amino acid was assessed with regards to solvent channel 
size. With an arbitrary cut-off of a 7.5% increase in pocket size, two further potentially 
favourable mutations were identified: L42A and R248S. While neither of these substitutions are 
118 
 
present in other AAT enzymes, their effect on solvent channel size outweighed the risk of loss 
of activity for this preliminary work.  
Each of these EcAAT point mutants were made through overlap PCR, and then cloned into a 
pET21a plasmid between restriction sites BamHI and XhoI. The presence of each point mutation 
was confirmed through gene sequencing by GATC Biotech (Germany). Figure 4.15 shows the 
proportion of butyl butyrate, -hexanoate and -octanoate produced by E. coli C43 (DE3) 
expressing each of the point mutated EcAAT genes, as well as the wild type EcAAT. EcAAT 
expression was carried out as described in section 4.2.1, including substrate feeding. Four of 
these mutations – L42A, M94F, F185I, and R248S – severely reduced the rate of butyl ester 
production. Each of these mutants produced only butyl butyrate at significantly reduced titres 
compared to the wild type EcAAT, suggesting that they had either reduced the activity or 
production of active enzyme. The F313V mutation, interestingly, produced nearly 60% more 
butyl butyrate and 35% less butyl hexanoate than the wild type EcAAT, indicating it may have 
an increased the protein’s substrate specificity for the shorter butyrate chain length. Of the seven 
point mutations made, only two, S99G and L178F, resulted in a significant improvement in 
butyl octanoate production, with a 620% and 475% increase, respectively. In both cases, the 
corresponding residue to which the native residue was changed is highly conserved amongst 
other AAT enzymes. Not only did these mutations have an impact on final butyl octanoate titres, 
but they both also marginally increased the final titres of butyl hexanoate compared to the wild 
type EcAAT (though this increase was only significant for the S99G mutant, p=0.0139), while 
having no significant impact on the amount of butyl butyrate produced. This suggests that both 
the S99G and L178F mutations may favourably improve activity towards the longer hexanoyl-
CoA and octanoyl-CoA chain lengths by increasing solvent channel size. While both of these 
mutants produced similar final butyl butyrate titres as the wild type EcAAT, this is 






Figure 4. 15 Proportion of butyl butyrate, -hexanoate, and -octanoate present in the supernatant of E. 
coli cultures expressing the wild type EcAAT protein and seven point mutation EcAAT variants. The 
first letter represents the original residue before mutation, the number represents the location of the 
residue in the protein (where 1 would be the starting methionine), and the second letter represents the 
new residue present at that position in the mutant. L = leucine, A = alanine, M = methionine, F = 
phenylalanine, S = serine, G = glycine, I = isoleucine, R = arginine, V = valine. Data are the mean + 
standard deviation of three biological replicates. 
 
 
To further determine whether these two individual point mutations were synergistic, a double 
EcAAT mutant of both S99G and L178F was created, cloned into pET21a, and transformed into 
E. coli strain C43 (DE3). Cultures of the double S99G L178F mutant were expressed alongside 
cultures of the single S99G and L178F mutants as well as the wildtype EcAAT, as described 
previously, for comparison. Final butyl ester profiles for each are shown in Figure 4.16. Here, it 
was found that while the double mutant appeared to produce more butyl octanoate than the next 
highest producer, the S99G mutant, this is not statistically significant (p = 0.344). Therefore, 
there appears to be no additive or synergistic effect in combining the S99G and L178F 
mutations. Unsurprisingly, none of these mutants increase substrate specificity towards longer 
acyl-CoA chain lengths as an increase in butyl octanoate production is not paired with a 
decrease in either butyl butyrate or -hexanoate production. By increasing the size of the solvent 
channel, the shorter chain esters are not precluded from accessing the active site (although the 
reverse may be true, vis F313V, Figure 4.15. Instead, to minimize the production of butyl 
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butyrate and hexanoate, it may be more effective to engineer endogenous E. coli fatty acid 




Figure 4. 16 Proportion of butyl butyrate, -hexanoate, and -octanoate present in the supernatant of E. 
coli cultures expressing the wild type EcAAT protein, the S99G single mutant, L178F single mutant, 
and the S99G L178F double mutant. The inset above shows the proportion of butyl octanoate 




4.2.4.2 Metabolic engineering  
 
An alternative strategy to improve production of butyl octanoate over other chain acyl lengths 
would be to engineer the metabolism of E. coli to increase the intracellular availability of the 
octanoyl-CoA substrate, and decrease the availability of the competing butyryl and hexanoyl-
CoA substrates. This strategy would involve the manipulation of E. coli fatty acid synthesis and 
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degradation and could be employed on its own, or in combination with protein engineering of 
the EcAAT protein for improved substrate specificity towards the octanoyl-CoA substrate. As 
well, this strategy could be used in conjunction with octanoic acid feeding to maximize 
intracellular availability of this substrate. Fatty acid synthesis (FAS) and degradation (FAD) are 
two highly regulated processes of lipid metabolism in E. coli and involves the de novo synthesis 
of fatty acids from acetyl-CoA and the degradation of fatty acids to acetyl-CoA, respectively 
(Clark and Cronan, 2005; Lennen et al., 2012; Janβen et al., 2014). Through fatty acid synthesis, 
intracellular acetyl-CoA, obtained from a number of carbon sources, is converted in several 
enzymatic steps to acetoacetyl-ACP, the first molecule in the fatty acid elongation cycle. This 
substrate is then further extended in chain length by two carbons for every cycle with the 
addition of an acetate (donated from malonyl-ACP) to the growing acyl-ACP chain through the 
activity of five enzymes, FabG, FabZ, FabI, FabF, and FabB (Figure 4.17 right). This process 
primarily produces C16:0, C16:1, and C18:1 acyl-ACPs which are then further incorporated into 
phospholipids, fatty aldehydes, triglycerides, etc., or instead may be hydrolysed to produce a 
free fatty acid (Fujita et al., 2007; Lennen et al., 2012). The production of a free fatty acid, 
specifically, from an acyl-ACP substrate occurs via the enzymatic removal of the ACP unit by a 
thioesterase enzyme (TE). Thioesterases are a member of the hydrolase family and are 
responsible for the cleavage of the acyl-ACP thioester to a free fatty acid and ACP-SH (Figure 
4.17; Hunt et al., 2002). They often possess distinct substrate specificity for the chain length and 
saturation of the acyl-ACP substrate, and ultimately control the composition of free fatty acids 
in the cell (Salas and Ohlrogge, 2002). Unlike in FAS, during FAD, a free fatty acid is first 
esterified to a CoA-SH to produce a fatty acyl-CoA. Doing so not only primes the fatty acid to 
enter the β-oxidation cycle for degradation, but acyl-CoAs may also act as substrate for the 
further production of wax esters, ketones, phospholipids, etc. (Clark and Cronan, 2005; Fujita et 
al., 2007; Lennen et al., 2012). Should the acyl-CoA enter the β-oxidation pathway, it is 
iteratively shortened in chain length by two carbons for every one cycle (Figure 4.17) to produce 
acetyl-CoA that may be further utilized other metabolic processes.  
Many groups have worked towards increasing the free fatty acid production of E. coli through 
manipulation of the FAS and FAD pathways; often as a means for biofuel production (Lu et al., 
2008; Lennen et al., 2010; Lui et al., 2010; Dellomonaco et al., 2011; Jeon et al., 2011; Lennen 
et al., 2011; Zhang et al., 2011; Zhang et al., 2012; Youngquist et al., 2012). Typically, this 
process has involved three general steps: upregulation of FAS, expression of a TE enzyme that 
possesses specificity for the desired free fatty acid(s), and downregulation of FAD. Unlike these 
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groups, however, this work is interested in increasing the availability of a specific acyl-CoA – 
octanoyl- CoA. Thus far, octanoic acid has been exogenously fed into cultures to increase the 
intracellular concentration of this acid chain length, which has been moderately successful. 
Exogenously fed fatty acids are converted directly to acyl-CoAs upon movement into the cystol 
(as there is no mechanism in E. coli for the conversion of exogenously fed fatty acids to acyl-
ACP). Thus, exogenously fed octanoic acid is converted to directly to octanoyl-CoA 
intracellularly, the desired acyl chain length for butyl ester production. However, it was found 




Figure 4. 17 Bacterial metabolic pathways for the synthesis of free fatty acids (right) and β-oxidation 
for the breakdown of free fatty acids (left). Fab = Fatty Acid Biosynthesis, Fad = Fatty Acid 
Degradation. Modified from Lennen et al., (2012). 
 
 
into cultures expressing EcAAT, that significantly more butyl hexanoate and -butyrate were 
produced than butyl octanoate. Also, it was noted that E. coli C43 (DE3) cultures expressing 
EcAAT in which only butanol, and no acid, was exogenously fed produced only trace amounts of 
butyl butyrate and butyl hexanoate and no butyl octanoate (data not shown). Together, this 
suggests that in E. coli cultures exogenously fed octanoic acid, that it is being oxidized by the 
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FAD pathway after its conversion to octanoyl-CoA in the cell to the shorter C6:0 and C4:0-CoA 
chain lengths, and that these substrates are then preferentially being esterified over the octanoyl-
CoA by the EcAAT enzyme. As these shorter chain butyl esters are toxic to E. coli, a strategy 
similar to that employed by other groups working towards engineering increased free fatty acid 
production in E. coli was used here to engineer an increase in octanoyl-CoA abundance, and 
minimize its degradation to the shorter chain hexanoyl and butyryl-CoAs in E. coli.  
First, the possibility of increasing the proportion of octanoyl-CoA over hexanoyl- and butyryl-
CoA upon exogenous octanoic acid feeding by downregulating FAD was investigated. To 
increase free fatty acid abundance in E. coli, many groups have knocking out the FadD gene, 
which is an acetyl-CoA synthase responsible for converting a free fatty acid to an acyl-CoA 
(Yoo et al., 2001). However, doing this would be disadvantageous for the present work as acyl-
CoA is the substrate for AAT enzymes. Therefore, FadD activity is required to convert 
exogenously fed – or endogenously produced – octanoic acid to octanoyl-CoA. Instead, an E. 
coli FadE gene knockout strain (JW5020) from the CGSC (Coli Genetic Stock Center; Baba et 
al., 2006) was obtained. FadE is the enzyme responsible for the second reaction step in β-
oxidation, which is the conversion of an acyl-CoA to an enoyl-CoA (Figure 4.17). This would 
mean that in a FadE knockout strain, exogenously fed octanoic acid should continue to be 
converted to octanoyl-CoA by the action of FadD, but not further degraded by β-oxidation to the 
hexanoyl and butyryl-CoA chain lengths. Several groups have used ΔFadE strains in the past to 
successfully increase the production of a number of valuable acyl-CoA derivative products 
(Steen et al., 2010; Yu et al., 2011). The JW5020 E. coli strain was transformed with pFRANK 
and cultured for butyl ester production as described previously in section 4.2.1, including 
butanol and octanoic acid feeding. Unexpectedly, this strain produced no butyl ester of any 
chain length, however it was observed that at the point of analysis at 18 hours, that all octanoic 
acid had been consumed (data not shown). This was interesting as it has previously been 
observed in cultures of wildtype C43 (DE3) E. coli exogenously fed octanoic acid that at the 
point of analysis at 18 hours that a significant amount of octanoic acid remained (data not 
shown). As other groups had successfully expressed a long chain alcohol acyltransferase (also 
called a wax synthase) in a ΔFadE E. coli knockout strain to produce high titres of long chain 
FAEEs (fatty acid ethyl esters) (Steen et al., 2010), it was initially suspected that the JW5020 
strain acquired was not a true FadE knockout. Therefore, to confirm the presence of the gene 
knockout in the JW5020 strain, the genomic region in which the FadE gene is located was 
amplified by PCR in wildtype E. coli strain C43 (DE3) and strain JW5020. From this, it was 
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found that strain JW5020 was, in fact, a true FadE knockout, as the DNA band size amplified 
corresponds to the expected size of the kanamycin resistance gene, and not the FadE gene (as 
seen in the C43 (DE3) strain) (Figure 4.18). Initially, an explanation as to why the EcAAT 
produces no butyl ester in the JW5020 background is unclear, especially considering that the 
total consumption of exogenously fed octanoic acid in culture was observed. It may be the case 
that the octanoic acid was being consumed by other lipid synthesizing pathways that are up 
regulated to compensate for the decreased activity of β-oxidation in this FadE knockout strain. 
Acyl-CoA substrates, as mentioned above, can also be converted to a number of other lipid 
product in vivo; such as wax esters, triglycerides, ketones, phospholipids, etc. It may be the case 
that one or more of these pathways has been upregulated to compensate for the decrease in 
FAD, and that these endogenous pathways are outcompeting the EcAAT for substrate. To 




Figure 4. 18 Agarose gel showing the PCR amplification over the genomic region containing the 
FadE gene for both wild type E. coli C43 (DE3) strain and JW5020 (ΔFadE) knock-out strain. 
Primers annealed 150 bp upstream and downstream of the FadE gene. 
 
 
exogenously fed 2.5 mM octanoic acid were compared. Cultures were incubated for 18 hours at 
20℃ from the point of octanoic acid addition. This analysis was of all free and bound 
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intracellular fatty acids, and thus included free acids as well as those present in esters, 
triglycerides, phospholipids etc. Figure 4.19 demonstrates the proportion of each fatty acid 
present in C43 (DE3) and JW5020. Here it can be seen that the JW5020 strain possessed more 
than double the amount of octanoic acid compared to the C43 (DE3) strain of E. coli. Unlike in 
the wildtype C43 (DE3) E. coli strain, where the octanoic acid is both entering β-oxidation and 
being converted to other lipid compounds, the JW5020 strain is unable to breakdown this acid, 
accounting for its increased abundance. This, paired with the observations that no free octanoic 
acid remained in cultures of E. coli strain JW5020 expressing EcAAT that had been exogenously 
fed this acid for the purposes of butyl ester formation, suggested, rather, that instead it is being 
incorporated into other lipid compounds. In both the C43 (DE3) and JW5020 E. coli strains, the 
amount of detected acid of chain lengths below C8:0 were too small to reliably quantify. 
Interestingly, the amount of each individual fatty acid quantified from E. coli strain JW5020 was 
either equal to or smaller than the respective amount quantified from strain C43 (DE3). This was 
unexpected as downregulation of β-oxidation should affect abundance of all fatty acids in this 
knockout strain. Unfortunately, upon reflection of this work, the explanation for the lack of 
EcAAT activity in this ΔFadE genetic background became clear, and is a result of an 
unremarkable and trivial error. The parent strain of JW5020 is E. coli K-12, a strain that does 
not possess the gene that codes for T7 RNA polymerase. Thus, transcription of the EcAAT gene 
from pFRANK, which is under the control of a T7 RNA polymerase promoter, is not possible in 
the JW5020 strain. While this is an unfortunate error, it does mean that the use of a ΔFadE E. 
coli strain that does contains the T7 RNA polymerase gene – such as C43 (DE3) – may still be a 
valid strategy for increasing the intracellular abundance of octanoyl-CoA by minimizing its 
degradation to shorter acyl-CoAs by β-oxidation; and thus improving butyl octanoate product 
specificity via EcAAT esterification. The next approach for increasing the abundance of 
available octanoyl-CoA in the cell was to express a thioesterase enzyme that has substrate 
specificity for hydrolysing octanoyl-ACP to octanoic acid. Thioesterase enzymes typically 
possess activity for either CoA or ACP linked substrates, though some are able to work on both. 
This work required the employment of a thioesterase that is specific for hydrolysing only the 





Figure 4. 19 Analysis of the total internal lipid content of E. coli strains C43 (DE3) and JW5020 
(ΔFadE). Cultures were exogenously fed 2.5 mM octanoic acid and grown for 24 hours before 
analysis. Data are the mean + standard deviation of three replicates. 
 
 
activity for hydrolysing octanoyl-CoA would be detrimental to this system as it is the direct 
substrate of the EcAAT enzyme. A number of thioesterases from plants have been characterized, 
and one specifically from Cuphea palustris, named FATB1, demonstrates nearly exclusive 
substrate specificity for hydrolysing a C8:0-ACP to octanoic acid (Dehesh et al., 1996; Jing et 
al., 2011). Ultimately, the expression of CpFATB1 (where Cp stands for Cuphea palustris) 
would be most beneficial in an E. coli background where β-oxidation is also downregulated 
(such as the ΔFadE trialled above), as it would establish a system where free octanoic acid 
abundance is increased via the TE activity and its degradation to other shorter acid chain lengths 
is decreased via β-oxidation perturbation. This has been done previously by Torella et al., 
(2013) by the expression of a thioesterase in an E. coli ΔFadD strain, where free fatty acid titres 
were improved over a wildtype E. coli strain expressing the same thioesterase. As the reason for 
the lack of butyl ester production in the JW5020 E. coli strain via EcAAT expression from 
pFRANK had not been elucidated at this point, expression of the C8:0-ACP specific FATB1 
thioesterase from C. palustris was done in both the wild type C43 (DE3) E. coli strain and the 
JW5020 ΔFadE knockout strain – where the JW5020 strain was used as an example of a β-
oxidation hindered strain. Additionally, the potential benefit of supplementing cultures with the 
antibiotic cerulenin was investigated. The mode of action of cerulenin is to target fatty acid 
synthesis enzymes FabB and FabF, thus inhibiting fatty acyl-ACP elongation but not the initial 
condensation reaction of FabH that enter acetoacetyl-ACP into FAS (Kawaguchi et al., 1982; 
127 
 
Torella et al., 2013). The result of this is an accumulation of medium chain acyl-ACP in vivo; 
which is most likely a consequence of both the decreased elongation of medium chain acyl-
ACPs to long chain acyl-ACPs, as well as the resulting relief in feedback inhibition of FabH due 
to the decrease in long chain acyl-ACP abundance (Jiang and Cronan, 1994; Heath and Rock, 
1996; Torella et al., 2013). Thus, the CpFATB1 sequence was codon optimized to the genome 
of E. coli, synthesized as a gene string by GeneArt, and subsequently cloned into pET21a 
between restriction sites BamHI and XhoI. pET21a::CpFATB1 was then transformed into both E. 
coli strains C43 (DE3) and JW5020. Cultures of C43 (DE3) and JW5020 harbouring 
pET21a::CpFATB1 were incubated in M9 + 1% glycerol media and induced with 0.4 mM IPTG 
before being incubated at 30℃ for 24 hours. To those cultures in which cerulenin was added, 
this was done at the point of induction. Figure 4.20 shows the abundance of total octanoic acid 
present in the cell pellet fraction both E. coli strains with or without CpFATB1 expression or the 
addition of cerulenin. Here it can be seen that heterologous expression of this thioesterase 
increased the intracellular abundance of octanoic acid in both the E. coli C43 (DE3) and 
JW5020 strains by 2-fold and 5-fold, respectively, over their individual controls. As well, media 
supplementation with cerulenin further increased the titres of octanoic acid achieved by both E. 
coli stains, with a 3.8-fold increase over the control for strain C43 (DE3) expressing CpFATB1, 
and a 9.5-fold increase over the control for strain JW5020 expressing CpFATB1 (Figure 4.20). 
The higher abundance of octanoic acid produced by the cultures of JW5020 harbouring 
pET21a::CpFATB1 compared to the JW5020 control suggests that CpFATB1 is being expressed 
to some degree regardless of the lack of T7 RNA polymerase in this strain. The accumulation of 
all other fatty acids was not significantly different between these two strains in each condition 
trialled (data not shown). Overall, CpFATB1 thioesterase expression in the ΔFadE background 
resulted in significantly higher octanoic acid titres compared to the C43 (DE3) wildtype strain, 
suggesting that the use of an E. coli ΔFadE strain that possesses T7 RNA polymerase would be 
highly beneficial to this strategy for increasing intracellular octanoyl-CoA abundance. While the 
expression of CpFATB1 successfully increased the intracellular abundance of octanoic acid in 
both E. coli strains C43 (DE3) and JW5020, this is a measurement of total octanoic acid in the 
cell, and not necessarily octanoyl-CoA – our desired product. The enzyme responsible for the 
conversion free fatty acid to acyl-CoA is an acyl-CoA synthetase enzyme named FadD, which 
activates these substrates for β-oxidation (Yoo et al., 2001). As such, it is often a knockout 
target for metabolic engineering aimed at increasing free fatty acid production in E. coli (Lu et 
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al., 2008; Steen et al., 2010; Lennen et al., 2011; Zhang et al., 2012). Conversely, however, it 




Figure 4. 20 Total internal octanoic acid content of E. coli strains C43 (DE3) and JW5020 (ΔFadE) 
alone, heterologously expressing FATB1 from C. palustris, or heterologously expressing FATB1 in 
the presence of the antibiotic cerulenin to retard fatty acid elongation. Cultures were grown in M9 
media + 1% glycerol and induced with IPTG at an OD600 of 0.8. Cerulenin addition occurred at the 
point of induction. Cultures were grown for 24 hours before lipid analysis. Data are the mean + 
standard deviation of three biological replicates.  
 
 
heterologous thioesterase expression improves the production of acyl-CoA derived products– 
such as FAEEs and fatty alcohols – over thioesterase expressing E. coli strains where there was 
no FadD overexpression (Steen et al., 2010). This suggests that FadD overexpression increases 
the conversion of free fatty acids to acyl-CoAs. As such, it was hypothesized that co-expression 
of the heterologous CpFATB1 and homologous FadD in E. coli would increase the abundance 
of available octanoyl-CoA in the cell, which could then act as a substrate for butyl octanoate 
production by the EcAAT enzyme. Therefore, plasmid pVICTOR 2.0 was further modified by 
inserting the CpFATB1 gene and E. coli FadD gene downstream of the Fdh gene to create a new 
plasmid named pSHELLEY (Figure 4.21). Ideally, this pSHELLEY plasmid would be co-
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transformed with the pEL11 plasmid into an E. coli derivative strain of JCL166 which also 
posseses a FadE gene knockout for perturbation of β-oxidation. In theory, this strain would be 
capable of (i) endogenous production of butanol, (ii) increased production of octanoyl-CoA with 
minimal degradation of this acyl chain length, and (iii) conversion both of these substrates to 
butyl octanoate via EcAAT esterification. Additionally, this strain could be exogenously fed 
octanoic acid should the endogenously produced titres be limiting. However, for this to be 
possible, resolution of the overhanging problem of Ter-EcAAT co-expression would be required. 
Until this problem is resolved, quantification of the impact CpFATB1 and FadD overexpression 
have on the total amount/composition of butyl esters produced by E. coli expressing 




Figure 4. 21 Plasmid map of pSHELLEY, a derivative of pVICTOR2.0. FATB from C. palustris 
was cloned between restriction sites SalI and SacI, and FadD from E. coli was cloned between 






In this work, the detoxification of endogenously produced butanol via incorporation into the 
non-toxic butyl octanoate ester in E. coli by an AAT enzyme from A. chinensis was investigated. 
Supplementation of E. coli cultures heterologously expressing the AAT with both butanol and 
octanoic acid resulted in a mix of butyl octanoate, -hexanoate, and -butyrate esters; the latter two 
of which were undesirable end-products as they are more toxic to E. coli than butanol. Activity 
of the AAT enzyme in an E. coli strain that endogenously produces butanol resulted in very low 
titres of butyl ester, and further investigation identified that AAT expression in this strain is 
reduced due to co-expressed with a Ter gene that encodes for a protein that carries out an 
intermediate step in the butanol production pathway. Efforts to improve AAT substrate 
specificity towards the octanoic acid substrate chain length via protein engineering identified 
two point mutations that increase butyl octanoate production five times over the wildtype 
enzyme, but did not reduce production of butyl hexanoate or -butyrate. In this chapter, efforts to 
engineer an E. coli strain to increase its endogenous accumulation of the desired octanoyl-CoA 
substrate, and to reduce the degradation of octanoyl-CoA to the shorter chain hexanoyl-CoA and 
butyryl-CoA substrates, was begun, but not finished. However, should a compatible ΔFadE 
knockout E. coli strain be created, it may be possible to improve butyl octanoate titres via AAT 
activity in this engineered strain.  
Ultimately, however, developing a strain of E. coli that incorporates endogenously produced 
butanol into butyl octanoate effectively enough for detoxification would require a significant 
protein and strain engineering. Incorporation of butanol into butyl ester as a general strategy for 
detoxification warrants further investigation, however butyl octanoate may not be a practical 
end-product for butanol detoxification due to the low substrate specificity of the AAT enzyme 
and the low AAT gene expression when co-expressed with the Ter gene required for butanol 








5. Esterification as a strategy for reducing toxicity of geraniol 
and improving both yield and recovery from E. coli 
engineered for monoterpenoid production 
 
 
5.1 Introduction  
 
Geraniol (trans-3,7-dimethyl-2,6-octadien-1-ol) is an acyclic monoterpene alcohol found in the 
essential oils of plants such as lemongrass, rose, and geranium (Talapatra, S.K., and Talapatra, 
B., 2015). Due to its distinctly sweet and floral aroma, it has played a significant role in the 
flavour, fragrance, and cosmetic industries. More recently, however, several pharmaceutical 
applications for geraniol have been suggested, including use as an anti-cancer, anti-
inflammatory, and pain relief agent. Additionally, geraniol has also been proposed as a 
promising gasoline alternative, superior to other biofuels such as ethanol, by virtue of its low 
volatility, low hygroscopicity and high energy density (Peralta-Yahya and Keasling, 2010; 
Guimarães et al., 2013; de Cássia da Silveira e Sá et al., 2013; Cho et al., 2016; Liu et al., 
2016). As a consequence, the worldwide demand for geraniol has surpassed 1000 metric 
tons/year (Lapczyski, 2008). Currently, the predominant methods for obtaining geraniol include 
extraction from plant material and chemical synthesis; both of which are costly and inefficient 
(Sell, 2003; Liu et al., 2015). Therefore, there has been a growing interest in developing 
biotechnological methods for terpene production in a more sustainable and economical way 
(Ignea et al., 2013). Over the last decade, systems metabolic engineering of microbial hosts, 
such as Saccharomyces cerevisiae and E. coli, has proven to be successful for the production of 
a number terpenes from renewable resources (Martin et al., 2003; Leonard et al., 2010; Lee et 
al., 2012; Ding et al., 2014). 
 
Monoterpene biosynthesis is dependent on the condensation of two C5 isoprene precursors, 
isopentenyl pyrophosphate (IPP) and its isomer dimethylallyl pyrophosphate (DMAPP), to 
produce geranyl pyrophosphate (GPP) – the universal building block to all monoterpenes. These 
C5 precursors can be synthesized via two independent pathways: the mevalonate-dependent 
(MEV) pathway and the methylerythritol 4-phosphate (MEP) pathway. Prokaryotes, such as E. 
coli typically use a native MEP pathway (Martin et al., 2003; Hunter, 2007; Zebec et al., 2016). 
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Early efforts to develop E. coli as a platform for commercial terpene production focused both on 
improving the expression and regulation of this native MEP pathway, as well as heterologous 
expression of the non-native MEV pathway sourced from a number of host organisms (Farmer 
et al., 2000; Huang et al., 2001; Alper et al., 2005; Martin et al., 2003; Pitera et al., 2007; 
Anthony et al., 2009; Yoon et al., 2009; Redding-Johansen et al., 2011). In recent years, the 
iterative optimization of both the MEP and MEV pathways in E. coli for the production of 
various end point terpenes has been undertaken, with notable success in the production of 
several sesquiterpenes, such as artimisinic acid, bisabolene and farnesene (Tsuruta et al., 2009; 
Peralta-Yahya et al., 2011; Wang et al., 2011). In contrast to the high microbial titres achieved 
for these sesquiterpenes, monoterpene production in E. coli has been significantly less 
successful, hindering industrial scale production.  
 
Efforts to produce monoterpenes from engineered E. coli has proven to be challenging due to 
their high toxicity compared to the longer chain sesqui- and diterpenes, with typical titres 
remaining in the mg/L range. Several groups have developed E. coli strains for geraniol 
production, though, to date, the titres achieved have been too low to be economically viable 
(Shah et al., 2013; Zhou et al., 2014; Liu et al., 2015; Liu et al., 2016). The obstacles that 
impede high geraniol production are (i) its high microbial toxicity and (ii) product loss due to 
bioconversion to other monoterpenoids – which are themselves toxic to various degrees – 
(Trombetta et al., 2005; Chen and Viljoen, 2010; Brennan et al., 2012) by endogenous E. coli 
enzymes. Geraniol toxicity has been attributed to its amphiphilic nature, endowing it with the 
ability to interact with cell membranes and impact their integrity and permeability, as well as 
interact with intracellular components (Trombetta et al., 2005; Brennan et al., 2012). Shah et al., 
(2013) demonstrated that geraniol exposure in E. coli causes DNA damage, adding further 
evidence that this compound has a multifaceted mode of toxicity. In addition to the problem of 
microbial toxicity, several groups have reported loss of geraniol in E coli cultures due to 
biotransformation of the endogenously produced geraniol to other geranoids (geranial, nerol, 
neral) and monoterpenoids such as citronellol and linalool (Fisher et al., 2013; Zhou et al., 
2014). This has been attributed to the presence of promiscuous endogenous E. coli enzymes that 
possess monoterpene alcohol modifying capability; one such identified enzyme is yjgB, a 
geraniol dehydrogenase that converts geraniol to geranial (Zhou et al., 2014). Ultimately, the 




 Both of the above-mentioned obstacles impeding microbial monoterpene production need to be 
resolved in order to achieve industrially viable geraniol titres from E. coli. Typically, to address 
the former issue of toxicity, microbial cultures producing terpenes are grown in the presence of a 
secondary organic phase, the purpose of which is the in situ sequestration of the produced 
terpene to minimize its exposure to the microbial cells and alleviate toxicity (Brennan et al., 
2012). While this has been successful for hydrophobic sequi- and diterpenes that partition well 
into the organic phase, the amphiphilic nature of monoterpenes means they partition less 
efficiently and remain, in part, in the aqueous milieu where they can continue to interact with 
cellular activity. Further, this inefficient sequestration facilitates their exposure to promiscuous 
endogenous enzymes that are capable of modifying the desired monoterpene end-product.  
Ultimately, terpene hydrophobicity/philicity appears to be a central factor in the success of 
sequi- and diterpene production from microbial culture, and the failure of monoterpene 
production. This would suggest that employing a strategy where the hydrophobicity of a 
monoterpene is increase would promote its sequestration into a second organic phase. Here it is 
hypothesized that the further conversion of geraniol to a more hydrophobic acetate ester may 
improve final titres and minimize microbial toxicity by promoting its extraction into the organic 
layer of a two-phase culture. The partial acetylation of monoterpenoids has been previously 
reported for geraniol and perillyl alcohol via the promiscuous activity of a chloramphenicol 
acetyltransferase (CAT) used as a resistance marker in the plasmids harbouring these 
heterologous pathways (Alonso-Gutierrez et al., 2013; Liu et al., 2016). However, a rational 
investigation into this esterification strategy for the improvement of monoterpene extraction in a 
biphasic culture has not been done. Here this strategy is explored by the deliberate conversion of 
geraniol to geranyl acetate in vivo through the heterologous activity of an alcohol acyltransferase 
(AAT) enzyme from Rosa hybrida that possesses distinct substrate specificity for the acetylation 
of geraniol.  
In this work, the strategy for detoxification via esterification that was previously attempted for 
butanol production was applied to the toxic monoterpene, geraniol. To do this, three aims were 
outlined: (1) to engineer E. coli to produce geranyl acetate from glucose through the 
heterologous expression of the mevalonate pathway, a geraniol synthase (GES) from Ocimum 
basilicum, and an alcohol acyltransferase (AAT) from R. hybrida (Figure 5.1); (2) to optimize 
the production of geranyl acetate in flask culture; (3) to scale up production of geranyl acetate to 





Figure 5. 1 Diagram of the two E. coli expression constructs used in this study harbouring (A) the 
pMIB13 plasmid harbouring a mevalonate pathway (MEV) leading towards the production of the 
monoterpene geraniol. Plasmid pMIB13 was modified from the limonene producing plasmid pJBEI-
6410 (Alonso-Gutierrez et al., 2013) by replacing the terminal terpene synthase with one specific for 
making geraniol (GES) from O. basilicum. (B) A second plasmid, pET28a::RhAAT, harbouring an 
alcohol acyltransferase (AAT) from R. hybrida with activity for esterifying geraniol and acetyl-CoA 
to produce geranyl acetate.  
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5.2 Results and Discussion 
 
 
5.2.1 Geraniol and geranyl acetate production in E. coli 
 
The previously described pJBEI-6410 plasmid (Alonso-Gutierrez et al., 2013), harbouring an 
optimized MEV pathway with the requisite genes for limonene production was modified for the 
production of geraniol (Figure 5.1). This was done by replacing the terminal limonene synthase 
gene (LS) present in pJBEI-6410 with a geraniol synthase gene (GES) from O. basilicum – 
resulting in a modified plasmid that was named pMIB13. The GES enzyme from O. basilicum 
was chosen as the geraniol producing monoterpene synthase for this work as it has been well 
characterised in the literature. The full-length coding sequence of the GES gene was optimized 
to the genome of E. coli, including the N-terminal plastidial targeting sequence, which was not 
truncated as it had previously been demonstrated not to interfere with expression of the 
recombinant enzyme (Iijima et al., 2004; Liu et al., 2016; optimized GES sequence in 
Appendix). The replacement of the LS gene with the codon optimized GES gene was done using 
Gibson Assembly cloning, however as there was no available restriction site directly upstream 
of the LS gene in pJBEI-6410, the plasmid was instead cut at restriction sites KpnI and BamHI – 
the former site located 185 bp into the upstream Geranyl PyroPhosphate Synthase (GPPS) gene, 
and the later located directly downstream of the LS gene. A DNA fragment composed of the 
remaining 709 bp of the upstream GPPS gene followed by a SalI restriction site and the GES 
gene was flanked on either end with Gibson overhangs complementary to the vector sequence 
(primer sequences in Appendix) and inserted into pJBEI-6410 to reconstitute the GPPS gene 
and replace the limonene synthase with the desired geraniol synthase. The insertion of a SalI 
restriction site directly upstream of the GES gene was done to facilitate any future exchange of 
the terpene synthase. Figure 5.2 shows an agarose gel of the DNA digests of plasmid pMIB13 at 
either restriction sites KpnI/BamHI or SalI/BamHI to demonstrate the successful insertion of the 
GES gene and SalI restriction site, as well as the reconstitution of the KpnI restriction site. A full 





Figure 5. 2 Agarose gel showing the DNA double digests of pMIB13 with either restriction enzymes 
KpnI/BamHI (lane A) or SalI/BamHI (lane B). Lane A shows the 2400 bp fragment composed of the 
inserted GES gene with ~700 bp of the upstream GPPS gene. Lane B shows the 1700 bp fragment of 
the inserted GES gene, having been digested with the newly constituted SalI restriction site directly 
upstream of the inserted GES gene.  
 
 
E. coli strain C43 (DE3) was then transformed with plasmid pMIB13 to create a geraniol 
producing E. coli strain named DLG2 (Methods Table 2.1). Strain DLG2 was cultured for 24 
hours at 30℃ after induction with 50 µM IPTG, a 10% dodecane top layer was added directly 
after induction to create a two-phase extractive culture. At the point of analysis, it was observed 
that 35 mg/L of geraniol was present in the organic top layer (Figure 5.4). Interestingly, in 
addition to producing geraniol, this strain also produced significant amounts of the 
monoterpenoids nerol and citronellol, as well as the sesquiterpenoid farnesol, which were 
detected using GC-MS (Figure 5.4). Previous work has determined that the GES enzyme from 
O. basilicum has strict substrate specificity for synthesizing only geraniol from the geranyl 
pyrophosphate precursor (Iijima et al., 2004), suggesting that the observation of additional 
terpene products is the result of modifications made to geraniol by endogenous E. coli enzymes. 
Fisher et al., (2013) previously demonstrated that upon GES expression the composition of the 
resulting terpene profile is heavily dependent upon the heterologous host in which it is being 
expressed. Ultimately, this further endogenous manipulation of geraniol by host enzymes is 
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limiting to industrial level production, and several groups have worked towards minimizing this 
bioconversion (Zhou et al., 2014). Also hindering industrial microbial production of geraniol is 
its high cytotoxicity, which is characteristic of monoterpenes. While the exact mechanisms of 
geraniol toxicity are poorly understood its moderate water solubility is most likely a contributing 
factor – endowing it with the capacity to migrate across aqueous environments and interact with 
and damage lipid membranes and intracellular components (Trombetta et al., 2005; Brennan et 
al., 2012; Shah et al., 2013). Even when being produced in a biphasic extractive culture, the 
moderate water solubility of monoterpenes allows a proportion to remain in aqueous solution, 
exerting toxic effect. Therefore, it is proposed that a chemical modification that leads to a 
decrease in the water solubility of a monoterpene may result in a concomitant decrease in its 
microbial toxicity by further promoting its sequestration into the organic layer of a two-phase 
culture. A simple and effective chemical modification to decrease the water solubility of 
geraniol would be to esterify it, as this would occlude the free hydroxyl group of the 
monoterpene alcohol, decreasing its capacity for hydrogen bonding and consequential moderate 
aqueous solubility. In considering potential end-point esters into which to sequester geraniol, 
geranyl acetate was an ideal candidate. The primary reasons for this being that the requisite acyl 
substrate to produce geranyl acetate, acetyl-CoA, is readily available in the cell – thus substrate 
feeding or additional pathway manipulation/ heterologous expression would not be necessary. 
As well, there are a number of AAT enzymes that have been characterized with activity for 
producing geranyl acetate in the literature (D’auria et al., 2002; Shalit et al., 2003; Beekwilder 
et al., 2004; Lucchetta et al., 2007; Balbontin et al., 2010).  
First, to confirm that geranyl acetate would be extracted into the organic phase of a two-phase 
culture more efficiently than geraniol – the keystone to the success of this strategy – the relative 
organic and aqueous solubility of both compounds was assessed. This was done by incubating 
either geraniol or geranyl acetate for several hours in a biphasic culture under the same 
conditions used when culturing strain DLG2 (described above), followed by an analysis of the 
proportion of geraniol or geranyl acetate present in either the aqueous and organic phase. From 
this, it was observed that the esterified form of geraniol possessed significantly reduced water 
solubility compared to the non-esterified form. An analysis of the proportion of each compound 
found in the organic and aqueous phases of the two-phase system showed that 4% of geranyl 
acetate was present in the aqueous layer with the rest partitioning into the organic phase, 
whereas 34% of geraniol remained in the aqueous phase (Table 5.1). These results support the 
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use of geranyl acetate as the end-point monoterpene ester as it is partitions nearly entirely into 
the organic phase.  
 
 
Table 5. 1 Percent geraniol and geranyl acetate present in the aqueous and organic layers of the two-
phase system. 
  % Aqueous % Top Layer 
Geraniol a 34 + 3 66 + 7 
Geranyl acetate a 4 + 0.6 96 + 2 
a TB+2% glucose with a 10% dodecane top layer was supplemented with 5 mM geraniol or geranyl 




In order to engineer E. coli to further convert endogenously made geraniol to geranyl acetate, 
the expression of an AAT enzyme is required. Of the AAT enzymes that have been 
characterized with activity for the synthesis of geranyl acetate, most possessed promiscuous 
substrate specificity, which is undesirable for the purposes of this work. One enzyme, however, 
from Rose (R. hybrida) had been shown to possess nearly exclusive activity for catalysing the 
esterification of acetyl-CoA to geraniol (Shalit et al., 2003) (Figure 5.1), and thus was carried 
forward. The coding sequence of this AAT (RhAAT) was codon-optimized to the genome of E. 
coli and cloned into a high copy pET plasmid to drive expression under the strong T7 promoter 
(Methods Table 2.1; optimized sequence in Appendix). In order to confirm the previously 
documented specificity of this AAT enzyme for producing geranyl acetate, a single phase 
culture of E. coli strain C43 (DE3) heterologously expressing the pET28a::RhAAT plasmid was 
induced with 0.4 mM IPTG, exogenously fed 0.5 mM geraniol and 10 mM acetic acid two hours 
post induction, and cultured for 18 hours. Product analysis at 18 hours confirmed that geranyl 
acetate was nearly exclusively produced in these cultures (Figure 5.3), with only trace amounts 
of citronellyl-, neryl- and linallyl acetate detected by GC/MS (data not shown). Geranyl acetate 
was present in both the supernatant and pellet fractions, as no second organic extractive phase 
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was used, and the production of geranyl acetate had no significant impact on the OD600 of 
cultures compared to wild type E. coli C43 (DE3) producing no monoterpene ester. Ultimately, 
this suggests that RhAAT is an ideal alcohol acyltranferase for the purposes of this work as it 




Figure 5. 3 Geranyl acetate accumulated in the supernatant and cell pellet of E. coli cultures 
expressing an AAT from R. hybrida. Cultures were exogenously fed acetic acid and geraniol after 
induction and grown in a solvent-free system for 18 hours at 20°C before analysis. Data are the mean 
± standard deviation from three biological replicates. 
 
 
With the successful construction of a plasmid that possesses the requisite genes for geraniol 
production (pMIB13), and a second plasmid that harbours an AAT enzyme with high specificity 
for acetylating geraniol (pET28a:RhAAT), E. coli C43 (DE3) was co-transformation with both 
plasmids to generated the geranyl acetate producing strain, DLGA3 (Methods Table 2.1). 
Interestingly, expression of strain DLGA3 produced high titres of exclusively geranyl acetate 
(350 mg/L) from glucose after 24 hours of fermentation, post induction with 0.1 mM IPTG, in a 
two-phase culture (Figure 5.4). A second organic phase was used in geranyl acetate producing 
cultures as it was found that high concentrations of geranyl acetate supplemented into cultures of 
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wild type E. coli C43 (DE3) impacted growth compared to a no geranyl acetate addition control 
over the course of incubation (Appendix, Supplementary Figure 9). A GC-MS analysis of the 
culture supernatants after 9 hours of incubation with 10 mM geranyl acetate showed the 
presence of geraniol in addition to the acetate ester (data not shown), suggesting that 
promiscuous endogenous esterases were hydrolysing geranyl acetate to produce the highly toxic 
geraniol. Geranyl acetate was quantified exclusively from the organic phase, and cultures had no 
additional substrate supplementation with either geraniol or acetic acid. As well, no geraniol was 
detected in these cultures, suggesting that all produced geraniol had been converted to geranyl 
acetate.  Overall, strain DLGA3 shows a marked improvement in product formation over strain 
DLG2 which was previously shown to produce a maximum of 35 mg/L of geraniol from glucose 
after 24 hours – as well as a number of other terpene end-products (Figure 5.4). A comparison of 
the geraniol titres achieved by the two strains showed that DLGA3 produced approximately 8-
fold more geraniol than DLG2. A partial explanation for the difference in product titre between 
strains DLG2 and DLGA3 can be related back to the respective organic phase solubilities of 




Figure 5. 4 A. Gas chromatographs of the dodecane phase of two-phase cultures of E. coli strains 
DLG2 (top panel) producing several terpenols, and DLGA3 (bottom panel) producing only geranyl 
acetate. B. The total production (mg/L) of either geraniol or geranyl acetate produced by strain 
DLG2 and DLGA3, respectively. Cultures were induced with IPTG, followed by the addition of a 
10% dodecane top layer for product extraction. Product analysis occurred after 24h of growth at 
30°C. Chromatograph peaks for citronellol, nerol, geraniol, farnesol, and geranyl acetate are 
indicated. Data are the mean ± standard deviation from three biological replicates. 
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quantified, the proportion of the geraniol produced by strain DLG2 that remained in the aqueous 
phase had not been factored in. However, this end-product solubility alone is not a complete 
explanation for the significantly higher titre achieved by strain DLGA3. Even extrapolating for 
the total amount of geraniol produced by DLG2 – taking into consideration the amount not 
extracted into the top layer using the aqueous phase solubility found in table 5.1 as a guide – 
resulted in a total of 47 mg/L of geraniol, approximately 6-times less than the amount of 
geraniol produced by strain DLGA3.  A potential alternative explanation for the disparity in 
product formation between the two strains relates to intrinsic pathway regulation. It may be the 
case that geraniol acts as an end-product feedback inhibitor to the mevalonate pathway, and that 
its accumulation in the aqueous phase of cultures of strain DLG2 allows it to exert this activity, 
limiting further geraniol production.  Whereas in strain DLGA3, where geraniol is further 
sequestered into an acetate ester that is efficiently extracted into the organic layer, end-product 
feedback inhibition is alleviated, therefore driving further production. Should geraniol be 
involved in negative feedback inhibition of the MEV pathway, the most likely protein it would 
interact with would be the terminal GES enzyme. The reason for this being that all upstream 
enzymes in the MEV pathway are communally used for the production of all terpenes, many of 
which are integral to cell form and function, and thus unlikely to have their expression regulated 
by a single end product. To assess the potential inhibition of geraniol on GES enzyme activity, 
the optimized GES gene was amplified without a stop codon cloned into the MCS of an empty 
pET28a plasmid upstream of a His6x tag. The GES enzyme was subsequently purified using 
cobalt resin from cultures expressing the pET21a::GES, and used for in vitro enzyme assays 
assessing GES activity for synthesizing geraniol in the presence of increasing concentrations of 
geraniol with the colorimetric Malachite Green assay. It was observed, however, that even at the 
highest geraniol concentrations tested, there was no significant impact on GES activity (Table 
5.2), as is evident by the unchanged Vmax, Km, and kcat/Km values observed for the GES activity 
while in the presence of increasing concentrations of geraniol as a potential inhibitor. Should 
there be any product inhibition, depending on the type, these values would be changed from the 
0 µM geraniol control. This suggests that the presence of geraniol is not inhibitory towards the 
activity of this enzyme. However, though unlikely, this does not exclude the possibility that 
geraniol may interact with and inhibit one of the enzymes upstream in the MEV pathway, as this 
pathway has been well documented in the literature to be subject to complex regulation 
(Dimster-Denk et al., 1999; Primak et al., 2011). 
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Table 5. 2 In vitro activity of the GES enzyme from O. basilicum converting GPP to geraniol in the 
presence of varying concentrations of geraniol. Kinetic parameters were determined using the 
malachite green assay in the presence of increasing geraniol concentrations. Data are the mean ± 
standard error from three replicates.   
  Geraniol (µM)   
 0 100 200 400 
Vmax (µmol/min/mg) 1.7 (+ 0.2) 1.6 (+ 0.2) 1.5 (+ 0.1) 1.6 (+ 0.1) 
Km (µM) 121 (+ 16) 96 (+ 10) 98 (+ 12) 98 (+ 14) 
kcat (s-1) 1.8 (+ 0.2) 1.7 (+ 0.2) 1.6 (+ 0.1) 1.7 (+ 0.1) 
kcat/Km (µM-1/s-1) 0.016 0.018 0.017 0.018 
 
 
In addition to the improved product titres observed in strain DLGA3, there was also a marked 
improvement in product specificity – with geranyl acetate being the sole end-product (Figure 
5.4). This, again, is most likely a result of the reduced water solubility of geranyl acetate 
compared to geraniol. In strain DLGA3, the geranyl acetate produced is extracted more 
efficiently into the organic phase and therefore less available for manipulation by endogenous E. 
coli enzymes, unlike geraniol which accumulates in the aqueous phase to a larger proportion and 
is subsequently converted to other monoterpenoids (Figures 5.4 & 5.8). Ultimately, what is 
observed is that the esterification of geraniol is beneficial not only for improved product 
formation, but also for improved product specificity, the two primary problems hindering 
geraniol production on an industrial scale.  
 
 
5.2.2 Acetic acid feeding to improve Geranyl Acetate production  
 
To further improve geranyl acetate titres we considered pathway bottlenecks. While the MEV 
pathway used here had been previously optimized to balance gene expression and flux of 
intermediates (Alonso-Gutierrez et al., 2013), accommodations for the increased consumption of 
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acetyl-CoA had not been taken into consideration. Acetyl-CoA is a node from which much 
cellular metabolism branches and the introduction of a heterologous pathway that requires seven 
acetyl-CoA molecules for each geranyl acetate molecule imposes a significant demand on flux 
through this node. Previously it has been shown that genetic manipulations aimed at increasing 
acetyl-CoA precursor availability in E. coli and S. cerevisiae have resulted in improved product 
titres of the terpenes lycopene and amorphadiene, respectively (Alper et al., 2005; Shiba et al., 
2007). As an alternative approach, here we investigated the viability of media supplementation 
with acetic acid as a means to increase the abundance of available acetyl-CoA. When grown in 
the presence of fermentable sugars, E. coli converts acetyl-CoA to acetate through the action of 
the reversible PTA-ACK pathway (using phosphotransacetylase/acetate kinase), with the acetate 
produced being subsequently excreted (Wolfe, 2005). It has been found, however, that the 
direction of the PTA-ACK pathway is dependent upon the extracellular concentration of acetate, 
with acetate being assimilated by E. coli when present in an external concentration above a 
threshold value of 8 mM, even in the presence of excess glucose (Enjalbert et al., 2017). This 
suggests that the exogenous addition of acetic acid in E. coli cultures grown on glucose may be 
used as a strategy to increase the pool of intracellular acetyl-CoA as the driving force of the 
PTA-ACK pathway is pushed towards its synthesis, resulting in acetyl-CoA accumulation both 
from the consumption of glucose and acetate simultaneously (Castaño-Cerezo et al., 2009; 
Krivoruchko et al., 2015; Yang et al., 2016; Enjalbert et al., 2017). Strain DLGA1 was cultured 
in media supplemented with either no acetic acid, 5 mM, 10 mM, or 20 mM acetic acid, which 
was added immediately post induction. After 24 h, cultures fed no acetic acid had produced 585 
mg/L of geranyl acetate while the cultures supplemented with 20 mM acetic acid produced 940 
mg/L, a 60% increase in product titre (Fig. 3). Those fed 5 mM and 10 mM produced 
intermediate amounts of geranyl acetate (Fig. 3). This clearly demonstrates that the production 
of geranyl acetate in these strains is limited by the availability of acetyl-CoA, either as a 
precursor for geraniol biosynthesis or for acetylation of geraniol, and that further increase in flux 
to geranyl acetate by increasing acetyl-CoA production should be possible.  Although high 
concentrations of acetic acid are detrimental to cell growth as it can uncouple the 
transmembrane pH gradient and inhibit methionine biosynthesis (Roe et al., 2002; Wolfe, 2005), 
media supplementation with up to 20 mM acetic acid (1.2 g/L) had no significant impact on 
final culture OD600, probably due to the buffering capacity of TB media. (Fig. 3).  
Further improvement on this acetic acid supplementation strategy may be achieved by de-
regulating expression of an acetyl-CoA synthase (ACS) enzyme – which catalyses the direct 
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condensation of acetate and coenzyme A (CoA). Transcription of the endogenous E. coli acs is 
repressed in the presence of glucose (Krivoruchko et al., 2015). Yang et al., (2016) have 
recently shown that dual expression of an ACS from Acetobacter pasteurianus and an 
acetoacetyl CoA synthase (AACS) from Streptomyces sp. strain CL190 in an E. coli strain 
engineered for β-caryophyllene production results in improved product titres when acetic acid is 




Figure 5. 5 Geranyl acetate production by E. coli strain DLGA2 after 24h when supplemented with 0 
mM, 5 mM, 10 mM or 20 mM acetic acid. Following induction with 100µM IPTG, cultures were 
overlaid with a 10% dodecane top layer, and fed +/- acetic acid before being incubated at 30°C. 
Average culture OD600 for no acetic acid feeding and 20 mM acetic acid feeding are 33 and 36, 
respectively. Data are the mean ± standard deviation from four biological replicates. 
 
 
5.2.3 Geraniol and geranyl acetate formation under fed-batch conditions 
 
To scale up geraniol and geranyl acetate production, fed batch fermentations of strains DLG2 
and DLGA3 were performed in a 1.5 L batch reactor. Both strains were cultured in a modified 
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TB media (MTB) in which the phosphate buffer salts were replaced with sodium chloride; this 
substitution was made as the culture pH would be maintained at 6.8 by the addition of acid and 
base. Cultures were grown at 30°C and induced with either 50 µM IPTG (strain DLGA2) or 125 
µM IPTG (strain DLGA3) when culture OD600 reached 20. Culture OD600 and product formation 
were tracked over the course of 115 hours for both strains. With strain DLG2, geraniol 
production peaked at 34 hours with 220 mg/L, after this culture geraniol decreased while 
citronellol and nerol increased (Figure 5.6A). An analysis of total monoterpenoids suggests that 
after the peak in geraniol at 34 hours, the total amount of terpene remains relatively stable, with 
only the proportion of each monoterpenoid altering over time. This would suggest that the 
formation of citronellol and nerol are not de novo, but rather a result of the biotransformation of 
geraniol by endogenous E. coli enzymes. Figure 5.7 shows the proposed scheme for the 
bioconversion of geraniol to nerol and citronellol. To support this model, wild-type C43 (DE3) 
E. coli was incubated in the presence of either 0.5 mM geraniol or nerol for 6 hours and then 
evaluated the terpene profiles of each culture by GC-MS (Figure 5.8). It was observed that 
despite the incubation of these cultures in the discrete presence of one monoterpene, the 
presence of all three – geraniol, nerol, and citronellol – was detected, supporting the proposed 
scheme. When wild-type C43 (DE3) E. coli was incubated in the presence of 0.5 mM citronellol 
no biotransformation to other terpenes was observed (data not shown); an occurrence that has 
been previously reported in S. cerevisiae as well (King and Dickinson, 2000). Previously, 
several groups have identified possible enzymes responsible for the reduction, isomerization and 
dehydrogenation of geraniol in E. coli, S. cerevisiae, and other organisms (Steyer et al., 2013; 
Zhou et al., 2014; Liu et al., 2016). Interestingly, over the course of the batch fermentation of 
strain DLG2, citronellol became the dominant terpene product, culminating in 290 mg/L at 112 
hours with minimal amounts of geraniol and nerol present at this time point (Figure 5.6A). No 
enzyme has been identified that is capable of converting citronellol to either geraniol or nerol. 
From data, it may be possible that GES expression in E. coli could be used not only as a means 
for geraniol production, but that it may also be considered as a platform for citronellol 






Figure 5. 6 Monoterpene and monoterpene ester production in E. coli under fed-batch fermentation 
using a two-phase system. A Accumulation of geraniol (purple), nerol (blue), citronellol (red) and 
total monoterpene (grey) in E. coli strain DLG2. B Accumulation of geranyl acetate (green) in E. coli 
strain DLGA3. Both cultures were induced at an OD600 of ~20 with either 50µM IPTG (A) or 
125µM IPTG (B), followed by the addition of a 10% dodecane top layer. Culture (B) was further 







Figure 5. 7 Proposed pathway for the conversion of geraniol to the similar monoterpenoids, nerol 
and citronellol, by endogenous E. coli enzymes. The GES enzyme from O. basilicum has exclusive 
substrate specificity for converting GPP to geraniol. In E. coli culture expressing the GES enzyme, 
the observed accumulation of both nerol and citronellol over time is most likely the result of 
endogenous enzymes catalysing the isomerization of geraniol to nerol and vise versa, as well as the 





Figure 5. 8 Gas chromatographs showing the monoterpenes formed in E. coli C43 (DE3) after 
incubation in the presence of either geraniol or nerol. Panels A and C show internal standards of 
geraniol and nerol, respectively. Panel B and D show the monoterpenes present in the cell pellet of 
wild type E. coli C43 (DE3) incubated in the presence of either 0.5 mM geraniol or 0.5 mM nerol 
respectively, for 6 h. The peaks corresponding to citronellol, nerol and geraniol are indicated.  
149 
 
As previously observed in shake flask fermentation, strain DLGA3 produced exclusively 
geranyl acetate in a fed-batch bioreactor run with MTB media. The culture was fed 20 mM 
acetic acid directly post induction, as it was previously shown to increase product titre (Figure 
4). Geranyl acetate titres peaked at 95 hours with 4.8 g/L (approximately 100 mg/OD unit) 
(Figure 5.6B). This is approximately 2.4 times more geranyl acetate than the previously reported 
highest titres achieved by Liu et al., (2016), where bioconversion of geraniol to geranyl acetate, 
via the unexpected activity of a promiscuous chloramphenicol acetyltransferase (CAT) enzyme, 
was also used. Further, strain DLGA3 was also cultured in a fed-batch bioreactor using a semi-
defined media (FM) that is more typical of industrial production. Here, geranyl acetate 
production peaked at 77 hours with 422 mg/L (approximately 50 mg/OD unit) (Figure 5.9), and 
again was the only product observed over the course of the fermentation. Though these titres are 
lower than those observed in the rich MTB media (Figure 5.6B), further optimization of 




Figure 5. 9 Production of geranyl acetate in E. coli strain DLGA3 under fed-batch fermentation 
using a two-phase system with a semi-defined media. The culture was grown in a fermentation media 
+2% glucose at 30°C and induced when OD600 reached ~5.5 using 100µM IPTG, followed by the 
addition of a 10% dodecane top layer and media supplementation with 20 mM acetic acid. 
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5.3 Conclusion  
 
Here, a rationally developed E. coli platform for the detoxification of the monoterpenoid 
geraniol through its esterification into an acetate ester. Using this strategy, 4.8 g/L of geranyl 
acetate can be produced from glucose in fed batch culture. This represents nearly a 2.5 times 
improvement from previous geraniol producing systems, which had been hindered by the high 
microbial toxicity of geraniol (Shah et al., 2013; Zhou et al., 2014). As well, here it has been 
shown that sequestering geraniol into an acetate ester results not only in higher product titres, 
but also eliminates the bioconversion of geraniol to other monoterpenoids, which has been a 
continuing obstacle to industrial production. Ultimately, this work provides a strategy for the 
improved production of other commercially valuable monoterpenoids, such as terpineol, 
linalool, fenchol, and perillyl alcohol (POH) using this ‘detoxification via esterification’ 
approach. Further metabolic engineering efforts to improve acetyl-CoA and cofactor 
availability, and the characterization of additional AAT enzymes will aid in developing this 


















6. General discussion and conclusions 
 
 
The development of microbes as industrial platforms for the synthesis of commercially valuable 
compounds requires high titre product formation for the process to be economically viable. The 
high titres required, however, often exceed the native tolerance levels of the microbial host, 
creating an undesirable trade-off between culture health and productivity that ultimately limits 
the attainable yields (Dunlop et al., 2011). As such, a large amount of research has gone into 
developing stress-tolerant strains and in situ end-product removal strategies to minimize the 
toxic impact that the accumulation of the desired end-product exerts on the microbial host; with 
the ultimate goal of improving achievable titres in culture and creating more cost-effective 
platforms. This project aimed to investigate an alternative strategy for the detoxification of value 
compounds in the bacterial platform host, E. coli, that involves in vivo sequestration. Unlike the 
sequestration strategies currently used in industrial fermentations, which aim to continuously 
remove the end-product from the culture to minimize its accumulation and exposure to the cells, 
this strategy focused on engineering the microbial host to further incorporate the toxic end-
product into a more neutral compound that exerts little to no toxicity on the host, even at high 
concentrations. The category of toxic end-product used as a model in this work was an alcohol, 
while the more neutral molecule into which it was incorporated was an ester. Alcohol 
esterification was the chosen strategy for detoxification in this work as it is a simple single step 
reaction that requires only the activity of a single enzyme to catalyse the condensation of an 
alcohol to an acid. As well, there is no significant change in structure to the alcohol component, 
but rather it can easily be recovered downstream from the ester molecule through hydrolysis. To 
investigate the effectiveness of this strategy for the detoxification of commercially valuable 
alcohols in E. coli, it was applied to the production of two toxic alcohols: butanol and geraniol. 
For geraniol, this strategy proved to be highly effective, whereas for butanol it showed minimal 
success. A comparison of several factors illustrates the reasons for the discrepancy in the 
effectiveness of this strategy towards these two alcohols.  
 
The first factor influencing the success of this strategy involved the substrate specificity of the 
AAT enzyme responsible for the esterification reaction. In chapter 3, it was identified that the 
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shortest chain aliphatic butyl ester to exert no toxicity at high concentrations in E. coli cultures, 
was butyl octanoate. All butyl esters of shorter acyl chain examined negatively impacted the 
growth rate of E. coli at lower concentrations than butanol – thus butyl octanoate became the 
target end-point ester for this detoxification strategy. Identifying an AAT enzyme capable of 
esterifying butanol and octanoic acid became difficult as most of the AAT enzymes that have 
been characterised possess substrate specificity for shorter acyl chain substrates (C2:0 and C4:0) 
(Table 4.1), and for those AATs that do possess activity towards longer acyl chains, they are 
often not the preferred substrate. This was the case for the EcAAT enzyme from A. chinensis 
that was used for butyl octanoate production in this work. Exogenous feeding of butanol and 
octanoic acid into cultures of E. coli expressing the EcAAT resulted in a small amount of butyl 
octanoate, but significantly more butyl butyrate, and butyl hexanoate – as this EcAAT from A. 
chinensis prefers the shorter butyrate and hexanoate substrates over octanoate (Günther et al., 
2011). This is especially problematic as both of these shorter chain butyl esters are toxic to E. 
coli at low concentrations. The two potential solutions to this problem of product specificity 
would be either: (i) significant engineering the EcAAT enzyme to alter its substrate specificity 
to exclusively accept the octanoate chain length (this could be paired with metabolic engineering 
to increase octanoyl-CoA abundance intracellularly), (ii) or to identify a different AAT enzyme 
with stricter substrate specificity for producing butyl octanoate, and not the shorter chain esters. 
While the latter option would be the ideal solution, to date no AAT enzyme with this specific 
substrate specificity has been characterised. Efforts to engineer the EcAAT enzyme to improve 
its specificity for the octanoate chain length in chapter 4 were minimally successful; while two 
individual point mutations did result in a small increase in butyl octanoate production, neither 
mutation resulted in a decrease in toxic butyl hexanoate or -butyrate production – negating the 
effectiveness of the esterification strategy for detoxifying butanol. Future efforts aimed at 
engineering AAT enzymes would benefit significantly from a crystal structure, as currently none 
is available. Unlike the EcAAT enzyme, however, the RhAAT from R. hybrida displayed high 
specificity for producing geranyl acetate. While Shalit et al., (2013) demonstrated in vitro that 
the RhAAT enzyme has low activity towards acetylating citronellol and nerol alcohols as well, 
expression of RhAAT in geraniol producing E. coli cultures esterified geraniol to geranyl acetate 
more quickly than endogenous E. coli enzymes could convert geraniol to either citronellol or 
nerol – thus preventing the accumulation of these substrates for the RhAAT to acetylate. Thus, 
the high geraniol substrate specificity of the RhAAT enzyme contributed to the improved 
product titres and product specificity achieved for E. coli in Chapter 5. Ultimately, the 
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successful application of esterification as a strategy for detoxification relies on the use of an 
AAT enzyme with high specificity for producing the desired end-product.  
 
The second factor influencing the successful application of this strategy is the chain length of 
the acid substrate required for esterification of the alcohol into a nontoxic ester. The octanoyl-
CoA substrate needed to produce butyl octanoate has low natural abundance in E. coli as it is 
typically an intermediate product in the β-oxidation of long chain fatty acids for acetyl-CoA 
production, or a substrate for incorporation into other lipid compounds (Iram and Cronan, 2006; 
Torella et al., 2013). This was problematic as the acyl-CoA substrate for this esterification 
strategy should not be limiting. Thus, to improve intracellular octanoyl-CoA availability in E. 
coli for butyl octanoate formation via EcAAT activity, either exogenous culture supplementation 
with octanoic acid, or engineering of E. coli lipid metabolism for increased intracellular 
octanoyl-CoA, is required. Both of these strategies were explored in Chapter 4. Exogenous 
supplementation of E. coli cultures expressing the EcAAT with 5 mM octanoic acid was 
effective for butyl ester formation and did not negatively impact on culture health. However, 
product analysis after 18 hours of incubation showed that all exogenously supplemented 
octanoic acid had been consumed, suggesting it may be a limiting substrate for higher butyl ester 
production. Culture supplementation with higher concentrations of octanoic acid, however 
would be detrimental as Royce et al., (2013) showed that the addition of 10 mM octanoic acid 
has a significant impact on E. coli culture density. Thus, for exogenous octanoic acid 
supplementation to be effective, a balance between maximizing product formation and 
minimizing culture toxicity must be established. To achieve this, octanoic acid supplementation 
would need to be done gradually at a low concentration over the course of the fermentation, thus 
facilitating a constant surplus of octanoyl-CoA for the EcAAT enzyme, but not exceeding native 
E. coli tolerance to this acid. For this to be possible, careful monitoring of octanoic acid and 
butyl ester titres in culture – as well as culture pH – over the course of the fermentation would 
be required; a task that is difficult to do in shake flask. More difficult would be the engineering 
of E. coli metabolism to maximize endogenous octanoyl-CoA abundance, as this involves 
manipulation of the highly regulated processes of fatty acid synthesis and β-oxidation. The work 
done towards this end in Chapter 4 was unfinished, but the could prove to be effective in a 
ΔFadE knockout E. coli strain that possesses the phage T7 RNA polymerase gene. Whether 
such a strain could successfully produce high titres of butyl octanoate and minimal titres of butyl 
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hexanoate and -butyrate, however, is unlikely without improvement of the AAT enzyme activity 
and substrate specificity. Conversely, the acyl substrate required for geranyl acetate production 
via RhAAT activity in E. coli is acetyl-CoA; a substrate that is abundant in the cell as it is an 
essential intermediate in a number of biosynthetic pathway (Chohnan et al., 1998). Geraniol 
producing E. coli cultures expressing RhAAT were capable of producing high titres of geranyl 
acetate from endogenous acetyl-CoA pools (i.e. no acetic acid supplementation). As well, these 
cultures did not appear to have reduced health; impressive as seven acetyl-CoAs are required to 
produce one geranyl acetate via the heterologously expressed MEV pathway and RhAAT 
enzyme – a significant investment of acetyl-CoA from the cell. The ability of RhAAT 
expressing E. coli cultures to produce geranyl acetate without the need for exogenous acyl 
substrate supplementation is a stark contrast to the cultures expressing the EcAAT, which 
produce no butyl octanoate without exogenous octanoic acid addition. Further, supplementation 
of RhAAT expressing cultures with 20 mM acetic acid improved geranyl acetate production by 
60% over cultures that had no supplementation, and resulted in no observable impact on culture 
health. This is again in contrast to octanoic acid supplementation in EcAAT expressing cultures, 
which would become inhibitive at 10 mM. It would be interesting to see what the top limit of 
acetic acid supplementation is before becoming detrimental to culture health. Ultimately, the 
intracellular availability of acetyl-CoA, and tolerance for exogenous acetic acid 
supplementation, contributed to the observed high titre production of geranyl acetate in E. coli. 
 
Third factor influencing the successful application of this detoxification strategy was the use of a 
second organic extractive phase. Cultures producing geranyl acetate were grown in the presence 
of a 10% dodecane layer for in situ extraction. This was done as it is common practise to culture 
terpene producing cultures with a second phase due to their high toxicity (Brennan et al., 2012). 
This second organic phase was effective at sequestering approximately 96% of geranyl acetate 
produced, minimizing its exposure to the culture. This was beneficial for two reasons, first, it 
prevented the geranyl acetate from accumulating intracellularly. It was found in Chapter 5 that 
E. coli cultures producing geranyl acetate without the use of an organic extractive phase resulted 
in the majority of the product accumulating in the cell pellet fraction after centrifugation. 
Second, it minimized the exposure of geranyl acetate to endogenous E. coli enzymes. Such 
exposure could result in undesirable manipulations of the geranyl acetate, such as hydrolysis by 
non-specific esterases, or biotransformations of the geraniol component, as was seen in the 
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geraniol producing cultures. For butyl ester production in the EcAAT expressing E. coli 
cultures, however, a second organic phase was not used. The reason for this being, that unlike in 
the geraniol producing cultures, the titres of butanol and butyl ester being achieved did not 
exceed E. coli tolerance limits. The use of an organic top-layer for butyl ester sequestration in 
EcAAT expressing cultures would be possible should an organic solvent be identified into 
which the ester products readily partition, while the butanol and acid substrates do not. Layton et 
al., (2016) demonstrated the effective use of hexadecane as an organic phase in E. coli cultures 
producing short chain esters. The use of a top layer in this work would be additionally beneficial 
as it would mean that engineering of the EcAAT enzyme to decrease its activity for producing 
the shorter chain butyl butyrate and -hexanoate esters would no longer be required. Instead, 
these toxic end-products would be extracted into the organic phase, minimizing their exposure to 
the culture. However, the original goal of this work was to develop a stand-alone detoxification 
strategy for butanol that would require no additional detoxification techniques, such as the use 
of an extractive phase that would increase industrial fermentation costs. This is in contrast to the 
work done by Layton et al., (2016), for whom ester production was the end goal.  
 
The question remains, however, whether this esterification strategy would be effective for 
butanol detoxification. The answer is most likely, no. Currently the highest titre production of 
butanol in E. coli flask cultures is 15 g/L after 75 hours (Shen et al., 2011), while the highest 
titre of total butyl ester achieved in this work – including all three butyl esters chain lengths 
present in both the pellet and supernatant fractions – was 165 mg/L after 18 hours. Not only that, 
but this is the butyl ester titre achieved in cultures that were exogenously fed both the butanol 
and octanoic acid substrates, as the titres achieved by cultures endogenously producing butanol 
were significantly lower. For this esterification strategy to be effective for butanol 
detoxification, it would require that more than 15 g/L of ester be achieved after 75 hours of 
culturing, which is 90 times more ester than what was produced by E. coli after 18 hours in this 
work. Achieving this is unlikely as it would require an immense amount of strain engineering as 
well as a resolution of the AAT/Ter co-expression problem. Instead, the development of a cost-
effective microbial platform for butanol production that is able to compete with petroleum 
derived fuels and chemicals will most likely be achieved by optimizing multiple aspects of 
butanol fermentation, and not just toxicity alone. Gas stripping as a form of in situ extraction has 
been very effective for butanol recovery in both E. coli and clostridial fermentation cultures 
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(Shen et al., 2011; Xue et al., 2012), and optimization of factors such as gas recycle rate and 
bubble size could further improve gas stripping as a technique for butanol recovery (Zheng et 
al., 2009). Further, the high butanol titres achieved in microbial fermentations have used glucose 
as the carbon source, an expensive substrate. The use of low cost substrates such as 
lignocellulose would be ideal for butanol production, and engineering strains for more efficient 
bioconversion of cellulose and hemicellulose would increase the economic success of industrial 
production of butanol (Zheng et al., 2009; Chen et al., 2016). It will be interesting to see in the 
future whether Clostridia or E. coli is favoured as an industrial butanol producing host. While 
clostridial strains such as C. acetobutylicum are currently able to produce and tolerate more 
butanol than the heterologous host E. coli, the genetic tools available to clostridia are less 
advanced and it more difficult to culture.  
While esterification of butanol may not be the next big breakthrough in tolerance engineering, 
medium chain butyl esters such as those produced in this work have their own commercial value 
as flavour and fragrance additives. While several groups have engineered E. coli for the 
synthesis of short chain ester (Rodriguez et al., 2013; Guo et al., 2014; Tai et al., 2015), very 
little work has gone into developing strains for the production of medium chain butyl esters, and 
those that have been produced in E. coli have been low in titre (Layton et al., 2016). As was 
explored in the appendix chapter with clostridia, the production of butyl esters in E. coli could 
be used as a platform for these valuable flavour and fragrance additives, instead of as a butanol 
detoxification strategy. 
 
While the use of esterification for the detoxification of butanol in E. coli was not successful, the 
application of this strategy to the detoxification of the monoterpene geraniol was highly 
effective, and resulted in an increase in both product titre and specificity. Previous attempts to 
alleviate monoterpene toxicity have had minimal success (Shah et al., 2013), and this work 
represents the highest titres achieved for geraniol to date. The application of this strategy to the 
production of other monoterpene alcohols in E. coli would likely also be successful in 
improving titres. Potential future candidates for this would be citronellol, linalool, terpineol, 
lavandulol, and perillyl alcohol; each of which has commercial value (Rottava et al., 2011; 
Alonso-Gutierrez et al., 2013; Amiri et al., 2016). The bottleneck, however, is the availability of 
AAT enzymes that have been characterised as high activity for esterifying these monoterpene 
alcohols. While several have been shown to work accept perillyl alcohol and linalool (D’auria et 
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al., 2002; Beekwilder et al., 2004; Shalit et al., 2013), they are not preferred substrates. 
Further fundamental work needs to be done to identify and characterise novel AAT 
enzymes from plants that produce these monoterpene products. For instance, the plant 
Lavandula x intermedia produces both lavandulol and lavandulyl acetate, however the AAT 
enzyme responsible for this esterification reaction has not yet been identified (Sarker et al., 
2015). 
Ultimately, the use of esterification for the detoxification of value alcohols – or, just as equally, 
acids – is not a universal solution for microbial toxicity. Its success is dependent upon a number 
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Supplementary Figure  1 Full length sequence of each gene used in this study that have been either 
codon harmonized or optimized to the genome of E. coli. Codon harmonization was carried out by 
hand using codon usage tables. Codon optimization was done using GeneArt software. 
 
 
Supplementary Table  1 Oligonucleotide primers used in this study. All primers were synthesised 










































































Supplementary Figure  2 Growth rate of wild type DH5α E. coli exogenously fed 0 mM, 50 mM, 
100 mM, and 150 mM of butyl benzoate. Cultures were grown at 37℃ and 250 rpm, and the OD600 
was taken every 30 minutes until stationary phase was reached. Butyl ester was fed 1.5 hours after 




Supplementary Figure  3 Quantification of butyl esters present in the supernatant of cultures of E. 
coli strain C43 (DE3) harbouring pET21a::EcAAT incubated in different growth medias. Culture 
supernatants were analysed after growth at 20℃ for 21 hours after induction with 0.4 mM IPTG. 
Cultures were grown in either 2TY +/- 2% glucose media or TB+/- 2% glucose media. Data are the 




Supplementary Figure  4 Time course of butyl ester production from pET21a::EcAAT. Cultures 
were grown in TB+2% glucose at 20℃ and 250 rpm. Cultures were induced with 0.4 mM IPTG and 
incubated for 2 hours before the addition of 10 mM butanol and 5 mM octanoic acid. Lipid analysis 





Supplementary Figure  5 SDS-PAGE gel showing of the soluble protein fraction of A E. coli strain 
C43 (DE3), B E. coli strain C43 (DE3) harbouring pET21a::EcAAT without induction, and C E. coli 
C43 (DE3) harbouring pET21a::EcAAT with induction. Cultures were incubated at 37℃ until OD600 
reached 0.8, and then incubated at 20℃ for 18 hours before analysis. The culture of C43 (DE3) 
harbouring pET21a::EcAAT run in lane C was induced with 0.4 mM IPTG at OD600 0.8. The EcAAT 




Supplementary Figure  6 Plasmid maps showing the creation of pFRANK. The Hygromycin 
resistance gene from pAG32 (i) was inserted in the place of the Ampicillin resistance gene of 
pBEST::GFP (ii) to create pBEST::GFP+Hygromycin (iii). This was done using Gibson assembly 
where the Hygromycin gene from pAG32 and the pBEST::GFP backbone were amplified with 
complementary overhangs before assembly. In the second step, the Hygromycin gene and p15A ori 
region of pBEST::GFP+Hygromycin (iii) was inserted in the place of the Ampicillin resistance gene 
and pColE1 ori region of pET21a::EcAAT (iv) to create pFRANK (v). This was done using Gibson 
assembly where each respective region was amplified with overhangs and assembled.  
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AeAAT      1 ----MASSV---RLVKKPVLVAPVDPTPSTVLSL-SSLDSQLFLRFPIEYLLVYASPH-G 
Ban-AAT    1 --------MSFAVTRTSRSLVTPCGVTPTGSLGL-SAIDRVPGLRHMVRSLHVF------ 
MpAAT1     1 ----MMSFSVLQVKRLQPELITPAKSTPQETKFL-SDIDDQESLRVQIPIIMCYKDNPSL 
AcAAT      1 -MASFPPSLVFTVRRNEPTLVLPSKSTPRELKQL-SDIDDQEGLRFQVPVIMFYKRKL-S 
CmAAT1     1 -------DFSFHVRKCQPELIAPANPTPYEFKQL-SDVDDQQSLRLQLPFVNIYPHNP-S 
CmAAT2     1 METMQTIDFSFQVRKCQPELIAPANPTPYEFKQL-SDVDDQQSLRFQLPLVNIYHHNP-S 
VpAAT      1 -MAEKASSLMFNVRRHEPELITPAKPTPREIKLL-SDIDDQDGLRFQVPIIQFYKNNS-S 
CmAAT3     1 ----MASSLVFQVQRSQPQLIPPSDPTPHEFKQL-SDIDDQEGLRFQIPVIQFYRHDP-R 
BEBT       1 --MAHDQSLSFEVCRRKPELIRPAKQTPHEFKKL-SDVEDQEGLRFQIPVIQFYKHNNES 
BEAT       1 ----------MNVTMHSKKLLKPSIPTPNHLQKLNLSLLDQIQIPFYVGLIFHYETLSDN 
CmAAT4     1 ----------MEVKVLSKETIIPSSPTPPHLQPLNLSLLDQLSPMLYIPLLLFYPMKKSY 
RhAAT      1 -------MEKIEVSIISRDTIKPSAAS-SSLHPYKLSIIDQFTPTTYFPVIFFYPITDRV 
SAAT       1 -------MEKIEVSINSKHTIKPSTSS-TPLQPYKLTLLDQLTPPAYVPIVFFYPITDHD 
VAAT       1 -------MEKIEVSIISKHTIKPSTSS-SPLQPYKLTLLDQLTPPSYVPMVFFYPITGPA 
 
AeAAT     52 VD--RAVTAARVKAALARSLVPYYPLAGRVKTRPD-STGLDVVCQAQGAGLLEAVSDYTA 
Ban-AAT   46 RQ--GREPARIIREALSKALVKYYPFAGRFVDDPEGGGEVRVACTGEGAWFVEAKADCSL 
MpAAT1    56 NK--NRNPVKAIREALSRALVYYYPLAGRLREGP--NRKLVVDCNGEGILFVEASADVTL 
AcAAT     58 ME--GEDPVKVIREALAEALVFYYPFAGRLIEGP--NRKLMVDCTSEGVLFIEADADIEV 
CmAAT1    52 LE--GRDPVKVIKEAIGKALVFYYPLAGRLREGP--GRKLFVECTGEGILFIEADADVSL 
CmAAT2    59 LE--GRDPVKVIKEAIAKALVFYYPLAGRLREGP--GRKLFVECTGEGILFIEADADVSL 
VpAAT     58 MQ--GKNPAKIIKSALAETLVHYYPLAGRLREGF--GRKLMVECTGEGILFIEADADVTL 
CmAAT3    55 MA--GTDPARVIKEAIAKALVFYYPFAGRLREGP--GRKLFVECTGEGVMFIEADADVSL 
BEBT      58 MQ--ERDPVQVIREGIARALVYYYPFAGRLREVD--GRKLVVECTGEGVMFIEADADVTL 
BEAT      51 ----SDITLSKLESSLSETLTLYYHVAGRYN-----GTDCVIECNDQGIGYVETAFDVEL 
CmAAT4    51 QHQDHNKAIATLKTSLSKTLSRFYLLAGRII-----GK-S-IHCNDKGAVFMEATINSNM 
RhAAT     53 FN--LPQTLTDLKNTVSQALTLYHPLSGRIK-----NN-LYIDDFEAGIPYLEARVNFHM 
SAAT      53 FN--LPQTLADLRQALSETLTLYYPLSGRVK-----NN-LYIDDFEEGVPYLEARVNCDM 
VAAT      53 VF--NLQTLADLRHALSETLTLYYPLSGRVK-----NN-LYIDDFEEGVPYLEARVNCDM 
 
 
AeAAT    109 SDFQRA--PRSVTEWRKLLLVE-----V---FKVVPPLVVQLTWLSDGCVALGVGFSHCV 
Ban-AAT  104 EDVKYLDLPL--MIPEDALLPKPCPGLN---PLDLP-LMLQVTEFVGGGFVVGLISVHTI 
MpAAT1   112 EQL-GDKILPPCPLLEE-FLYNFPGSDG---IIDCPLLLIQVTCLTCGGFILALRLNHTM 
AcAAT    114 NQLIGDTIDPGFSYLDE-LLHDVPGSEG---ILGCPLLLIQVTRFRCGGWAFAIRLNHTM 
CmAAT1   108 EEF-WDTLPYSLSSMQNNIIHNALNSDE---VLNSPLLLIQVTRLKCGGFIFGLCFNHTM 
CmAAT2   115 EQF-RDTLPYSLSSMENNIIHNSLNSDG---VLNSPLLLIQVTRLKCGGFIFGIHFDHTM 
VpAAT    114 HEF-GDDLPPPFPCLVE-LLYDVPGSSG---IIDTPLLLIQVTRLKCGGFIFALRLNHTM 
CmAAT3   111 EQF-GDALQPPFPCLEE-PLFDVPNSSG---VLDCPLLLIQVTRLKCGGFIFALRLNHTM 
BEBT     114 EQF-GDALQPPFPCFDQ-LLFDVPGSGG---ILDSPLLLIQVTRLKCGSFIFALRLNHTM 
BEAT     102 HQFLLG---EESNNLDL-LVGLSGFLSE---TETPPLAAIQLNMFKCGGLVIGAQFNHII 
CmAAT4   104 FDILKE---PNNEVLTK-LLPCSLLCN-TKPIEEYPQIVVQANIFECGGIAISLCLLHKL 
RhAAT    105 IDFLRL---PKIEWLNE-FVPMAPYRKETIS-EFLPLLGIQVNIFDS-GIAIGVSFSHKI 
SAAT     105 TDFLRL---RKIECLNE-FVPIKPFSMEAISDERYPLLGVQVNVFDS-GIAIGVSVSHKL 
VAAT     105 NDFLRL---PKIECLNE-FVPIKPFSMEAISDERYPLLGVQVNIFNS-GIAIGVSVSHKL 
 
 
AeAAT    159 IDGIGSSEFLNLFAELATGRARLSEFQ-----PKPVWDRH--LLNSAGRTNL-GTH---P 
Ban-AAT  158 ADGLGVVQFINAVAEIARGLP-K--PT-----VEPAWSRE--VIPN--PPKLPPGG---P 
MpAAT1   167 CDAAGLLLFLTAIAEMARGAH-A--PS-----ILPVWERE--LLFARDPPRITCAH---H 
AcAAT    170 SDAPGLVQLLTTIAEFARGAEGA--PS-----VPPVWQRE--FLAARQPPSITFQH---H 
CmAAT1   164 ADGFGIVQFMKATAEIARGAF-A--PS-----ILPVWQRA--LLTARDPPRITFRH---Y 
CmAAT2   171 ADGFGIAQFMKAIAEIARGAF-A--PS-----ILPVWQRA--LLTARDPPRITVRH---Y 
VpAAT    169 SDASGLVQFMTAVGEMARGQR-S--LS-----IQPVWERH--LLNARDPPRVTHIH---H 
CmAAT3   166 SDASGLVQFMMAVGEMARGAT-A--PS-----VRPVWQRA--LLNARDPPKVTCHH---R 
BEBT     169 ADAAGIVLFMKAVGEMARGAA-T--PS-----TLPVWDRH--ILNARVPPQVTFNH---R 
BEAT     155 GDMFTMSTFMNSWAKACRVGIK--------EVAHPTFGLAP-LMPSAK------------ 
CmAAT4   159 IDAATFCCFLRSWATTNRELLSLDHSSPNNNMVCVDYKSFSSLFPQTN--LLPFHQSLIN 
RhAAT    159 NDGQTASCFLKSWVAIFRGYRN--------KIIHPNLSQAALLLPSRD--DLPEK----- 
SAAT     160 IDGGTADCFLKSWGAVFRGCRE--------NIIHPSLSEAALLFPPRD--DLPEK----- 




AeAAT    208 EFGRVPDLSGFV-TRFTQERLSPTSITFDKTWLKELKNIAMSTSQPG---E--FPYTSFE 
Ban-AAT  203 P----------V---FPSFKLLHATVDLSPDHIDHVKS-----RHLE---LTGQRCSTFD 
MpAAT1   214 EYEDVIGHSDGSYASSNQSNMVQRSFYFGAKEMRVLRK-----QIPP---HLISTCSTFD 
AcAAT    218 EYEQVINTT--T---DDNKSMTHKSFFFGPKEIRAIRS-----HFPP---HYRSVSSTFD 
CmAAT1   211 EYDQVVDMKSGL---IPVNSKIDQLFFFSQLQISTLRQ-----TLPA---HLHDCPS-FE 
CmAAT2   218 EYDQVVDTKSTL---IPANNMIDRLFFFTQRQISTLRQ-----TLPA---HLHDCSS-FE 
VpAAT    216 EYDDLEDTKGTI---IPLDDMVHRSFFFGPSEMAAIRR-----LVPA---HFHRS-TTSE 
CmAAT3   213 EYDEVVDTKGTI---IPLDDMAHRSFFFGPSEISAIRK-----ALPS---HLRQCSS-FE 
BEBT     216 EYEEVKGT--IF---TPFDDLAHRSFFFGSTEISAMRK-----QIPP---HLRSCSTTIE 
BEAT     194 -VLNIPPP-----PSFEGVKFVSKRFVFHENALTRLRKEATEEDGDGDDDQKKKRPSRVD 
CmAAT4   217 NDKAVVPP-----SSIFNRKRRFQRFVFRSEAILDLKAKAKSC--------DIPNPTCVE 
RhAAT    204 -YVAMMER-----MWFGEKKVVTRRFVFDAKAISALQDEGKSE--------YVPKPSRVQ 
SAAT     205 -YVDQMEA-----LWFAGKKVATRRFVFGVKAISSIQDEAKSE--------SVPKPSRVH 
VAAT     205 -YARQMEG-----LWFVGKKVATRRFVFGAKAISVIQDEAKSE--------SVPKPSRVQ 
 
 
AeAAT    262 VLSGHIWRSWARSLNLP-----AKQVLKLLFSINIRNRVK----PSLPAGYYGNAFVLGC 
Ban-AAT  242 VAIANLWQSRTRAINLD-----PGVDVHVCFFANTRHLLRQVVLLPPEDGYYGNCFYPVT 
MpAAT1   266 LITACLWKCRTLALNIN-----PKEAVRVSCIVNARGKHNN---VRLPLGYYGNAFAFPA 
AcAAT    265 VLTACLWRCRTCALGLD-----PPKTVRISCAANGRGKHD----LHVPRGYYGNVFAFPA 
CmAAT1   259 VLTAYVWRLRTIALQFK-----PEEEVRFLCVMNLRSKID----I--PLGYYGNAVVVPA 
CmAAT2   266 VLAAYVWRLRTIAFQLK-----PEEEVRFLCVVNLRSKID----I--PLGFYGNAIVFPA 
VpAAT    264 VLTAYLWRCYTIALQPD-----PEEEMRVICVVNSRTKLN----PPLPTGFYGNGIAFPA 
CmAAT3   261 VLTACLWRFRTISLQPD-----PEEEVRVLCIVNSRSKFN----PPLPTGYYGNAFAFPV 
BEBT     263 VLTACLWRCRTLAIKPN-----PDEEVRMICIVNARSKFN----PPLPDGYYGNAFAIPA 
BEAT     248 LVTAFLSKSLIEMDCAPK-ELTKSRPSLMVHMMNLRKRTKL---ALE-NDVSGNFFIVVN 
CmAAT4   264 TLTCFIWKYLMKVADDGD----SQRPSTLSHVVNIRKML-E---PSLGEVSLGNIMWGTV 
RhAAT    250 ALTGFLWKHQLAASRALSSGT-STRFSVASQTVNLRSKMNM---KTTLDNAIGNIFLWAS 
SAAT     251 AVTGFLWKHLIAASRALTSGTTSTRLSIAAQAVNLRTRMNM---ETVLDNATGNLFWWAQ 
VAAT     251 AVTSFLWKHLIATSRALTSGTTSTRLSIATQVVNIRSRRNM---ETVWDNAIGNLIWFAP 
 
 
AeAAT    313 AQ----TSVKDLTEKGLGYCADLVRGAKERVGDEYAREVVESVSWP-------------R 
Ban-AAT  297 AT----APSGRIASAELIDVVSIIRDAKSRLPGEFAKWAAGDFKDD-------------P 
MpAAT1   318 AI----SKAEPLCKNPLGYALELVKKAKATMNEEYLRSVADLLVLR-------------G 
AcAAT    316 VV----SRAGMISTSSLEYTVEEVKKAKARMTGEYLRSVADLMVTK-------------G 
CmAAT1   308 VI----TTAAKLCGNPLGYAVDLIRKAKAKATMEYIKSTVDLMVIK-------------G 
CmAAT2   315 VI----TTVAKLCGNPLGYAVDLIRKAKAKATKEYIKSMVDFMVIK-------------G 
VpAAT    315 AI----SQAKKICENPFGYTLQLVKQTKVDVTEEYMRSAADLMAMK-------------G 
CmAAT3   312 AL----TTAGKLCQNPLGYALELVRKAKADVTEDYMKSVADLMVIK-------------G 
BEBT     314 AV----TTAGKLCNNPLGFALELIRKAKREVTEEYMHSVADLMVAT-------------G 
BEAT     303 AESK-ITVAPKITDL---------TESLGSACGEIISEVAKVDDAEVVSSMVLNSVREFY 
CmAAT4   316 AHHFSTTRNEEFEGLELSKLVSLLRQSFKKINKDYIKELIMGGDKE-RRNGVMKLVGE-I 
RhAAT    306 ARLDLNDTAPGSSDLKLCDLVNLLNESIKEFNSDYLEILKGKEGYG-GMCDLLDFMEEGS 
SAAT     308 AILELSHTTPEISDLKLCDLVNLLNGSVKQCNGDYFETFKGKEGYG-RMCEYLDFQRTMS 
VAAT     308 AILELSHTTLEISDLKLCDLVNLLNGSVKQCNGDYFETFMGKEGYG-SMCEYLDFQRTMS 
 
 
AeAAT    356 RASPDSVGVLI-ISQWSRLGLDRVDFGLGRP--VQVGPICC--------DRYCLFLPVR- 
Ban-AAT  340 Y-ELSFTYNSLFVSDWTRLGFLDVDYGWGKPLHVIPFAYLDIMAVGIIG------APPA- 
MpAAT1   361 RPQYSSTGSYLIVSDNTRVGFGDVNFGWGQ--PVFAGPV--KA-----LDLISFYVQHKN 
AcAAT    359 RPLYTVAGNYI-VSDTTRVGFDAIDFGWGK--PVYGGPA--RA-----FPLISFYARFKN 
CmAAT1   351 RPYFTVVGSFM-MSDLTRIGVENVDFGWGK--AIFGGPT--TTGARITRGLVSFCVPFMN 
CmAAT2   358 RPRFTEIGPFM-MSDITRIGFENVDFGWGK--AIFGGPI--IGGCGIIRGMISYSIAFMN 
VpAAT    358 RPHFTVVRRYM-VSDVTRAGFGLVDFGWGRPEPVYGGPA--KGGVGPIPGVTSFFVPFKN 
CmAAT3   355 RPHFTVVRTYL-VSDVTRAGFEDVDFGWGK--AMYGGPA--KGGVGAIPGVASFYIPFKN 
BEBT     357 RPHFTVVNTYL-VSDVTRAGFGEVDFGWGE--AVYGGPA--KGGVGVIPGVTSFYIPLRN 
BEAT     353 YEWGKGEKNVFVYSSWCRFPLYEVDFGWGIPSLV--DTT------AFP---FGLIVLMDE 
CmAAT4   374 NKWP--ISNYYFFTSWKNLKLNEVDFGWGKPLWS--AIA------GDPNEMMGNIIVLVD 
RhAAT    365 FVEP--APEFYSFSSWTRF-FDQVDFGWGRPSWV--GFS------GRVETR--NFTIFVE 
SAAT     367 SMEP--APDIYLFSSWTNF-FNPLDFGWGRTSWI--GVA------GKIESASCKFIILVP 
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VAAT     367 SMEP--APEIYLFTSWTNF-FNQLDFGWGRTSWI--GVA------GKIESAFCNLTTLVP 
 
AeAAT    404 -D-RTESVKVMVAVPTSAVDRYEYFIRSPYS----------------------------- 
Ban-AAT  392 -P-QKGTRVMAQCVEKEHMQAFLEEMKGFA------------------------------ 
MpAAT1   412 -N-TEDGILVPMCLPSSAMERFQQELERITQEPKE-DICN-----NLRSTSQ-------- 
AcAAT    409 NR-GEDGTVVLICLPEAAMKRFQDELKKMTEEH--VDGPFEYKLIKVMSKL--------- 
CmAAT1   406 RN-GEKGTALSLCLPPPAMERFRANVHASLQVKQVVDAVDSHMQ-TIQSASK-------- 
CmAAT2   413 RN-GEKGIVVPLCLPPPAMERFRANVHASLQVIQVLDKVDRDMQ-TILSAL--------- 
VpAAT    415 RK-GEKGIVVPTCLPTPAMERFAKLMNEILQNQLLVSAE-ENKSVFIVSAI--------- 
CmAAT3   410 KK-GERGILVPLCLPAPAMERFVKELDALLKAGKTIDGVDNKKPLFIASAL--------- 
BEBT     412 RQ-GEKGIVLPICLPSAAMEIFAEALNNTLNGKE-IEIAK----HFTQSSL--------- 
BEAT     402 APAGDG-IAVRACLSEHDMIQFQQHHQ-------LLSYVS-------------------- 
CmAAT4   424 NVLDDGSTEAWILLDEKEMQLLEQIPQ-------FLEFALLNPSINLPHNQKTADEIFSN 
RhAAT    412 TQCDDG-IDAWVTVDEKQMAMLEQDPQ-------FLAFASPNPRISIASSVGMD------ 
SAAT     416 TQCGSG-IEAWVNLEEEKMAMLEQDPH-------FLALASPKTLI--------------- 
VAAT     416 TPCDTG-IEAWVNLEEEKMAMLEQDPQ-------FLALASPKTLISRY------------ 
 
 
AeAAT        --- 
Ban-AAT      --- 
MpAAT1       --- 
AcAAT        --- 
CmAAT1       --- 
CmAAT2       --- 
VpAAT        --- 
CmAAT3       --- 
BEBT         --- 
BEAT         --- 
CmAAT4   477 KLI 
RhAAT        --- 
SAAT         --- 
VAAT         --- 
 
Supplementary Figure  7 Amino acid sequence alignment of fruit or flower derived AAT enzymes 
from a number of different plant species. Sequences correspond to Genbank accession numbers: Ae 
(Actinidia eriantha) AAT (HO772637); Ban (Musa sapientum) AAT (AW025506); Mp (Malus 
pumila) AAT (AY707098); Ac (Actinidia chinensis) AAT (HO772640); Cm (Cucumis melo) AAT1 
(CAA94432), AAT2 (AAL77060), AAT3 (AAW51125), AAT4 (AWW51126); Vp (Vasconcellea 
pubescens) AAT (FJ548611); Cb (Clarkia breweri) BEBT (AAN09796), BEAT (AAF04787); Rh 
(Rosa hybrid) AAT (AAW31948); Fa (Fragaria x ananassa) SAAT (AAG13130); Fv (Fragaria 
vesca) VAAT (AAN07090). Sequences were aligned using Clustal Omega and BoxShade. Residues 







Supplementary Figure  8 Plasmid map of pMIB13 modified from Alonso-Gutierrez et al., (2013) 
with the substitution of a terminal limonene synthase (LS) gene for a geraniol synthase gene (GES). 
Map shows the location of the original KpnI and BamHI restriction sites, as well as the newly 




Supplementary Figure  9 Wild type C43 (DE3) E. coli exogenously fed either geraniol (A) or 
geranyl acetate (B). Geraniol was exogenously fed into cultures to a final concentration of 0 mM, 0.5 
mM, 1 mM, or 2 mM; while geranyl acetate was fed into cultures to a final concentration of 0 mM, 1 
mM, 10 mM, or 50 mM. Cultures were grown at 37℃ and 250 rpm, and the OD600 was taken every 
30 minutes until stationary phase was reached. Geraniol or geranyl acetate was fed 1.5 hours after 
first reading. Data are the mean ± standard deviation from three biological replicates. 
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A – Primary investigations of into the viability of producing 
commercially valuable butyl esters in clostridial species C. 





Clostridia are a diverse spore-forming gram positive genus of bacteria that are typically strict 
anaerobes; over the last two centuries they have been employed in a number of biotechnological 
processes – including the industrial production of secreted toxins for therapeutics and 
pharmacological agents from such species as C. perfringens, C. botulinum and C. tetani species, 
cancer therapy agents from C. histolyticum and C. oncolyticum, as well as alcohols and organic 
acids for use as biofuels and commercial product additives from C. acetobutylicum and C. 
beijerinckii (Jones and Woods, 1986; Schlechte and Elbe, 1988; Rood et al., 1997; Gheshlaghi 
et al., 2009).  
The latter solventogenic species were first exploited for their fermentation of alcohols and acids 
during World War I as the acetone they produced was used for cordite manufacturing (Lütke-
Eversloh and Bahl, 2011; Sauer, 2016). These clostridia naturally produce acetone, butanol and 
ethanol in a ratio of 3:6:1 through a process known as ABE (acetone-butanol-ethanol) 
fermentation (Figure A.1). A distinguishing characteristic of this clostridial solvent production is 
that it is a biphasic fermentation. The first phase is termed the ‘acidogenic’ phase, which occurs 
during exponential growth and involves the production and secretion of acetate, butyrate, carbon 
dioxide and hydrogen as the major products (Grupe et al., 1992; Amador-Noguez et la., 2011). 
The second phase is termed the ‘solventogenic’ phase, which is believed to be in-part initiated 
by the drop in culture pH and involves a halt to culture growth and the re-assimilation of the 
previously made acids for use as co-substrates for the synthesis of the major products, acetone, 





Figure A. 1 ABE fermentation pathway from C. acetobutylicum. Reactions leading towards n-
butanol production are in black, while reactions leading to acetone and ethanol production are in dark 
grey. The acidogenesis reactions leading towards acetate and butyrate production are in light grey. 
Enzymes responsible for each reaction are indicated by italic letters next to each arrow.  
 
 
Utilization of the second solventogenic phase of clostridial ABE fermentation for the purpose of 
n-butanol (normal butanol) production became popular after the war, as it was used to produce 
lacquers for the automobile industry (Sauer, 2016). In more recent years, much interest has 
developed in exploiting butanol as a renewable fuel alternative to gasoline; with it having been 
described as a superior biofuel compared to the more traditionally used bio-ethanol (Dürre, 
2007; Ezeji et al., 2007; Papoutsakis, 2008). Additionally, butanol has become an important 
intermediate in a number of chemical industries; notably it is used for making amino resins, 
plastics and polymers, lubricants, and specialty solvents for multiple commercial preparations 
(Lee et al., 2008; Lütke-Eversloh and Bahl, 2011). Butanol’s multiple commercial applications, 
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as well as the general growing interest in naturally sourced chemicals and fuels, has powered the 
development of clostridia as a production platform for butanol in biotechnology over the last 
few decades. Thus far, clostridial strain development has focused on optimizing fermentation 
techniques and downstream processing to maximize butanol production, as well as rational 
metabolic engineering strategies to minimize side product formation and also to improve upon 
solvent toxicity. The latter strategy, involving molecular manipulation, has grown in popularity 
in recent years as the portfolio of genetic tools available to clostridial species continues to grow 
(Ezeji et al., 2004; Papoutsakis, 2008; Lütke-Eversloh and Bahl, 2011; Zue et al., 2012; 
Branduardi et al., 2014).  
The microbial production of butanol derivatives for commercial products generally involves the 
extraction of butanol produced via ABE fermentation, followed by downstream chemistry to 
make such compounds as: butyl glycol ethers, butyl acrylates, butyl esters, 1-butene, etc. for a 
number of commercial applications (see above; http://www.greenbiologics.com). However, in 
recent years, as the genetic toolbox available to clostridial species has improved, interest in 
engineering strains for the production of these butanol derivative in vivo has become an 
attractive and lower cost option to the biotech industry. Butyl esters, specifically, have many 
commercial applications, including use as additives for flavour and fragrance products, 
cosmetics, and food, and as emulsifiers, emollients, and lubricants (Burdock, 1997; Rieger and 
Rhein, 1997; Schrader et al., 2004; Winter, 2009). clostridia do not naturally produce butyl 
esters as an end-product, and to engineer a strain to do so would involve heterologous 
expression of an alcohol acyltransferase (AAT), which is an enzyme responsible for catalysing 
the esterification of a volatile alcohol to an acyl-CoA moiety to produce an ester (Salas, 2004; 
Souleyer et al., 2005). AAT enzymes, which are generally found in plants, are responsible for 
synthesizing the ester compounds present in fruit and flower aroma. These enzymes display 
distinct substrate specificity for a number of alcohol and acyl-CoA substrates which varies 
depending on the enzyme in question (Olías et al., 2002; El-Sharkawy et al., 2005). Engineering 
clostridia for the production of esters has been attempted previously by several groups for 
acetate and butyrate esters (Horton et al., 2003; Horton et al., 2005; Van Den Berg et al., 2013). 
This was first attempted for isoamyl acetate production in C. acetobutylicum by heterologous 
expression of the acetyltransferase 2 (ATF2) enzyme from S. cerevisiae. However even with 
excess substrate feeding, titres remained negligible (Horton et al., 2003). In addition, significant 
degradation of isoamyl acetate was observed in culture feeding experiments, suggesting that this 
ester is being enzymatically broken down by endogenous esterase enzymes – a factor which may 
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be influencing the low product yields observed. More recent attempts at ester production – 
including butyl butyrate – in clostridia have also been met with low product titres, though no 
published work has further investigated the possibility of enzymatic breakdown of these 
products (Horton et al., 2005; Van Den Berg et al., 2013). To date, there is no available 
information on the prevalence of endogenous esterase or lipase enzymes capable of hydrolysing 
esters in solventogenic strains of clostridia.         
In this work, the feasibility of using solventogenic clostridia as platform organisms for the 
production of commercially valuable butyl esters was investigated. To do this, three aims were 
outlined: (1) to investigate the potential microbial toxicity of a number of high value butyl and 
dibutyl esters (Table A.2) in two solventogenic clostridial species: C. 
saccharoperbutylacetonicum and C. acetobutylicum, (2) identify and characterise the chain-
length substrate specificity of a number of putative esterases/lipases from each clostridial 
species, and (3) to determine whether or not any of our desired end-product esters are 
hydrolysed in culture. 
 
 
Table A. 1 List of the butyl and dibutyl esters investigated in this work for possible microbial 
toxicity in clostridial strains C. acetobutylicum and C. saccharoperbutylacetonicum. Their chemical 
structure and commercial applications are listed above. 

















































































A.2.1 Investigation of butyl and dibutyl ester toxicity in cultures of Clostridium 
acetobutylicum and C. saccharoperbutylacetonicum 
 
To identify feasible butyl ester end-product for these clostridial production platforms the 
microbial toxicity of 10 commercially valuable potential ester candidates was first assessed. 
This was done as ideally our end-product(s) would have low to no toxicity in culture. These 
candidates included butyl and dibutyl esters that ranged both in acid chain length and saturation 
(Table A.1). To assess the toxicity of these candidates, cultures of C. 
saccharoperbutylacetonicum and C. acetobutylicum were exposed to a range of incrementally 
higher concentrations of a given ester and the effect on culture growth observed over the course 
of eight hours compared to a control with no added ester. This was done using the OD600 as an 
indicator of culture health. Figures A.2 and A.3 show the results of these toxicity tests for C. 
saccharoperbutylacetonicum and C. acetobutylicum, respectively. From these growth curves, it 
can be seen that the patterns of toxicity are very similar between both clostridial strains, with the 
general trend being that butyl ester toxicity decreases as the chain length of the ester increases. 
The less polar longer chain esters such as butyl laurate, -stearate, -oleate, and dibutyl sebacate, 
exhibited no significant effect on growth rate compared to the wild type even at concentration 
up to 100 mM in culture (approximately 3-4% v/v in culture). Conversely, the shorter chain 
esters such as butyl acetate, -acrylate, and -butyrate, as well as the more polar long-chain esters 
dibutyl maleate and -succinate, displayed toxic effects beyond concentrations of 10 mM in 
culture (approximately 0.13-0.2% v/v in culture), with C. saccharoperbutylacetonicum being 
more susceptible than C. acetobutylicum at these lower concentrations. This is a general trend 
that has also been observed in E. coli and S. cerevisiae in work previously done by the Leak 
group (see chapter 3), and can be most likely attributed to the amphiphilic nature of these more 
polar esters. While the exact mode by which these compounds work to disrupt cell function is 
unknown, it has been hypothesized that it involves their incorporation with membrane lipids and 
subsequent disruption of essential function, and/or denaturation of crucial enzymes (Inoue et al., 
1991; Isken et al., 1998; Mukhopadhyay, 2015). Often the LogP(ow) value, which is the logarithm 
of thepartition coefficient of a compound between octanol and water, is a good predictor of a 
compound’s s microbial toxicity, with values lower than 3.4-3.8 predicting high cellular toxicity 
(Inoue et al., 1991). The results obtained here correlate with this LogP(ow) toxicity prediction as 
we observed that butyl acetate, -acrylate, -butyrate, dibutyl maleate, and dibutyl succinate – 
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which all have LogP(ow) values near or below 3 – exhibited high microbial toxicity, while all 
other esters tested – which have LogP(ow) values above 4 – exhibitted low microbial toxicity 
(Table A.2). Interestingly, butyl lactate, which hass a LogP(ow) value of 1.16, was well tolerated 
by both clostridial strains, and only began to cause a notable reduction in growth rate when 
present at a concentration of 50 mM in culture. This higher microbial tolerance for butyl lactate 
compared to other short chain butyl esters has also been observed in E. coli (data not shown). 
An explanation for this may be that its higher aqueous solubility compared to the other butyl 
esters investigated in this work, it is less likely to interact with and disrupt membrane function.  
Ultimately, the toxicity tests done in this work suggest that nonpolar medium/long chain butyl 
esters are the best candidates as end-products for this clostridial production platform in terms of 
host tolerance.  However, further considerations need to be made, including the availability of 
an AAT enzyme that possesses the requisite substrate specificity to make these compounds, and 
the absence of any endogenous mechanisms capable of breaking down the end-product ester to 
its alcohol and acid components. While these butyl esters possess intrinsic toxicity, the impact 
on growth rate observed in this work does not differentiate between inherent toxicity and 
toxicity that may arise from the alcohol and acid by-products that result from possible ester 





Figure A. 2 Growth of wild type C. acetobutylicum exposed to varying concentrations of A butyl 
acetate, B butyl acrylate C butyl lactate, D butyl laurate, E dibutyl succinate, F butyl stearate, G 
dibutyl maleate, H dibutyl sebacate. Cultures were grown at 32℃ and 250 rpm and the OD600 
readings were taken every 90 minutes for 8 hours. Ester feeding was done 1.5 hours after first 






Figure A. 3 Growth of wild type C. saccharoperbutylacetonicum exposed to varying concentrations 
of A butyl acetate, B butyl acrylate, and C butyl butyrate, D butyl lactate, E butyl laurate, F dibutyl 
succinate, G butyl stearate, H dibutyl maleate, I dibutyl sebacate. Cultures were grown at 32℃ and 
250 rpm and the OD600 readings were taken every 90 minutes for 8 hours. Ester feeding was done 1.5 




Table A. 2 List of butyl and dibutyl esters and their respective LogP(ow) values. 
Ester LogP(ow)a 
Butyl acetate 1.82 
Butyl acrylate 2.36 
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Butyl butyrate 2.68 
Butyl lactate 1.16 
Butyl laurate 6.51 
Butyl stearate 8.82 
Butyl oleate 8.68 
Dibutyl succinate 2.88 
Dibutyl maleate 3.12 
Dibutyl sebacate 5.97 




A.2.2 Identification and characterization of putative esterases/lipases in C. 
saccharoperbutylacetonicum and C. acetobutylicum 
 
In addition to the innate microbial toxicity these butyl esters may exhibit, an additional concern 
when developing a clostridial platform for the production for these compounds is their potential 
in situ hydrolysis by endogenous enzymes. Not only could butyl ester hydrolysis possibly result 
in increased culture toxicity due to the accumulation of breakdown products, but it could also 
result in end-product loss. Hydrolysis may occur either spontaneously or enzymatically; the 
latter could be addressed in a microbial system by identifying and potentially knocking 
out/down this activity. Hydrolysis of carboxylic acid esters is typically carried out by two 
classes of enzyme; either an esterase or a lipase. These two enzyme classes can be differentiated 
based on their substrate specificity, whereas esterases preferentially hydrolyse water soluble 
short-chain esters (≤C8), lipases possess a much broader substrate range that is dictated 
primarily by substrate solubility (Fojan et al., 2000). As such, lipases generally hydrolyse long-
chain esters (≥C8) and triglycerides that display low aqueous solubility, however they can also 
have activity for short chain esters should their concentration in solution exceed their solubility. 
Both carboxyl esterases and lipases, however, generally display quite promiscuous substrate 
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specificity, which can extend beyond carboxyl esters, making it difficult to classify putative 
hydrolases based on substrate specificity alone (Fojan et al., 2000; Bornscheuer et al., 2002; 
Chahinian and Sarda 2009; Glogauer et al., 2011). Thus, categorising these enzymes also relies 
heavily on sequence analysis and the identification of specific conserved features that are unique 
to esterases/lipases, although this can be challenging in its own right as these enzymes generally 
display enormous sequence diversity (Martinez-Martinez et al., 2013). However, the majority of 
them do possess common features, such as the conserved consensus sequence motifs: G-X-S-X-
G (where X may represent any amino acid) which is present in the majority of carboxyl 
esterases and lipases, or G-D-S-L which is present in some as well (Arpigny and Jaeger, 1999; 
Bornscheuer et al., 2002; Chepyshko et al., 2012). To date, no carboxyl esterases or lipases have 
been characterized from any solventogenic species of clostridia. Recently, however, the 
genomes of both C. acetobutylicum or C. saccharoperbutylacetonicum have been sequenced, 
which facilitated our search for potential candidates in each strain. To do so a number of 
enzymes were identified that had been categorised as ester hydrolases in the NCBI (National 
Center for Biotechnology Information) database, and then analysed for the presence of 
identifying conserved features. From this, six putative esterases/lipases were identified from C. 
saccharoperbutylacetonicum, and three from C. acetobutylicum that were probably active 
towards carboxyl esters. These proteins have been annotated in this work as: Cs2848, Cs4859, 
Cs5680, Cs2944, Cs2130, Cs5781, Ca2917, Ca1962, and CaLipG, with the first two letters 
representing the host strain. Each putative esterase/lipase has a G-X-S-X-G consensus sequence, 
with the exception of Cs5680, which had been predicted to be an ester hydrolase regardless of it 
lacking this identifying consensus sequences. Table A.3 shows the primary sequence length of 
each of the nine proteins, as well as their respective consensus sequence. It is evident that the 
length of each putative ester hydrolase is quite variable. Additionally, the amino acid sequence 
identity between each protein was quite low – with a range between 11.6% to 28.6% identity 
between these nine enzymes (data not shown). This variability of sequence length and sequence 





Table A. 3 List of putative esterases/lipases from C. saccharoperbutylacetonicum and C. 
acetobutylicum. The length of each gene sequence, and the amino acid residues that constitute the 
consensus sequence for each esterase/lipase are indicated. 
Gene Length (aa) Consensus sequence 
(G-X-S-X-G) 
C. saccharoperbutylacetonicum   
Cs2848 244 GHSMG 
Cs4859 511 GQSAG 
Cs5680 241 - 
Cs2944 379 GTSAG 
Cs2130 314 GDSAG 
Cs5781 264 GYSMG 
C. acetobutylicum   
Ca2917 273 GFSAG 
Ca1962 243 GYSLG 




Figure A. 4 A 1% agarose gel electrophoresis showing the restriction digest of each of the cloned 
constructs containing genes encoding putative esterases/lipases from either C. 
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saccharoperbutylacetonicum or C. acetobutylicum. Digestion was carried out using NdeI and 
BamHI. The size of the bands (in bp) is indicated to the left of the ladder.  
 
 
Each gene was amplified from the genomic DNA of either C. acetobutylicum or C. 
saccharoperbutylacetonicum with gene specific primers that contained NdeI and XhoI restriction 
sites – on the forward and reverse primers, respectively – to insert each gene into the multiple 
cloning site (MCS) upstream of a 6xHis tag, under the control of the strong rhamnose inducible 
promoter in the E. coli expression vector pJOE2792. Figure A.4 shows the electrophoretogram 
of the fragments from a restriction digestion of each successfully cloned construct. 
Subsequently, each putative esterase/lipase was expressed in E. coli and the enzyme was 
purified using a cobalt resin for in vitro activity assays to determine substrate specificity and 
chain length preference. The activity assay used in this work was a colorimetric assay using p-
nitrophenol esters of increasing acid chain length from C2:0-C14:0 as the substrate. This was 
designed to determine whether any of these enzymes displayed hydrolytic activity and, if so, 
what their acyl chain length specificity was. From this information, their role as either an 
esterase or lipase could be deduced, narrowing down which of these enzymes could hydrolyse 
any of our desired end-product butyl ester. Initially, activity of each of these putative 
esterases/lipases was quantified for p-nitrophenol esters with acid chain lengths of C2:0, C4:0 
and C8:0, to identify potential esterase activity for shorter chain substrates. Table A.4 shows the 
kinetic data for each of the nine enzymes for these three substrates; here it can seen that each of 
the putative esterases/lipases displayed some degree hydrolysis activity, although their chain 
length substrate specificity varied. All of the putative hydrolases had activity towards the p-
nitrophenyl acetate (C2:0) and -butyrate (C4:0) substrates, with the exception of Cs2130, which 
was only able to hydrolyse p-nitrophenyl acetate chain with a relatively low affinity for this 
substrate when comparing its KM to that of the other enzymes. As an example of the data from 
which these kinetics were derived, figures A.5 and A.6 shows the Michaelis-Menton and Hanes-
Woolf plots for two of the putative esterases/lipases, Cs4859 and CaLIPG, for p-nitrophenyl 
acetate (A) and -butyrate (B) substrates. Interestingly, the majority of the putative carboxyl 
hydrolases either did not have activity for – or had low activity for – p-nitrophenyl octanoate 
(C8:0). However, as mentioned above, the majority of hydrolase enzymes display broad 
substrate range (Bornscheuer et al., 2002). This would suggest either that these enzymes are less 
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promiscuous than most of the members of this enzyme family, or that perhaps carboxyl esters 
are not their primary substrate. 
  
 
Table A. 4 In vitro activity of the putative esterase/lipase enzymes for the hydrolysis of p-
nitrophenol acetate, -butyrate, and -octanoate. Kinetic parameters were determined using a 
colorimetric assay.  Data are the mean ± standard error from two replicates. 
enzyme p-NP-acetate (C2) p-NP-butyrate (C4) p-NP-octanoate (C8) 
Cs2848 Vmaxa: 21.6 + 3.1 
KMb: 2.0 + 0.5 
Vmax: 17.4 + 2.7 
KM: 1.7 + 0.6 
NA 
Cs4859 Vmax: 129.5 + 7.1 
KM: 5.1x10-2 + 1.2x10-2 
Vmax: 187.8 + 65.6 
KM: 0.3 + 0.2 
Trace activity 
Cs5680 Vmax: 121.5 + 15.1 
KM: 7.1x10-2 + 2.0x10-3 
Vmax: 61.2 + 2.6 
KM: 2.7x10-3 + 4.5x10-3 
Vmax: 28.4 + 5.1 
KM: 1.8 + 0.5 
Cs2944 Vmax: 36.0 + 5.7 
KM: 2.85 + 0.7 
Vmax: 27.2 + 3.8 
KM: 1.6 + 0.4 
NA 
Cs2130 Vmax: 149.8 + 71.4 
KM: 7.2 + 5.5 
NA NA 
Cs5781 Vmax: 58.7 + 21.4 
KM: 8.3 + 4 
Vmax: 113.8 + 8.6 
KM: 1.3 + 0.23 
Vmax: 69.1 + 6.4 
KM: 3.6 x10-3 + 0.01 
Ca2917 Vmax: 53.3 + 3.4 
KM: 0.18 + 2.6x10-2 
Vmax: 14.1 + 1.2 
KM: 3.2 + 0.4 
Trace activity 
Ca1962 Vmax: 21.6 + 3.1 
KM: 2.0 + 0.5 
Vmax: 17.4 + 2.7 
KM: 1.7 + 0.6 
NA 
CaLipG Vmax: 9.1 + 0.8 
KM: 6.7x10-2 + 1.7x10-2 
Vmax: 28.8 + 1.4 
KM: 0.1 + 1.5x10-2 
NA 




Figure A. 5 Michaelis-Menton (left) and Hanes-Woolf (right) plots of C. 
saccharoperbutylacetonicum Cs4859 esterase activity using A p-nitrophenyl acetate and B p-
nitrophenyl butyrate as substrate. Assays were carried out at 25℃ and p-nitrophenol concentration 
was measured at 400 nm. [S] is shown in mM and rate in µmol/min/mg protein. 
 
Figure A. 6 Michaelis-Menton (left) and Hanes-Woolf (right) plots of C. acetobutylicum CaLIPG 
esterase activity using A p-nitrophenyl acetate and B p-nitrophenyl butyrate as substrate. Assays 
were carried out at 25℃ and 400 nm. [S] is shown in mM and rate in µmol/min/mg protein. 
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Those enzymes that did display quantifiable or trace activity for the octanoate chain substrate 
(Cs4859, Cs5680, Cs5781, and Ca2917) were further characterized for activity towards long-
chain p-nitrophenyl esters (C14:0 and C16:0) to determine whether or not their activities may 
classify them as lipases. Interestingly, CaLipG had not had activity for the longer octanoate 
chain, despite its annotated name suggesting it has lipase activity. Each of the four enzymes 
displayed some activity for hydrolysing both the p-nitrophenyl myristate or -palmitate substrates 
when exposed to a concentration of 500 µM (Table A.5). This suggests that these enzymes may 
be categorised as lipases rather than esterases as it is common for a lipase enzyme to display 
hydrolytic activity towards shorter chain substrates in addition to the longer chains – as observed 
in this work with these four enzymes (Chahinian and Sarda 2009).  
 
 
Table A. 5 Activity (µmol p-NP/mg/min) of putative lipases using 500 µM p-nitrophenyl myristate, 
and –palmitate. Data are the mean ± standard error from three replicates. 
 Specific Activity (µmol p-NP/mg/min) 
 p-NP-myristate (C14) p-NP-palmitate (C16) 
Cs4859 0.364 + 6.7x10-2 0.066 + 5.1x10-3 
Cs5680 0.427 + 2.3x10-2 0.126 + 6.8x10-3 
Cs5781 0.055 + 1.5x10-2 0.077 + 1.6x10-2 
Ca2917 0.101 + 3.9x10-2 0.254 + 6.7x10-3 
 
 
Of the nine enzymes investigated here, all displayed some carboxyl ester hydrolytic activity, 
with the majority preferentially hydrolysing shorter chain esters of chain length C2:0 and C4:0. 
Generally, hydrolases such as esterases and lipases display broad substrate specificity as they are 
involved in a wide spectrum of biocatalysed processes (Busto et al., 2010), which does not 
correlate with the relatively narrow range of activity seen here for these putative carboxyl 
esterases/lipases. Possible explanations for these discrepancies may be:  
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a) That these enzymes are a different class of hydrolase that possesses some activity towards 
carboxyl esters when the substrate present at high concentrations, such as in an in vitro 
environment.  
b) That these enzymes display a substrate specificity that has not been looked at in this work, 
such as preferred activity towards saturated or branched acyl chains.  
c) That the assay used is not representative enough of the enzyme’s true cellular substrate. While 
p-nitrophenyl esters provide an excellent tool for quick and high throughput assessment of 
hydrolytic activity, they are structurally distinct from the true carboxyl ester substrates found in 
the cell. The broad substrate specificities of Cs4859, Cs5680, Cs5781, and Ca2917, however, 
was more akin to true carboxyl esterase/lipase activity, and as such, these enzymes would be the 
most probable candidates responsible for any detrimental butyl ester hydrolysis in a clostridial 
system of the nine enzymes examined here.  
 
 
A.2.3 Investigation of in vivo hydrolysis of fed butyl and dibutyl esters in cultures 
of C. saccharoperbutylacetonicum and C. acetobutylicum  
 
To determine whether or not there is any in vivo hydrolysis of our desired end-product butyl 
esters in either clostridial strain, the culture supernatant of both C. saccharoperbutylacetonicum 
and C. acetobutylicum was extracted and analysed after 8 hours of incubation in the presence of 
10 mM of an exogenously fed butyl ester. This was done to investigate whether after 
internalisation of a given butyl ester, it was being hydrolysed by internal clostridial enzymes, 
followed by secretion of the resulting alcohol and acid into the culture supernatant. The culture 
supernatant was analysed as the fatty acids and alcohols should readily diffuse out of bacterial 
cells (Liu et al., 2012; Wen et al., 2016). What was observed when examining the supernatant 
fatty acids was the presence of stearic acid (C18:0) in cultures of both clostridial strains grown 
in the presence of butyl stearate, as well as a small amount of lauric acid (C12:0) in cultures of 
C. saccharoperbutylacetonicum grown in the presence of butyl laurate. Hydrolysis products 
were not observed in cultures exposed to any of the other butyl esters examined, nor in the wild 
type controls for each strain (Figure A.7). This suggests that that both strains most likely contain 
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a lipase(s) with substrate specificity for hydrolysing long chain saturated esters such as butyl 
stearate and –laurate, as was observed in culture, but not unsaturated esters such as butyl oleate 
(C18:1), which possesses a double bond. Previously, nine potential esterases/lipases from C. 
saccharoperbutylacetonicum and C. acetobutylicum were identified, four of which demonstrated 
activity towards longer chain ester (Cs4859, Cs5680, Cs5781, and Ca2917), making them 
potential candidates for this in vivo hydrolysis. While in vitro, these four enzymes were also able 
to hydrolyse short chain esters, the lack of observed in vivo hydrolysis of these substrates is not 
wholly unexpected as lipases are able to work on shorter chain substrates only when present in 
excess – as is most likely not the case here. An additional possibility is that the observed 
hydrolysis of butyl laurate and -stearate in culture is being carried out by a yet uncharacterised 
enzyme. To further determine whether or not one of the nine esterase/lipases identified in this 
work is responsible for the observed hydrolysis we could further examine the transcript levels of 
each enzyme in cultures that are grown in the presence of either butyl laurate or -stearate. It may 
be the case that the presence of these butyl esters results in the upregulation of the responsible 
lipase(s) genes, resulting in increased hydrolysis. Interestingly, while both butyl laurate and -




Figure A. 7 Quantification of lauric acid (C12:0) and stearic acid (C18:0) found in the supernatant of 
cultures of C. saccharoperbutylacetonicum and C. acetobutylicum grown in the presence of 
exogenously fed butyl laurate and butyl stearate, respectively. 
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high at 100mM. While this low toxicity may be a true reflection of clostridia’s tolerance for 
these esters and their breakdown products, an alternative explanation for this could be that due 
to their size, these butyl esters are not able to pass across the cell membranes into the cell, and 
instead, are being broken down by extracellular lipase activity. Should this be the case, the 
inability to cross the cell membranes would be an undesirable quality of our end point ester 
product as it would increase the costs of product extraction from the culture. A possible strategy 
to investigate whether or not these esters are able to move across the membrane would be to 
heterologously express an internal lipase in cultures fed long chain butyl esters – as was done in 
chapter 3. Should the esters be internalized, they will be hydrolysed by the lipase and the 





Ultimately, the results obtained from this work would suggest that clostridia would make a good 
platform for the production of commercially valuable medium chain butyl esters such as dibutyl 
maleate, dibutyl succinate, to some extent butyl laurate, as well as other medium chain esters not 
yet investigated. The reason for this is that these medium chain butyl esters display low 
microbial toxicity in cultures of solventogenic clostridia when present in high concentrations, 
and also are minimally hydrolysed in culture. Additionally, previous work done in chapter 3 
demonstrated that medium chain butyl esters, such as butyl octanoate and decanoate, are able to 
pass across the cell membranes in E. coli to the extracellular milieu, which may be the same for 
clostridia. Therefore, this would indicate that medium chain butyl esters strike a happy balance 
between low culture toxicity, ability to pass across the cell membranes for ease of downstream 
recovery, and minimal enzymatic hydrolysis by esterase/lipase activity. The next key step in 
developing solventogenic clostridia as a platform for butyl ester production would be to identify 
alcohol acyltransferase (AAT) enzymes capable of producing these desired end products and 
expressing them in a solventogenic strain of clostridia. 
 
